data_1iry_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iry _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 13' ' ' LEU . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HB3' ' CB ' ' A' ' 32' ' ' TRP . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 103' ' ' PRO . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.709 0.29 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.534 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.531 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG13 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.454 ' CD2' ' CG ' ' A' ' 69' ' ' GLN . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.46 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.564 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.429 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.581 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.581 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.411 ' CE1' HG23 ' A' ' 71' ' ' VAL . 22.8 t-80 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE1' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.552 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 16' ' ' GLN . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.7 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.687 0.279 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 45' ' ' ILE . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.569 ' CD1' HG11 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 53' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 2.5 t-80 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.492 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' THR . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.61 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.61 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.432 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.425 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 36.0 m170 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 70' ' ' ILE . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.438 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' CG ' ' A' ' 134' ' ' HIS . 5.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.573 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' HG11 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.573 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HG13 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HG2' ' CE1' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.447 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' THR . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.433 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.433 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.469 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CE1' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.417 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 2.2 t60 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.46 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.406 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 13' ' ' LEU . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 32' ' ' TRP . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.544 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.544 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.446 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 95' ' ' PRO . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.461 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 72' ' ' PHE . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' CB ' HD11 ' A' ' 13' ' ' LEU . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.514 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.51 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 116' ' ' MET . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HG2' HD13 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.616 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.554 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD12 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 12.3 m170 -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 145' ' ' ILE . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.44 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.542 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.526 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLN . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.54 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.424 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 66' ' ' LYS . 10.6 t-160 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.524 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.446 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.462 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.535 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.637 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.565 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 145' ' ' ILE . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.446 ' HG2' ' CD1' ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 43' ' ' GLU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 72' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.462 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' THR . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.456 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.437 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.652 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.488 ' HD2' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.425 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.427 HD12 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.459 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 5.8 tp-100 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.563 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 122' ' ' TYR . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.443 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.751 0.31 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.493 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG11 ' HG3' ' A' ' 43' ' ' GLU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.472 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' THR . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.433 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 32.9 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HB2' HD12 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.442 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.419 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.427 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.507 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.507 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CE1' ' CD1' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.448 ' CG ' HD12 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 5.9 tp60 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.443 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.451 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.521 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.453 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.489 ' HE3' ' CZ2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.568 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CZ2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.505 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.556 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.493 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.493 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.413 ' NE2' ' CG ' ' A' ' 69' ' ' GLN . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.483 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.44 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.452 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.538 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.551 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.511 ' CD2' ' CE1' ' A' ' 137' ' ' PHE . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.551 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.604 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.413 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.405 ' CG ' ' OH ' ' A' ' 122' ' ' TYR . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.478 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' CE1' ' A' ' 124' ' ' PHE . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' C ' ' H ' ' A' ' 16' ' ' GLN . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.432 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' A' ' 112' ' ' PRO . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 HD22 ' A' ' 6' ' ' LEU . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG22 ' CD1' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.446 ' OG1' ' CD ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.473 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.475 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 19.4 m170 -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 145' ' ' ILE . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.442 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.522 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 HG12 ' A' ' 45' ' ' ILE . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.578 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 43' ' ' GLU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG3' HG11 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 45' ' ' ILE . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 133' ' ' PHE . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.501 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' THR . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.435 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.491 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 148' ' ' TYR . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.577 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.53 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CE1' ' CD1' ' A' ' 72' ' ' PHE . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.417 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.53 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' GLN . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.441 ' HB ' HD13 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.533 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG12 ' HG3' ' A' ' 43' ' ' GLU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD1' HG12 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG13 HD21 ' A' ' 53' ' ' LEU . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 84' ' ' HIS . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-160 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 60' ' ' THR . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.455 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.522 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.651 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.651 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.606 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' GLN . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.528 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 95' ' ' PRO . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 1.7 t-160 -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.505 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.505 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.552 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.501 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.451 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CD2' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.515 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.505 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.54 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.534 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 88' ' ' THR . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG22 ' CE1' ' A' ' 72' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 81' ' ' MET . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CG ' HG22 ' A' ' 45' ' ' ILE . 15.8 m170 -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.452 ' CG2' ' CG2' ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' THR . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.446 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.451 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.427 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.558 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 148' ' ' TYR . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.558 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.497 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.459 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' CD1' ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.549 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 124' ' ' PHE . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.477 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.541 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 8' ' ' THR . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.5 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG12 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.489 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.431 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.431 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.422 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.577 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.439 ' CG ' ' CD2' ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' CD2' ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.583 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 35' ' ' PHE . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.697 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.508 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.715 0.293 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.508 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.583 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.476 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.419 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.428 ' CD1' HD12 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.509 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 69' ' ' GLN . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.519 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.541 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.544 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 16' ' ' GLN . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' HD12 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.487 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG23 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.491 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.409 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.606 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.664 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 12.1 tp60 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.459 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.457 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 134' ' ' HIS . 20.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.461 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.758 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.478 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.501 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.492 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 4.5 t60 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE1' ' CD2' ' A' ' 84' ' ' HIS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.428 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.51 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.51 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 127' ' ' LEU . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.539 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.561 ' C ' ' H ' ' A' ' 16' ' ' GLN . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' C ' ' HG2' ' A' ' 16' ' ' GLN . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HB ' HD13 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.62 0.248 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' THR . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.509 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.426 ' CG ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.578 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.433 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.433 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' CB ' HD12 ' A' ' 13' ' ' LEU . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.602 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.602 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.406 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.589 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.579 ' HA ' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.468 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 137' ' ' PHE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.452 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 140' ' ' GLN . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.417 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.102 0.477 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.545 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.67 0.271 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.545 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.476 ' CD1' HG11 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.489 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' THR . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.431 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.431 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 108' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.444 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.562 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.421 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.562 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.675 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 20.8 m170 -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.47 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.446 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.786 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.786 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.702 0.287 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.422 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 43' ' ' GLU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.436 ' CG2' ' CG2' ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 8.9 mm-40 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.423 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.5 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.42 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.586 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.586 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.441 HD11 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.441 ' CG ' HD11 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.775 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.775 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 103' ' ' PRO . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.539 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HG3' ' A' ' 43' ' ' GLU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 ' CE1' ' A' ' 72' ' ' PHE . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 2.1 t60 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' THR . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.447 ' CZ2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.585 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.485 ' HA ' ' CE3' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.43 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.405 ' CD1' HD12 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 124' ' ' PHE . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.406 ' CE1' HG23 ' A' ' 71' ' ' VAL . 20.7 t-80 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.493 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 124' ' ' PHE . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' CD2' ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' N ' ' A' ' 19' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 ' CD1' ' HD2' ' A' ' 112' ' ' PRO . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.49 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' CD1' ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.424 ' CB ' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.486 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.447 ' N ' ' HD3' ' A' ' 95' ' ' PRO . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' CG ' ' HB3' ' A' ' 95' ' ' PRO . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.461 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.615 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.615 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CE1' ' CB ' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.449 ' CD2' ' CG2' ' A' ' 70' ' ' ILE . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.411 HG22 ' CD2' ' A' ' 134' ' ' HIS . 27.9 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.028 0.442 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 45' ' ' ILE . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.77 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.69 0.281 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.432 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' CG ' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.487 ' CD1' HG13 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' CB ' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 HG21 ' CE2' ' A' ' 137' ' ' PHE . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.416 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.481 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.504 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.589 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' CD2' ' CE1' ' A' ' 137' ' ' PHE . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.611 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.417 ' CE1' ' CB ' ' A' ' 69' ' ' GLN . 14.0 m170 -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.462 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 45' ' ' ILE . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.536 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 16' ' ' GLN . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 32' ' ' TRP . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.499 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.463 HG11 ' HG3' ' A' ' 43' ' ' GLU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 6' ' ' LEU . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.502 ' CD1' HG12 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.496 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CD2' HD11 ' A' ' 45' ' ' ILE . 1.5 m-70 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.504 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.43 HG12 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.437 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.459 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' CE1' ' O ' ' A' ' 118' ' ' PRO . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.504 ' CZ3' ' CG1' ' A' ' 85' ' ' VAL . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.572 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 45' ' ' ILE . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.476 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' TRP . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.733 0.301 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 HD23 ' A' ' 6' ' ' LEU . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.488 ' CD1' HG12 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.51 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' CG ' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.476 ' HE2' ' HB2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HB ' ' HE2' ' A' ' 81' ' ' MET . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.457 ' CD2' ' CG ' ' A' ' 69' ' ' GLN . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.456 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.432 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.441 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 108' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.458 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.583 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.574 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.458 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.473 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.409 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD22 HG12 ' A' ' 45' ' ' ILE . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.562 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.471 HG21 HD22 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 HG12 HD22 ' A' ' 6' ' ' LEU . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.461 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 134' ' ' HIS . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.456 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.491 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.437 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 111' ' ' ILE . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.645 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' N ' ' OD2' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.653 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.429 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 85' ' ' VAL . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.456 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.451 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' HG23 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 16' ' ' GLN . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CD1' HG23 ' A' ' 111' ' ' ILE . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 102' ' ' ARG . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.596 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 95' ' ' PRO . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' SER . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.561 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 64' ' ' LEU . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.455 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.474 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 97' ' ' GLU . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 97' ' ' GLU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' CB ' HD13 ' A' ' 13' ' ' LEU . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.451 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.573 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.56 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.465 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.416 ' HG2' ' CG ' ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.416 ' CG ' ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.516 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 124' ' ' PHE . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.646 0.26 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HG3' ' A' ' 43' ' ' GLU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 HD22 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD1' HG12 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 95' ' ' PRO . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG21 ' CD1' ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG22 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.49 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.424 HG21 ' HB ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.45 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.418 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.464 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.459 ' HG2' HD11 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.609 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.434 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.416 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 140' ' ' GLN . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.459 HD11 ' HG2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.4 ' CD1' HG22 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.628 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.462 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.38 0.133 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.44 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.431 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.546 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.71 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.423 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.553 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.455 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.553 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.638 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.427 ' CE1' HG23 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' ' 70' ' ' ILE . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 134' ' ' HIS . 17.2 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.073 0.463 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.805 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.654 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.3 p30 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 43' ' ' GLU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 45' ' ' ILE . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.509 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 14.9 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 88' ' ' THR . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.418 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.457 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 14' ' ' GLN . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.57 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.607 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.429 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.607 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.437 ' CD2' ' CG1' ' A' ' 153' ' ' VAL . 11.7 m170 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.454 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.437 HG12 ' CE1' ' A' ' 139' ' ' PHE . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.437 ' CG1' ' CD2' ' A' ' 134' ' ' HIS . 27.7 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.826 0.346 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.57 -178.0 35.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.2 -176.02 2.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 111.059 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.72 91.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 13' ' ' LEU . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HB3' ' CB ' ' A' ' 32' ' ' TRP . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 103' ' ' PRO . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.8 119.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.02 -113.2 0.73 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.379 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 10.4 p90 -100.24 74.88 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.77 23.94 2.94 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.101 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -55.7 93.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.817 0.309 . . . . 0.0 111.11 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.534 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.409 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.531 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG13 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.454 ' CD2' ' CG ' ' A' ' 69' ' ' GLN . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.46 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.564 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.429 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.581 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.581 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.411 ' CE1' HG23 ' A' ' 71' ' ' VAL . 22.8 t-80 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE1' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.52 167.87 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -169.64 -42.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.9 -178.63 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.141 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.95 118.31 0.82 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.558 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.21 86.34 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.106 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.47 97.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 16' ' ' GLN . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.7 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.37 153.31 5.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.22 -127.68 8.77 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.178 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.11 81.4 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.15 -3.46 3.71 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.339 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -45.69 120.1 2.46 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.996 0.398 . . . . 0.0 111.56 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 45' ' ' ILE . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.569 ' CD1' HG11 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 53' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 2.5 t-80 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.492 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' THR . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.448 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.61 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.61 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.432 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.425 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 36.0 m170 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 70' ' ' ILE . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.438 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' CG ' ' A' ' 134' ' ' HIS . 5.8 m -144.02 148.64 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -177.8 37.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.2 m -109.63 111.65 23.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.14 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.65 -83.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.26 -167.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p 56.61 89.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.573 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.04 160.66 24.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.75 9.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.272 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -100.0 78.4 2.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.62 -13.41 1.56 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.161 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -42.81 141.4 1.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.968 0.384 . . . . 0.0 111.624 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' HG11 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.573 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HG13 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HG2' ' CE1' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.447 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' THR . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.433 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.433 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.469 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CE1' HD11 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.417 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 2.2 t60 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.46 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.406 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.76 161.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -141.94 31.29 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -130.1 102.1 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.024 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.21 170.49 23.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.516 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.37 62.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -174.99 93.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.413 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 13' ' ' LEU . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 32' ' ' TRP . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.544 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -172.25 107.32 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.37 -117.85 0.65 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -100.01 23.71 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.01 32.09 0.04 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.837 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -54.66 103.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.544 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.446 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 95' ' ' PRO . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.461 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 72' ' ' PHE . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' CB ' HD11 ' A' ' 13' ' ' LEU . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.514 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.51 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 116' ' ' MET . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HG2' HD13 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.616 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.554 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD12 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 12.3 m170 -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 145' ' ' ILE . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.44 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.542 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.25 161.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.83 -33.2 9.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -103.27 156.16 17.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.084 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.8 0.333 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.59 52.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 -175.46 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.004 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.42 84.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 19' ' ' LEU . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.526 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLN . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.54 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.424 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.17 115.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.3 -119.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.08 23.78 9.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.271 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.45 30.77 0.05 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -54.53 146.8 15.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 66' ' ' LYS . 10.6 t-160 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.524 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.446 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.462 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.535 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.637 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.565 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 145' ' ' ILE . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.446 ' HG2' ' CD1' ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m -142.2 147.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -148.4 -50.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.6 m -68.13 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.151 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.55 -161.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.01 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.37 86.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HD3' ' CB ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -162.7 164.24 26.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.16 -130.13 10.12 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.18 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.24 83.34 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.66 0.2 3.65 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.457 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -45.63 146.64 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.168 0.484 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 43' ' ' GLU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 72' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.462 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' THR . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.456 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.437 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.652 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.488 ' HD2' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.425 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.427 HD12 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.459 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 5.8 tp-100 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.563 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 122' ' ' TYR . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.97 167.99 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -177.4 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -62.48 128.67 37.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.099 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.835 0.35 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.14 -56.28 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.96 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p 56.68 90.38 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.35 156.26 14.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.97 -127.72 8.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.086 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.14 79.88 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.982 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.11 1.31 2.93 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.623 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -46.2 143.63 2.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.311 0.555 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.493 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG11 ' HG3' ' A' ' 43' ' ' GLU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.472 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' THR . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.433 ' CE2' HD22 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 32.9 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HB2' HD12 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.442 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.419 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.427 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.507 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.507 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CE1' ' CD1' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.448 ' CG ' HD12 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 5.9 tp60 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.443 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.451 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.521 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.99 159.95 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.55 -47.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -91.75 164.82 13.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.037 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.85 -124.39 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 -172.04 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 111.111 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.59 88.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.489 ' HE3' ' CZ2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.568 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.92 151.34 7.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.68 -125.76 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.098 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -100.18 71.55 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.767 0.318 . . . . 0.0 110.769 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.64 -18.93 0.59 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.215 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -40.26 129.05 2.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.971 0.386 . . . . 0.0 111.755 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CZ2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.505 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.556 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.493 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.493 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' NE2' ' CG ' ' A' ' 69' ' ' GLN . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.483 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.44 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.452 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.538 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.551 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.511 ' CD2' ' CE1' ' A' ' 137' ' ' PHE . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.551 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.604 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.413 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.405 ' CG ' ' OH ' ' A' ' 122' ' ' TYR . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.478 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.1 m -145.3 157.14 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -144.82 -48.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.09 170.29 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.055 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.72 -127.15 5.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.62 61.49 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -174.82 93.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' CE1' ' A' ' 124' ' ' PHE . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' C ' ' H ' ' A' ' 16' ' ' GLN . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' A' ' 112' ' ' PRO . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.31 168.85 16.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.6 -130.35 10.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -100.18 72.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.64 -19.19 0.3 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.533 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -38.44 120.88 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.151 0.476 . . . . 0.0 111.798 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 HD22 ' A' ' 6' ' ' LEU . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG22 ' CD1' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.446 ' OG1' ' CD ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.473 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.475 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 19.4 m170 -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 145' ' ' ILE . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.442 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.522 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.5 m -141.71 144.16 26.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -133.91 -51.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.1 131.31 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.148 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.838 0.352 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.66 98.28 2.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.5 -168.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p 56.24 89.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 HG12 ' A' ' 45' ' ' ILE . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.63 143.35 3.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.82 -125.29 6.25 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.181 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -99.94 76.28 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 110.759 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.49 -12.69 2.25 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.062 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.578 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -42.01 106.4 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 43' ' ' GLU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG3' HG11 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 45' ' ' ILE . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 133' ' ' PHE . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.501 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' THR . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.435 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.491 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.476 ' CE1' ' CD1' ' A' ' 148' ' ' TYR . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.577 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.53 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CE1' ' CD1' ' A' ' 72' ' ' PHE . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.417 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.53 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.64 148.9 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -136.23 31.88 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.66 111.05 23.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.45 160.81 9.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.565 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.02 76.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.914 0.388 . . . . 0.0 111.124 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -175.47 94.57 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' GLN . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.441 ' HB ' HD13 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.533 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.55 115.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.09 -120.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.351 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -100.03 23.97 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.33 31.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.053 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -56.69 145.89 27.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG12 ' HG3' ' A' ' 43' ' ' GLU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD1' HG12 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG13 HD21 ' A' ' 53' ' ' LEU . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 84' ' ' HIS . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-160 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 60' ' ' THR . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.455 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.522 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.651 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.451 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.651 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.606 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.26 149.23 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -172.09 -55.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -86.44 155.29 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.071 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.753 0.311 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.48 -28.08 5.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.34 -170.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 111.079 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.12 106.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' GLN . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.528 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.7 146.26 5.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.74 -125.2 6.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.091 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.19 74.01 1.74 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.5 -12.18 1.35 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.372 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -42.13 119.44 1.35 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.081 0.441 . . . . 0.0 111.644 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 95' ' ' PRO . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' A' ' 69' ' ' GLN . 1.7 t-160 -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.505 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.505 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.552 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.501 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.451 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CD2' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.515 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.505 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.83 157.4 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.64 -40.26 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -60.15 -66.02 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.035 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.79 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.67 -171.6 12.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.64 -168.78 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.091 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.6 84.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.77 153.67 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.02 -127.04 8.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.13 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 78.44 2.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.767 0.317 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.84 -4.89 2.47 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.48 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -45.96 144.18 1.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.171 0.485 . . . . 0.0 111.525 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.534 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 88' ' ' THR . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG22 ' CE1' ' A' ' 72' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 81' ' ' MET . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CG ' HG22 ' A' ' 45' ' ' ILE . 15.8 m170 -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.452 ' CG2' ' CG2' ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' THR . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.446 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.451 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.427 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.558 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 148' ' ' TYR . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.558 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.497 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.459 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' CD1' ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.85 149.36 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.27 -54.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.5 t -88.83 158.65 18.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.102 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.815 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.06 -139.17 2.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.19 -168.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 90.17 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.549 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 124' ' ' PHE . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.477 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.07 142.9 2.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 133.84 -128.26 4.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.272 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -100.27 23.52 9.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.559 0.219 . . . . 0.0 111.322 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.15 18.72 0.09 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.551 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -57.9 148.79 24.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.124 0.462 . . . . 0.0 110.883 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.541 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 8' ' ' THR . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.5 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG12 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.489 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.431 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.431 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.435 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.422 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.577 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.439 ' CG ' ' CD2' ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' CD2' ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 174.71 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.56 33.33 20.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 38.2 m -83.91 132.05 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.147 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.64 43.44 4.84 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.549 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.12 -168.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p 56.31 87.77 0.05 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.583 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 35' ' ' PHE . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.697 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.508 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.3 139.02 2.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.28 -127.55 4.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.344 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.586 0.231 . . . . 0.0 111.31 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.85 22.17 0.09 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.342 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -57.11 147.36 24.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.95 0.375 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.508 ' CE2' ' HE2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.583 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.476 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.419 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.428 ' CD1' HD12 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.509 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 69' ' ' GLN . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.519 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.541 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 m -142.25 148.0 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -130.38 -47.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -78.51 125.39 29.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.096 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.882 0.373 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.07 80.02 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.75 81.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.58 92.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.544 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 16' ' ' GLN . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' HD12 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.49 151.94 6.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.96 -125.47 7.76 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -100.02 80.27 2.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.973 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 141.52 -13.95 2.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.947 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -44.02 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.487 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG23 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.491 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.409 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.499 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.606 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.664 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 12.1 tp60 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.459 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 134' ' ' HIS . 20.2 m -145.67 147.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -133.02 -46.9 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 27.7 m -95.58 102.63 14.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.016 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 76.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.09 99.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.084 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -177.8 99.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.758 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.534 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.48 118.59 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.53 -121.46 1.03 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -100.07 23.81 9.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.684 0.278 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.57 30.64 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.992 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -55.1 147.73 15.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.478 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.501 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.492 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 4.5 t60 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE1' ' CD2' ' A' ' 84' ' ' HIS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.428 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.51 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.51 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 127' ' ' LEU . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.56 169.4 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.5 27.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.7 t -78.97 79.75 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.089 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.32 140.52 24.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.94 75.75 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.18 91.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.539 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.561 ' C ' ' H ' ' A' ' 16' ' ' GLN . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' C ' ' HG2' ' A' ' 16' ' ' GLN . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HB ' HD13 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.67 119.92 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.07 -120.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.423 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.18 24.0 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.615 0.245 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.25 28.39 0.06 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.357 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -58.98 149.28 27.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.903 0.351 . . . . 0.0 110.826 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 8' ' ' THR . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.509 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' CG ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.578 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.433 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.433 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' CB ' HD12 ' A' ' 13' ' ' LEU . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.602 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.602 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.406 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.589 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.579 ' HA ' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.468 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 137' ' ' PHE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.452 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 140' ' ' GLN . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.417 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.86 161.81 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.75 -33.15 6.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.4 m -87.5 117.9 26.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.162 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.09 -174.09 32.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.51 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.98 -168.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 111.026 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p 56.02 86.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.23 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.545 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.41 151.74 8.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.56 -130.42 7.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.984 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -100.25 21.55 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.648 0.261 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.58 -1.93 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.314 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -45.93 153.24 0.31 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.739 0.77 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.545 ' CG1' ' CD2' ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.476 ' CD1' HG11 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' THR . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.431 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.431 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 108' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.562 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.421 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.562 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.675 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 20.8 m170 -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.441 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.47 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.5 m -145.81 159.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.96 31.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.864 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 23.5 m -151.1 -57.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.149 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.37 163.77 29.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.61 5.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.59 101.59 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.446 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.786 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.786 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.01 121.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.07 -122.17 1.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.376 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -100.18 23.08 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.628 0.251 . . . . 0.0 111.201 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.45 22.85 0.06 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -52.39 119.13 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.015 0.408 . . . . 0.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.422 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 43' ' ' GLU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.436 ' CG2' ' CG2' ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 8.9 mm-40 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 58' ' ' GLY . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.5 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.42 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.586 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.586 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.441 HD11 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.441 ' CG ' HD11 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.14 157.68 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.52 31.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -113.84 147.78 37.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.134 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.767 0.317 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.31 -32.72 2.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.49 92.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.81 99.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.775 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.775 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 103' ' ' PRO . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.539 ' HE2' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.49 121.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.35 -122.29 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.377 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.09 23.43 9.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.71 28.55 0.06 OUTLIER Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.126 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -56.4 149.09 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.848 0.324 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG11 ' HG3' ' A' ' 43' ' ' GLU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 ' CE1' ' A' ' 72' ' ' PHE . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 2.1 t60 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' THR . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.447 ' CZ2' ' CD2' ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.453 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.585 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.485 ' HA ' ' CE3' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.43 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.405 ' CD1' HD12 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.583 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 124' ' ' PHE . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.406 ' CE1' HG23 ' A' ' 71' ' ' VAL . 20.7 t-80 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.493 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.74 142.12 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.96 -55.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -121.06 83.61 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.127 -179.967 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.23 -65.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.574 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.67 -166.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.053 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p 55.96 85.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' A' ' 45' ' ' ILE . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 124' ' ' PHE . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' CD2' ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' N ' ' A' ' 19' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 ' CD1' ' HD2' ' A' ' 112' ' ' PRO . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -161.34 -179.22 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 -138.27 14.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.08 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -99.99 23.82 9.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.756 0.312 . . . . 0.0 110.833 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.08 -20.88 0.36 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.589 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -35.85 126.04 0.71 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.1 0.45 . . . . 0.0 112.025 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.49 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' CD1' ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.424 ' CB ' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.486 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.447 ' N ' ' HD3' ' A' ' 95' ' ' PRO . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' CG ' ' HB3' ' A' ' 95' ' ' PRO . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.461 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.432 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.46 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.615 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.615 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CE1' ' CB ' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.449 ' CD2' ' CG2' ' A' ' 70' ' ' ILE . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.411 HG22 ' CD2' ' A' ' 134' ' ' HIS . 27.9 m -142.93 174.86 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.64 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 m -84.93 109.37 18.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.1 -179.946 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.45 103.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.26 176.45 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t 177.77 103.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.026 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 45' ' ' ILE . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.77 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' N ' ' CG2' ' A' ' 18' ' ' VAL . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -167.47 138.82 3.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.99 -127.19 3.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.273 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.179 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.4 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -60.33 148.81 35.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.996 0.398 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.432 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' CG ' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' CD1' HG13 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' CB ' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.464 HG21 ' CE2' ' A' ' 137' ' ' PHE . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' THR . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.416 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.481 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.504 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.589 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' CD2' ' CE1' ' A' ' 137' ' ' PHE . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.611 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.417 ' CE1' ' CB ' ' A' ' 69' ' ' GLN . 14.0 m170 -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 144' ' ' THR . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.462 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.0 144.98 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.95 -46.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.967 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.8 m -63.84 143.41 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.174 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.833 0.349 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.32 65.29 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.37 -179.64 6.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.06 89.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 45' ' ' ILE . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.536 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 16' ' ' GLN . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 32' ' ' TRP . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.74 154.16 9.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -128.31 8.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.053 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -100.12 76.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.727 0.299 . . . . 0.0 110.909 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.42 -7.22 2.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.551 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -42.3 141.09 1.01 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.261 0.53 . . . . 0.0 111.711 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.499 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 HG11 ' HG3' ' A' ' 43' ' ' GLU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG11 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 6' ' ' LEU . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.502 ' CD1' HG12 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.496 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CD2' HD11 ' A' ' 45' ' ' ILE . 1.5 m-70 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.504 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.43 HG12 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.437 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.459 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' CE1' ' O ' ' A' ' 118' ' ' PRO . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.504 ' CZ3' ' CG1' ' A' ' 85' ' ' VAL . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 144' ' ' THR . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.572 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m -144.91 138.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.43 -48.32 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.5 m -99.42 -58.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.109 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.69 -92.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.523 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.86 96.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.77 99.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 45' ' ' ILE . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD1' ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.763 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.763 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' TRP . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.92 160.75 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 -128.54 9.59 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.221 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -100.12 80.82 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 110.91 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.9 -7.48 2.69 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.311 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -45.57 141.51 2.74 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.143 0.471 . . . . 0.0 111.516 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' HB3' ' CG ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 HD23 ' A' ' 6' ' ' LEU . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' CD1' HG12 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.51 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' CG ' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.476 ' HE2' ' HB2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HB ' ' HE2' ' A' ' 81' ' ' MET . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.457 ' CD2' ' CG ' ' A' ' 69' ' ' GLN . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.432 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.432 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.441 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 108' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.458 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.583 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.574 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 133' ' ' PHE . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.473 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.409 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.0 164.88 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.65 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -78.08 97.46 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.151 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.815 0.341 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.71 1.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.74 -167.94 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.054 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p 56.61 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD22 HG12 ' A' ' 45' ' ' ILE . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.471 HG21 HD22 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.78 140.63 6.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.91 -138.08 13.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.333 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.6 75.27 9.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.335 . . . . 0.0 110.762 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.35 -15.36 1.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 25' ' ' ARG . . . -43.5 94.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 HG12 HD22 ' A' ' 6' ' ' LEU . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.461 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 134' ' ' HIS . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.456 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.491 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 111' ' ' ILE . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.645 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' N ' ' OD2' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.653 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.429 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 85' ' ' VAL . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.456 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.451 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.33 138.55 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.92 -47.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 t -60.3 119.99 8.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.11 179.98 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.848 0.356 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.13 -135.51 2.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.03 -168.02 2.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.76 96.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 87' ' ' CYS . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' HG23 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 16' ' ' GLN . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CD1' HG23 ' A' ' 111' ' ' ILE . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 102' ' ' ARG . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.84 -178.21 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.08 -137.41 14.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.042 -179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.13 59.43 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.815 0.341 . . . . 0.0 110.701 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 29' ' ' ALA . . . 179.71 -31.62 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.388 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 28' ' ' GLY . . . -22.07 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.596 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 43' ' ' GLU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 95' ' ' PRO . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' SER . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 88' ' ' THR . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.561 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 64' ' ' LEU . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.455 ' CG2' ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.474 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 97' ' ' GLU . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 97' ' ' GLU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' CB ' HD13 ' A' ' 13' ' ' LEU . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.451 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.573 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.56 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.465 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.416 ' HG2' ' CG ' ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.416 ' CG ' ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.58 138.99 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.24 36.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.7 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.136 -179.992 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.21 178.78 11.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.55 76.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.866 0.365 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -175.98 95.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.516 HG12 ' CD1' ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 124' ' ' PHE . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 16' ' ' GLN . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.16 138.66 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.59 -125.7 3.54 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.132 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -100.32 23.45 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.911 -0.17 . . . . 0.0 111.423 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.94 17.07 0.08 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.713 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -58.34 123.52 16.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.263 0.532 . . . . 0.0 110.91 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HG3' ' A' ' 43' ' ' GLU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.464 HG12 HD22 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD1' HG12 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 95' ' ' PRO . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG21 ' CD1' ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG22 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG1' ' CZ3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.49 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.424 HG21 ' HB ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.45 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.464 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.459 ' HG2' HD11 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.609 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.434 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.416 ' CZ ' ' CG2' ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 140' ' ' GLN . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.459 HD11 ' HG2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.4 ' CD1' HG22 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.24 174.9 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.19 37.16 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.8 t -77.66 92.68 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.127 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.861 0.362 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.89 158.76 8.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.44 -172.08 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p 55.28 87.25 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD2' HG12 ' A' ' 45' ' ' ILE . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.628 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.462 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -141.97 -173.97 3.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 -144.69 17.38 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.929 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.43 25.26 7.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.524 0.202 . . . . 0.0 111.253 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -173.93 35.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.544 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . -41.09 -91.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.006 0.403 . . . . 0.0 110.994 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 43' ' ' GLU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' CD2' ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' CG ' ' CD1' ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.44 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.431 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.546 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.71 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.423 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.553 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.455 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.553 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.638 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.427 ' CE1' HG23 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' ' 70' ' ' ILE . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 134' ' ' HIS . 17.2 m -145.47 141.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.19 -53.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.998 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.23 143.44 48.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.97 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.798 0.333 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.19 46.33 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.78 95.86 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.065 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -177.36 100.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.038 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' CD2' ' CG1' ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' CD1' ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 124' ' ' PHE . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 19' ' ' LEU . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.805 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.805 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.21 127.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.69 -123.46 1.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.411 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.12 23.66 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.93 26.26 0.07 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.306 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' LYS . . . -58.23 144.02 42.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.858 0.329 . . . . 0.0 110.89 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.654 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.3 p30 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HB2' ' CG1' ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 43' ' ' GLU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 45' ' ' ILE . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 ' CD1' HG11 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 14.9 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 88' ' ' THR . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' A' ' 88' ' ' THR . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 ' HB ' ' CG ' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' HB ' ' CD2' ' A' ' 64' ' ' LEU . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.418 ' CD ' ' CG2' ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.457 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 14' ' ' GLN . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.57 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.607 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.429 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.607 ' NE1' ' HA ' ' A' ' 120' ' ' ASP . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 152' ' ' GLU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.437 ' CD2' ' CG1' ' A' ' 153' ' ' VAL . 11.7 m170 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.454 ' CG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.437 HG12 ' CE1' ' A' ' 139' ' ' PHE . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.437 ' CG1' ' CD2' ' A' ' 134' ' ' HIS . 27.7 m -144.34 141.96 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -176.54 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 36.4 m -66.48 90.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.105 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.845 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.855 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.041 HG22 HG22 ' A' ' 88' ' ' THR . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.55 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 HG23 ' A' ' 111' ' ' ILE . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 111' ' ' ILE . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.709 0.29 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.401 ' CA ' HD22 ' A' ' 20' ' ' LEU . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 6' ' ' LEU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.845 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.597 ' HG2' HD11 ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.787 HD22 HG21 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 91' ' ' ILE . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.839 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.969 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.969 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' A' ' 137' ' ' PHE . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.576 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 81' ' ' MET . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' HB2' HG21 ' A' ' 45' ' ' ILE . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 ' CE3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.041 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 59' ' ' LEU . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' LEU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.571 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.805 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.436 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HD2' HD11 ' A' ' 150' ' ' LEU . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.761 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 111' ' ' ILE . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.419 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 t60 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.677 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.675 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.654 ' HB2' HD11 ' A' ' 146' ' ' LEU . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.623 HD11 ' HD2' ' A' ' 122' ' ' TYR . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.974 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.918 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.998 HG22 HG22 ' A' ' 88' ' ' THR . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.1 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 111' ' ' ILE . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.609 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.687 0.279 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.609 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 20' ' ' LEU . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 10' ' ' VAL . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' THR . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 6' ' ' LEU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.912 HD11 HD21 ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.974 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CG ' HD12 ' A' ' 64' ' ' LEU . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.736 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.675 HD11 ' CG ' ' A' ' 123' ' ' TRP . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.834 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.4 t60 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG11 ' CE3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.897 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.998 HG22 HG22 ' A' ' 12' ' ' VAL . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.769 HG22 HG12 ' A' ' 61' ' ' VAL . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.592 HG22 HG23 ' A' ' 96' ' ' VAL . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 94' ' ' THR . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.53 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.961 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.584 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.616 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.628 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.918 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.786 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD23 HD12 ' A' ' 126' ' ' LEU . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 153' ' ' VAL . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.575 ' HB2' HD13 ' A' ' 126' ' ' LEU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.549 ' CE1' HG21 ' A' ' 153' ' ' VAL . 1.5 m-70 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.48 ' HE2' HG13 ' A' ' 75' ' ' VAL . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.517 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG21 ' CE1' ' A' ' 134' ' ' HIS . 5.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.953 HD22 HG21 ' A' ' 39' ' ' VAL . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.874 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.872 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.962 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 88' ' ' THR . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.796 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 59' ' ' LEU . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 111' ' ' ILE . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.608 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.884 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.608 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.428 ' CA ' HD22 ' A' ' 20' ' ' LEU . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.953 HG21 HD22 ' A' ' 6' ' ' LEU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HB3' HG12 ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HD21 ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.874 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.773 ' HB2' HG23 ' A' ' 60' ' ' THR . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 103' ' ' PRO . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.806 HD12 HD21 ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.773 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.861 HG21 ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.517 HD11 ' CD1' ' A' ' 123' ' ' TRP . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.694 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' OH ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.933 HG11 ' CE3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.057 HG22 HG22 ' A' ' 12' ' ' VAL . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.675 HD13 HD13 ' A' ' 59' ' ' LEU . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.897 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.897 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HD11 ' A' ' 19' ' ' LEU . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.414 ' C ' HG12 ' A' ' 18' ' ' VAL . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.755 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.443 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.596 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.962 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.777 HD13 ' CG ' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.777 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 16.4 t-80 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.694 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.704 ' HB2' HD11 ' A' ' 146' ' ' LEU . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.728 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.821 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.891 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' C ' HD13 ' A' ' 108' ' ' LEU . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.905 HG11 HG23 ' A' ' 111' ' ' ILE . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.86 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.819 HD11 HG22 ' A' ' 111' ' ' ILE . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.811 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.811 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.958 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.884 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HG21 ' A' ' 10' ' ' VAL . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.724 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.925 HG21 ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.925 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 123' ' ' TRP . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 70' ' ' ILE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.646 HG11 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.029 HG22 HG22 ' A' ' 12' ' ' VAL . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.929 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HB2' HD11 ' A' ' 19' ' ' LEU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.772 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.905 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.633 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.592 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.891 ' CH2' HD12 ' A' ' 11' ' ' LEU . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.787 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.787 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 146' ' ' LEU . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.865 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 118' ' ' PRO . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.562 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.817 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 88' ' ' THR . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 108' ' ' LEU . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.903 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.626 HD11 ' SD ' ' A' ' 116' ' ' MET . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 8' ' ' THR . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 6' ' ' LEU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.806 ' HB2' HG23 ' A' ' 60' ' ' THR . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.676 HD13 HD13 ' A' ' 91' ' ' ILE . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.804 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG13 ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.424 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.2 t60 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.738 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.9 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.988 HG22 HG22 ' A' ' 12' ' ' VAL . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.676 HD13 HD13 ' A' ' 59' ' ' LEU . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 94' ' ' THR . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 94' ' ' THR . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' THR . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.438 ' HE1' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.903 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.402 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.584 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.817 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.655 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.744 ' NZ ' HG13 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.587 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.694 ' HG2' HD11 ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.524 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.489 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.666 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 39' ' ' VAL . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.482 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.078 HG22 HG22 ' A' ' 88' ' ' THR . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 13' ' ' LEU . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.653 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.592 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.757 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.669 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 8' ' ' THR . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.96 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.787 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.836 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 10' ' ' VAL . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.915 HG21 ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.915 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.693 HG23 ' HE1' ' A' ' 137' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.681 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 7' ' ' TYR . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' HG21 ' A' ' 45' ' ' ILE . 13.4 t-80 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG11 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.078 HG22 HG22 ' A' ' 12' ' ' VAL . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 59' ' ' LEU . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.908 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.819 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.704 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.879 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.789 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.885 HD13 ' CB ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.719 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.885 ' CB ' HD13 ' A' ' 126' ' ' LEU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.585 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.693 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' CE ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.628 ' HB2' HD21 ' A' ' 146' ' ' LEU . 13.7 tp60 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' A' ' 132' ' ' LYS . 5.9 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.971 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.955 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.834 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.62 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 105' ' ' TRP . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.574 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.751 0.31 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.955 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.834 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.848 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.831 HD13 HD13 ' A' ' 91' ' ' ILE . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.848 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.869 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.869 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.684 HG21 ' CD2' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.626 HG22 ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.754 HG13 ' OD1' ' A' ' 82' ' ' ASP . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HG22 ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.576 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 64' ' ' LEU . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.061 HG22 HG22 ' A' ' 12' ' ' VAL . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.831 HD13 HD13 ' A' ' 59' ' ' LEU . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.652 HG22 HG23 ' A' ' 96' ' ' VAL . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.652 HG23 HG22 ' A' ' 94' ' ' THR . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.513 ' O ' HD12 ' A' ' 19' ' ' LEU . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.662 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 18' ' ' VAL . 21.2 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.657 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 150' ' ' LEU . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.932 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.768 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.768 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.674 ' HG2' HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.902 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.902 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.538 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD21 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.936 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.816 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.929 HG22 HG22 ' A' ' 88' ' ' THR . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.924 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.924 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 52' ' ' GLU . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.829 HG21 ' CB ' ' A' ' 84' ' ' HIS . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.936 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 64' ' ' LEU . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' CG ' ' HA3' ' A' ' 37' ' ' GLY . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 91' ' ' ILE . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.913 HG21 ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.913 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 127' ' ' LEU . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 123' ' ' TRP . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.494 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.829 ' CB ' HG21 ' A' ' 45' ' ' ILE . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.866 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.495 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.929 HG22 HG22 ' A' ' 12' ' ' VAL . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 59' ' ' LEU . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.865 ' HB2' HD11 ' A' ' 19' ' ' LEU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.837 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 20' ' ' LEU . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.564 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 150' ' ' LEU . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.898 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 116' ' ' MET . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 111' ' ' ILE . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.83 ' HB2' HD13 ' A' ' 126' ' ' LEU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CE1' HG23 ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 73' ' ' GLU . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HE2' HG22 ' A' ' 75' ' ' VAL . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 146' ' ' LEU . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CB ' ' A' ' 132' ' ' LYS . 13.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.741 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 88' ' ' THR . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 13' ' ' LEU . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 105' ' ' TRP . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.919 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.837 HG21 HD22 ' A' ' 6' ' ' LEU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 HG22 ' A' ' 8' ' ' THR . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HG2' HD11 ' A' ' 64' ' ' LEU . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.741 HD22 HG21 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD22 HD12 ' A' ' 91' ' ' ILE . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.89 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.89 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.586 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.758 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 71' ' ' VAL . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.868 HG11 ' CE3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.046 HG22 HG22 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 88' ' ' THR . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.676 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.647 ' SD ' HD21 ' A' ' 20' ' ' LEU . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.58 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.466 ' HD2' HD11 ' A' ' 150' ' ' LEU . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.868 ' CE3' HG11 ' A' ' 85' ' ' VAL . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.658 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 133' ' ' PHE . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.669 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.838 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 132' ' ' LYS . 23.5 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 39' ' ' VAL . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HB2' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.797 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 88' ' ' THR . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.601 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.772 ' CG2' HD22 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.618 ' CD1' HG22 ' A' ' 111' ' ' ILE . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.559 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.836 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HD22 ' A' ' 6' ' ' LEU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.596 ' HG3' HG13 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' THR . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.836 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 91' ' ' ILE . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.648 HD11 ' CD1' ' A' ' 123' ' ' TRP . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG23 ' A' ' 83' ' ' VAL . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' HG2' ' A' ' 81' ' ' MET . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.987 HG22 HG22 ' A' ' 12' ' ' VAL . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 59' ' ' LEU . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.895 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.78 ' HB2' HD11 ' A' ' 19' ' ' LEU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.716 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.591 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 150' ' ' LEU . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.746 ' NE2' HG21 ' A' ' 153' ' ' VAL . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.744 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 122' ' ' TYR . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.746 HG21 ' NE2' ' A' ' 134' ' ' HIS . 28.2 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.954 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.937 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.964 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 88' ' ' THR . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.557 ' N ' HD12 ' A' ' 13' ' ' LEU . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.749 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' HG22 ' A' ' 111' ' ' ILE . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.615 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.785 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.615 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.698 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.954 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.654 ' CG ' HD12 ' A' ' 64' ' ' LEU . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.645 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.787 HD13 HD13 ' A' ' 91' ' ' ILE . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.645 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 91' ' ' ILE . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.7 t60 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.813 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.787 HD13 HD13 ' A' ' 59' ' ' LEU . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 96' ' ' VAL . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' N ' HD21 ' A' ' 59' ' ' LEU . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 94' ' ' THR . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.569 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.627 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HB2' HD12 ' A' ' 145' ' ' ILE . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.665 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.449 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 150' ' ' LEU . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.964 ' CH2' HD12 ' A' ' 11' ' ' LEU . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.508 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 108' ' ' LEU . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HB3' HG23 ' A' ' 153' ' ' VAL . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.71 ' HB2' HD22 ' A' ' 126' ' ' LEU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.468 ' NE2' HG23 ' A' ' 71' ' ' VAL . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 122' ' ' TYR . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 132' ' ' LYS . 15.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.671 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.917 HG22 HG23 ' A' ' 45' ' ' ILE . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.814 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.894 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 88' ' ' THR . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.753 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.666 HD11 HG22 ' A' ' 111' ' ' ILE . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.582 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.403 ' CA ' HD22 ' A' ' 20' ' ' LEU . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 6' ' ' LEU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' HG12 ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.917 HG23 HG22 ' A' ' 8' ' ' THR . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.824 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 64' ' ' LEU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD22 HG21 ' A' ' 10' ' ' VAL . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.843 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.968 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.968 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD2' ' A' ' 127' ' ' LEU . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 137' ' ' PHE . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.671 HG22 ' HB2' ' A' ' 7' ' ' TYR . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CE3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.016 HG22 HG22 ' A' ' 12' ' ' VAL . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 94' ' ' THR . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.5 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.821 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.793 ' CD1' HD13 ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.708 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.402 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.549 ' HD2' HD11 ' A' ' 150' ' ' LEU . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.894 ' CH2' HD12 ' A' ' 11' ' ' LEU . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.6 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.838 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.649 ' HB2' HD21 ' A' ' 146' ' ' LEU . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.568 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.859 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.047 HG22 HG22 ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.934 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.934 HG23 HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 103' ' ' PRO . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.846 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.846 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.709 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.793 HG21 HD22 ' A' ' 6' ' ' LEU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 91' ' ' ILE . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.934 HG21 ' HG ' ' A' ' 64' ' ' LEU . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.934 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 68' ' ' GLY . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 ' CE1' ' A' ' 137' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.748 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.606 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.737 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.887 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.047 HG22 HG22 ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 59' ' ' LEU . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.944 ' HB2' HD11 ' A' ' 19' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.877 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.824 HD11 ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.793 ' CD1' HD11 ' A' ' 150' ' ' LEU . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.859 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.588 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.871 ' HB2' HD13 ' A' ' 126' ' ' LEU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 70' ' ' ILE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.752 ' HG2' HD21 ' A' ' 146' ' ' LEU . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.444 ' O ' ' NE2' ' A' ' 142' ' ' GLN . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.793 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 132' ' ' LYS . 9.9 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.85 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.96 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.07 HG22 HG22 ' A' ' 88' ' ' THR . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.709 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.709 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.709 ' CD2' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.605 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.863 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.605 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.631 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' HD11 ' A' ' 64' ' ' LEU . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.966 HG21 ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.966 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.699 HD11 ' CG ' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.744 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.07 HG22 HG22 ' A' ' 12' ' ' VAL . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.932 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.932 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.894 ' HB2' HD11 ' A' ' 19' ' ' LEU . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.887 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.572 ' O ' HG12 ' A' ' 18' ' ' VAL . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.666 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.666 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.6 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.96 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.912 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.744 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.874 ' HG2' HD11 ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.776 HG21 ' OE1' ' A' ' 140' ' ' GLN . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 138' ' ' LYS . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.983 HD22 HG21 ' A' ' 39' ' ' VAL . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.743 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.806 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 88' ' ' THR . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.71 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.599 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.828 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.828 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.715 0.293 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.983 HG21 HD22 ' A' ' 6' ' ' LEU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.821 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 64' ' ' LEU . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 91' ' ' ILE . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.851 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.892 HG21 ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 123' ' ' TRP . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 82' ' ' ASP . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 70' ' ' ILE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 71' ' ' VAL . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' CE3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.932 HG22 HG22 ' A' ' 12' ' ' VAL . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.536 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.812 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 20' ' ' LEU . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.533 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 150' ' ' LEU . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.806 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.673 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.601 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.905 ' HB2' HD13 ' A' ' 126' ' ' LEU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.585 ' CD2' HG11 ' A' ' 153' ' ' VAL . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.498 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.561 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 132' ' ' LYS . 20.2 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 39' ' ' VAL . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.929 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.76 HG21 HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.745 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 88' ' ' THR . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.82 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' C ' HD13 ' A' ' 108' ' ' LEU . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.566 ' N ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.82 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG22 ' A' ' 111' ' ' ILE . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.645 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.844 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' THR . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.941 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.929 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.804 HD21 HG13 ' A' ' 61' ' ' VAL . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.859 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.901 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.901 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.746 HD11 ' CD1' ' A' ' 123' ' ' TRP . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.741 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.077 HG22 HG22 ' A' ' 12' ' ' VAL . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' LEU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.778 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' VAL . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.409 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.47 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.746 ' CD1' HD11 ' A' ' 70' ' ' ILE . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.666 ' HB2' HD22 ' A' ' 126' ' ' LEU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.89 ' CD2' HG11 ' A' ' 153' ' ' VAL . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.784 ' HB2' HD11 ' A' ' 146' ' ' LEU . 5.5 tp-100 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.412 ' O ' ' NE2' ' A' ' 142' ' ' GLN . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 138' ' ' LYS . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 122' ' ' TYR . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.89 HG11 ' CD2' ' A' ' 134' ' ' HIS . 20.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 88' ' ' THR . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.884 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 103' ' ' PRO . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.658 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.807 HG21 HD22 ' A' ' 6' ' ' LEU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.754 HG12 HD21 ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 10' ' ' VAL . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.547 HD12 HD21 ' A' ' 19' ' ' LEU . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.93 HG21 ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.93 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.542 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG23 ' CE1' ' A' ' 137' ' ' PHE . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.676 ' OE1' HD22 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.676 HD22 ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 69' ' ' GLN . 38.3 t-80 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.799 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.012 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 59' ' ' LEU . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HB2' HD11 ' A' ' 19' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.789 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.884 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.652 ' HD2' HD11 ' A' ' 150' ' ' LEU . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.921 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.865 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 133' ' ' PHE . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.684 ' HB3' HG23 ' A' ' 153' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 146' ' ' LEU . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.938 ' HB2' HD11 ' A' ' 146' ' ' LEU . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 139' ' ' PHE . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 132' ' ' LYS . 28.5 m . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.002 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.879 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.93 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.001 HG22 HG22 ' A' ' 88' ' ' THR . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.581 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' HD13 ' A' ' 108' ' ' LEU . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.629 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.62 0.248 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.002 HG21 HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.818 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.755 HD21 HG13 ' A' ' 61' ' ' VAL . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.621 HG23 ' CE1' ' A' ' 137' ' ' PHE . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.856 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 80' ' ' LEU . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.877 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.001 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.947 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.947 ' HD2' HG22 ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 94' ' ' THR . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.666 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.417 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.93 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.828 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 13' ' ' LEU . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.717 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.856 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 70' ' ' ILE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.432 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 140' ' ' GLN . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.708 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.102 0.477 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD22 ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HG22 ' A' ' 88' ' ' THR . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' C ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.758 ' CD2' HD12 ' A' ' 59' ' ' LEU . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 111' ' ' ILE . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.923 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.67 0.271 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.838 HG21 HD22 ' A' ' 6' ' ' LEU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 64' ' ' LEU . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.83 HD22 HG21 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.758 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.715 ' CG1' HG21 ' A' ' 88' ' ' THR . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.654 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.897 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.86 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.787 ' HB3' HD22 ' A' ' 64' ' ' LEU . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.99 HG22 HG22 ' A' ' 12' ' ' VAL . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 59' ' ' LEU . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 94' ' ' THR . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.587 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.401 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.408 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.533 ' CD1' HD11 ' A' ' 150' ' ' LEU . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.86 ' CE3' HG11 ' A' ' 85' ' ' VAL . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.699 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 153' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.742 ' HB2' HD22 ' A' ' 126' ' ' LEU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.442 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 75' ' ' VAL . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.778 ' HB2' HD11 ' A' ' 146' ' ' LEU . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 118' ' ' PRO . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 140' ' ' GLN . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 132' ' ' LYS . 6.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.993 HD22 HG21 ' A' ' 39' ' ' VAL . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.965 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.803 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.802 ' CD2' HD12 ' A' ' 59' ' ' LEU . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.841 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.702 0.287 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB2' HG13 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 HD22 ' A' ' 6' ' ' LEU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.734 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.606 ' CG ' HD12 ' A' ' 64' ' ' LEU . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.843 HD22 HG21 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.802 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.77 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG22 ' HE2' ' A' ' 138' ' ' LYS . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.763 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CG ' HG21 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.87 HG11 ' CE3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.874 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.024 HG22 HG22 ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG12 ' A' ' 61' ' ' VAL . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 15.1 mm100 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 96' ' ' VAL . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' N ' HD21 ' A' ' 59' ' ' LEU . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 94' ' ' THR . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.423 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 20' ' ' LEU . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.428 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.965 ' CH2' HD12 ' A' ' 11' ' ' LEU . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.76 HD13 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.618 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.76 ' CG ' HD13 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.874 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 146' ' ' LEU . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 140' ' ' GLN . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.729 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.934 HD22 HG21 ' A' ' 39' ' ' VAL . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.93 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.734 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.928 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.116 HG22 HG22 ' A' ' 88' ' ' THR . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 20' ' ' LEU . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.934 HG21 HD22 ' A' ' 6' ' ' LEU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HG2' HD11 ' A' ' 64' ' ' LEU . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HG21 ' A' ' 10' ' ' VAL . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 19' ' ' LEU . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.856 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.962 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.962 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.59 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 123' ' ' TRP . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.61 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' PHE . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' HG2' ' A' ' 69' ' ' GLN . 18.6 t-80 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.616 HG11 ' CE3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.116 HG22 HG22 ' A' ' 12' ' ' VAL . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HD22 ' A' ' 59' ' ' LEU . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.949 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.949 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.442 ' HE2' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.967 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 18' ' ' VAL . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.833 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.641 HD11 HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.516 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD1' HD11 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.928 ' CH2' HD12 ' A' ' 11' ' ' LEU . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.862 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 111' ' ' ILE . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' CB ' HG23 ' A' ' 153' ' ' VAL . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HB2' HD22 ' A' ' 126' ' ' LEU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 7.4 t60 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.541 ' CE2' HG11 ' A' ' 71' ' ' VAL . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.675 ' CE1' HG23 ' A' ' 70' ' ' ILE . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.673 ' HB2' HD21 ' A' ' 146' ' ' LEU . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.426 HD11 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG23 ' CB ' ' A' ' 132' ' ' LYS . 11.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.622 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.893 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.833 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.882 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.042 HG22 HG22 ' A' ' 88' ' ' THR . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.688 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' N ' HD13 ' A' ' 108' ' ' LEU . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 59' ' ' LEU . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 111' ' ' ILE . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.568 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.568 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 6' ' ' LEU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.776 HG12 HD21 ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.908 ' HB2' HG23 ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.908 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.926 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 123' ' ' TRP . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.612 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.622 ' HE2' ' HB2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.48 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.77 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.042 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' A' ' 59' ' ' LEU . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 96' ' ' VAL . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.936 HG23 HG22 ' A' ' 94' ' ' THR . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 103' ' ' PRO . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.426 ' C ' HG12 ' A' ' 18' ' ' VAL . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.882 ' HH2' HD12 ' A' ' 11' ' ' LEU . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.725 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.775 HD13 ' CB ' ' A' ' 133' ' ' PHE . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 153' ' ' VAL . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.775 ' CB ' HD13 ' A' ' 126' ' ' LEU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.87 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 132' ' ' LYS . 27.9 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.028 0.442 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.902 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.023 HG22 HG22 ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' C ' HD13 ' A' ' 108' ' ' LEU . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.791 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' A' ' 111' ' ' ILE . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.614 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.85 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.85 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.69 0.281 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 20' ' ' LEU . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.856 HD13 HD21 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.938 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.84 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 91' ' ' ILE . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.914 HG21 ' HG ' ' A' ' 64' ' ' LEU . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.914 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 127' ' ' LEU . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 123' ' ' TRP . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.715 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.884 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.023 HG22 HG22 ' A' ' 12' ' ' VAL . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.51 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.903 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.903 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.818 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 18' ' ' VAL . 60.5 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.639 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 145' ' ' ILE . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 150' ' ' LEU . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.637 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.555 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 126' ' ' LEU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.671 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 118' ' ' PRO . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 132' ' ' LYS . 23.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 39' ' ' VAL . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.855 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.854 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.017 HG22 HG22 ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CE1' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' HD12 ' A' ' 13' ' ' LEU . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.619 ' HB ' HD22 ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 103' ' ' PRO . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.661 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.647 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.647 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.744 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.697 HG21 HD22 ' A' ' 6' ' ' LEU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.655 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 8' ' ' THR . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.855 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 64' ' ' LEU . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.844 ' HB2' HG23 ' A' ' 60' ' ' THR . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.844 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.95 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.95 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.666 HD11 ' CG ' ' A' ' 123' ' ' TRP . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.757 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.6 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 m80 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.017 HG22 HG22 ' A' ' 12' ' ' VAL . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.82 ' HB2' HD11 ' A' ' 19' ' ' LEU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.552 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.481 ' HB2' HD12 ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 116' ' ' MET . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.854 ' CH2' HD12 ' A' ' 11' ' ' LEU . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' LEU . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.708 ' HB2' HD22 ' A' ' 126' ' ' LEU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' HG11 ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.757 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' HD21 ' A' ' 146' ' ' LEU . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.592 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 39' ' ' VAL . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HE1' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 88' ' ' THR . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.782 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 HG22 ' A' ' 111' ' ' ILE . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.61 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.854 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.733 0.301 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.61 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' CA ' HD22 ' A' ' 20' ' ' LEU . 2.6 p-10 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.732 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 6' ' ' LEU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.812 HG22 HG22 ' A' ' 8' ' ' THR . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.854 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HG2' HD11 ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.855 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.927 HG21 ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.927 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 127' ' ' LEU . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.763 HG23 ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.813 ' CD ' HD22 ' A' ' 80' ' ' LEU . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.625 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.548 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.813 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.527 ' HE1' ' HB ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' VAL . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 45' ' ' ILE . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.587 HG11 ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.058 HG22 HG22 ' A' ' 12' ' ' VAL . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.748 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.622 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.45 ' C ' HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.89 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.743 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.589 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.59 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.42 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD11 ' A' ' 150' ' ' LEU . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.763 ' CE1' HG23 ' A' ' 70' ' ' ILE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.774 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.82 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.976 HD22 HG21 ' A' ' 39' ' ' VAL . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.875 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 88' ' ' THR . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.636 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 103' ' ' PRO . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.598 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.78 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.598 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.722 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 8' ' ' THR . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.772 HD22 HG21 ' A' ' 10' ' ' VAL . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 91' ' ' ILE . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.873 HG21 ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.873 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.747 HG23 ' CE1' ' A' ' 137' ' ' PHE . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.57 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.654 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.555 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.688 HG11 ' CE3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.028 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.911 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.911 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' LEU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.82 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.999 HD13 HD21 ' A' ' 128' ' ' LEU . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.688 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 20' ' ' LEU . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 118' ' ' PRO . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 117' ' ' TRP . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.841 ' CD1' HD11 ' A' ' 150' ' ' LEU . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.875 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 133' ' ' PHE . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.999 HD21 HD13 ' A' ' 108' ' ' LEU . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 153' ' ' VAL . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.866 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' HG23 ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.747 ' CE1' HG23 ' A' ' 70' ' ' ILE . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.799 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.841 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 132' ' ' LYS . 16.8 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.014 HD22 HG21 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.991 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.569 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.926 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.538 ' N ' HD12 ' A' ' 13' ' ' LEU . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.652 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 33' ' ' ASN . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.572 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 31' ' ' ARG . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' N ' HD22 ' A' ' 20' ' ' LEU . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HD22 ' A' ' 6' ' ' LEU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 91' ' ' ILE . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.903 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 123' ' ' TRP . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.636 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.553 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.937 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.103 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 59' ' ' LEU . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 94' ' ' THR . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 96' ' ' VAL . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.418 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' LEU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.646 HG23 HG11 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.674 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 126' ' ' LEU . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.926 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.674 ' CE1' ' HE1' ' A' ' 116' ' ' MET . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.548 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 126' ' ' LEU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' NE2' HG23 ' A' ' 71' ' ' VAL . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.584 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.734 ' CG ' HD21 ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 118' ' ' PRO . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.734 HD21 ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.486 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 HG21 ' A' ' 39' ' ' VAL . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.95 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.975 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 88' ' ' THR . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.719 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 13' ' ' LEU . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.684 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.531 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.865 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.646 0.26 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.543 ' CB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.755 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.943 HG21 HD22 ' A' ' 6' ' ' LEU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.746 HD13 HD21 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.95 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.853 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.885 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.793 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.938 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.597 ' HB2' HG21 ' A' ' 45' ' ' ILE . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.059 HG22 HG22 ' A' ' 12' ' ' VAL . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' NH1' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.775 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.774 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' VAL . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 20' ' ' LEU . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 145' ' ' ILE . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.631 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.975 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.818 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.81 HD13 ' CG ' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.624 ' NE2' HG11 ' A' ' 153' ' ' VAL . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.793 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.591 ' CE1' HG23 ' A' ' 70' ' ' ILE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.728 ' CE ' HG13 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.921 ' HB2' HD11 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.701 HG21 ' CD ' ' A' ' 140' ' ' GLN . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.495 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.494 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.684 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.624 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.4 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.987 HD22 HG21 ' A' ' 39' ' ' VAL . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.825 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.764 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.807 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' C ' HD13 ' A' ' 108' ' ' LEU . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' N ' HD13 ' A' ' 108' ' ' LEU . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.778 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.722 HD11 HG22 ' A' ' 111' ' ' ILE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.594 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.38 0.133 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.727 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.987 HG21 HD22 ' A' ' 6' ' ' LEU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.791 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.825 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 91' ' ' ILE . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 123' ' ' TRP . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.645 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.056 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.962 ' CE2' HG23 ' A' ' 111' ' ' ILE . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.962 HG23 ' CE2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CE3' HG11 ' A' ' 85' ' ' VAL . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.66 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 153' ' ' VAL . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' HD22 ' A' ' 126' ' ' LEU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.877 ' NE2' HG11 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.529 ' HE2' HG13 ' A' ' 75' ' ' VAL . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.638 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.731 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 140' ' ' GLN . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.877 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.2 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.073 0.463 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HG22 ' A' ' 88' ' ' THR . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.817 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 103' ' ' PRO . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.8 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 p-10 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.822 HG21 HD22 ' A' ' 6' ' ' LEU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.925 HD11 HD21 ' A' ' 6' ' ' LEU . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.886 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.872 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.0 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' A' ' 19' ' ' LEU . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.872 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.869 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' CG ' ' A' ' 123' ' ' TRP . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.562 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.823 HG11 ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.869 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.97 HG22 HG22 ' A' ' 12' ' ' VAL . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.793 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.625 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 18' ' ' VAL . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 13' ' ' LEU . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.615 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.615 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.424 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.62 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.601 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 108' ' ' LEU . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.715 ' HB2' HD22 ' A' ' 126' ' ' LEU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.612 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 2.4 m80 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HE3' HG21 ' A' ' 75' ' ' VAL . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.664 ' OE1' HG21 ' A' ' 144' ' ' THR . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.664 HG21 ' OE1' ' A' ' 140' ' ' GLN . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 118' ' ' PRO . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.566 HG11 ' CE1' ' A' ' 134' ' ' HIS . 27.7 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.826 0.346 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.57 -178.0 35.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.2 -176.02 2.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 111.059 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.72 91.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.845 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.855 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.041 HG22 HG22 ' A' ' 88' ' ' THR . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.55 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 HG23 ' A' ' 111' ' ' ILE . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 111' ' ' ILE . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.8 119.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.02 -113.2 0.73 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.379 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 10.4 p90 -100.24 74.88 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.77 23.94 2.94 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.101 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -55.7 93.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.817 0.309 . . . . 0.0 111.11 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.401 ' CA ' HD22 ' A' ' 20' ' ' LEU . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 6' ' ' LEU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.845 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.597 ' HG2' HD11 ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.787 HD22 HG21 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 91' ' ' ILE . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.839 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.969 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.969 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' A' ' 137' ' ' PHE . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.576 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 81' ' ' MET . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' HB2' HG21 ' A' ' 45' ' ' ILE . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 ' CE3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.041 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 59' ' ' LEU . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' LEU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.571 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.805 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.436 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HD2' HD11 ' A' ' 150' ' ' LEU . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.761 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 111' ' ' ILE . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.419 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 t60 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.677 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.675 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.654 ' HB2' HD11 ' A' ' 146' ' ' LEU . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.623 HD11 ' HD2' ' A' ' 122' ' ' TYR . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.52 167.87 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -169.64 -42.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -101.9 -178.63 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 155' ' ' THR . 21.4 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.95 118.31 0.82 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.558 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.21 86.34 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.106 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.47 97.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.974 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.918 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.998 HG22 HG22 ' A' ' 88' ' ' THR . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.1 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 111' ' ' ILE . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.609 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.37 153.31 5.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.22 -127.68 8.77 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.178 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.11 81.4 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.15 -3.46 3.71 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.339 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.69 120.1 2.46 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.996 0.398 . . . . 0.0 111.56 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.609 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 20' ' ' LEU . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 10' ' ' VAL . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' THR . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 6' ' ' LEU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.912 HD11 HD21 ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.974 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CG ' HD12 ' A' ' 64' ' ' LEU . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.736 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.675 HD11 ' CG ' ' A' ' 123' ' ' TRP . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.834 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.4 t60 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG11 ' CE3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.897 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.998 HG22 HG22 ' A' ' 12' ' ' VAL . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.769 HG22 HG12 ' A' ' 61' ' ' VAL . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.592 HG22 HG23 ' A' ' 96' ' ' VAL . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 94' ' ' THR . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.53 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.961 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.584 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.616 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.628 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.918 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.786 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD23 HD12 ' A' ' 126' ' ' LEU . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 153' ' ' VAL . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.575 ' HB2' HD13 ' A' ' 126' ' ' LEU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.549 ' CE1' HG21 ' A' ' 153' ' ' VAL . 1.5 m-70 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.48 ' HE2' HG13 ' A' ' 75' ' ' VAL . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.517 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG21 ' CE1' ' A' ' 134' ' ' HIS . 5.8 m -144.02 148.64 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -177.8 37.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.2 m -109.63 111.65 23.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.14 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.65 -83.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.26 -167.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p 56.61 89.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.953 HD22 HG21 ' A' ' 39' ' ' VAL . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.874 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.872 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.962 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 88' ' ' THR . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.796 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 59' ' ' LEU . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 111' ' ' ILE . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.608 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.04 160.66 24.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.75 9.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.272 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -100.0 78.4 2.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.62 -13.41 1.56 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.161 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.884 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.81 141.4 1.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.968 0.384 . . . . 0.0 111.624 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.608 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.428 ' CA ' HD22 ' A' ' 20' ' ' LEU . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.953 HG21 HD22 ' A' ' 6' ' ' LEU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HB3' HG12 ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HD21 ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.874 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.773 ' HB2' HG23 ' A' ' 60' ' ' THR . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 103' ' ' PRO . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.806 HD12 HD21 ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.773 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.861 HG21 ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.517 HD11 ' CD1' ' A' ' 123' ' ' TRP . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.694 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' OH ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.933 HG11 ' CE3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.057 HG22 HG22 ' A' ' 12' ' ' VAL . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.675 HD13 HD13 ' A' ' 59' ' ' LEU . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.897 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.897 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HD11 ' A' ' 19' ' ' LEU . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.414 ' C ' HG12 ' A' ' 18' ' ' VAL . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.755 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.443 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.596 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.962 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.777 HD13 ' CG ' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HD2' HG11 ' A' ' 156' ' ' VAL . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.777 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 16.4 t-80 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.694 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.704 ' HB2' HD11 ' A' ' 146' ' ' LEU . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.728 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.76 161.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -141.94 31.29 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -130.1 102.1 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 132' ' ' LYS . 10.7 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.024 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.21 170.49 23.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.516 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.37 62.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -174.99 93.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.821 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.891 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' C ' HD13 ' A' ' 108' ' ' LEU . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.905 HG11 HG23 ' A' ' 111' ' ' ILE . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.86 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.819 HD11 HG22 ' A' ' 111' ' ' ILE . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.811 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -172.25 107.32 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.37 -117.85 0.65 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -100.01 23.71 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.01 32.09 0.04 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.837 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.811 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -54.66 103.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.958 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.884 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HG21 ' A' ' 10' ' ' VAL . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.724 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.925 HG21 ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.925 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 123' ' ' TRP . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 70' ' ' ILE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.646 HG11 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.029 HG22 HG22 ' A' ' 12' ' ' VAL . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.929 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HB2' HD11 ' A' ' 19' ' ' LEU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.772 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.905 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.633 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.592 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.891 ' CH2' HD12 ' A' ' 11' ' ' LEU . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.787 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.787 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 146' ' ' LEU . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.865 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 118' ' ' PRO . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.562 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.25 161.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.83 -33.2 9.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -103.27 156.16 17.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.084 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.8 0.333 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.59 52.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 -175.46 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.004 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.42 84.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.817 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 88' ' ' THR . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 108' ' ' LEU . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.903 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.626 HD11 ' SD ' ' A' ' 116' ' ' MET . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.17 115.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.3 -119.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.08 23.78 9.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.271 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.45 30.77 0.05 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -54.53 146.8 15.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 8' ' ' THR . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 6' ' ' LEU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.806 ' HB2' HG23 ' A' ' 60' ' ' THR . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.676 HD13 HD13 ' A' ' 91' ' ' ILE . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.804 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG13 ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.2 t60 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.738 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.9 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.988 HG22 HG22 ' A' ' 12' ' ' VAL . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.676 HD13 HD13 ' A' ' 59' ' ' LEU . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 94' ' ' THR . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 94' ' ' THR . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' THR . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.438 ' HE1' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.903 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.402 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.584 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.817 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.655 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.744 ' NZ ' HG13 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.587 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.694 ' HG2' HD11 ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.524 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.489 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.666 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m -142.2 147.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -148.4 -50.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.6 m -68.13 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.151 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.55 -161.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.01 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.37 86.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 39' ' ' VAL . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.482 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.078 HG22 HG22 ' A' ' 88' ' ' THR . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 13' ' ' LEU . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.653 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.592 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.757 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -162.7 164.24 26.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.16 -130.13 10.12 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.18 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.24 83.34 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.66 0.2 3.65 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.457 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.63 146.64 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.168 0.484 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.669 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 8' ' ' THR . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.96 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.787 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.836 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 10' ' ' VAL . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.915 HG21 ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.915 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.693 HG23 ' HE1' ' A' ' 137' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.681 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 7' ' ' TYR . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' HG21 ' A' ' 45' ' ' ILE . 13.4 t-80 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG11 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.078 HG22 HG22 ' A' ' 12' ' ' VAL . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 59' ' ' LEU . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.908 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.819 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.704 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.879 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.789 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.885 HD13 ' CB ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.719 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.885 ' CB ' HD13 ' A' ' 126' ' ' LEU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.585 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.693 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' CE ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.628 ' HB2' HD21 ' A' ' 146' ' ' LEU . 13.7 tp60 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' A' ' 132' ' ' LYS . 5.9 m -125.97 167.99 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -177.4 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -62.48 128.67 37.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.099 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.835 0.35 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.14 -56.28 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.96 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p 56.68 90.38 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.971 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.955 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.834 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.62 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 105' ' ' TRP . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.574 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.35 156.26 14.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.97 -127.72 8.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.086 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.14 79.88 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.982 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.11 1.31 2.93 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.623 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -46.2 143.63 2.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.311 0.555 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.955 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.834 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.848 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.831 HD13 HD13 ' A' ' 91' ' ' ILE . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.848 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.869 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.869 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.684 HG21 ' CD2' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.626 HG22 ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.754 HG13 ' OD1' ' A' ' 82' ' ' ASP . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HG22 ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.576 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 64' ' ' LEU . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.061 HG22 HG22 ' A' ' 12' ' ' VAL . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.831 HD13 HD13 ' A' ' 59' ' ' LEU . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.652 HG22 HG23 ' A' ' 96' ' ' VAL . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.652 HG23 HG22 ' A' ' 94' ' ' THR . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.513 ' O ' HD12 ' A' ' 19' ' ' LEU . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.662 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 18' ' ' VAL . 21.2 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.657 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 150' ' ' LEU . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.932 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.768 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.768 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.674 ' HG2' HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.902 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.902 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.538 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.99 159.95 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.55 -47.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -91.75 164.82 13.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.037 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.85 -124.39 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 -172.04 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 111.111 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.59 88.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD21 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.936 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.816 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.929 HG22 HG22 ' A' ' 88' ' ' THR . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.924 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.92 151.34 7.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.68 -125.76 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.098 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -100.18 71.55 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.767 0.318 . . . . 0.0 110.769 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.64 -18.93 0.59 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.215 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.924 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -40.26 129.05 2.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.971 0.386 . . . . 0.0 111.755 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 52' ' ' GLU . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.829 HG21 ' CB ' ' A' ' 84' ' ' HIS . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.936 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 64' ' ' LEU . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' CG ' ' HA3' ' A' ' 37' ' ' GLY . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 91' ' ' ILE . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.913 HG21 ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.913 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 127' ' ' LEU . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 123' ' ' TRP . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.494 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.829 ' CB ' HG21 ' A' ' 45' ' ' ILE . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.866 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.495 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.929 HG22 HG22 ' A' ' 12' ' ' VAL . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 59' ' ' LEU . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.865 ' HB2' HD11 ' A' ' 19' ' ' LEU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.837 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 20' ' ' LEU . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.564 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 150' ' ' LEU . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.898 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 116' ' ' MET . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 111' ' ' ILE . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.83 ' HB2' HD13 ' A' ' 126' ' ' LEU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CE1' HG23 ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 73' ' ' GLU . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HE2' HG22 ' A' ' 75' ' ' VAL . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 146' ' ' LEU . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CB ' ' A' ' 132' ' ' LYS . 13.1 m -145.3 157.14 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -144.82 -48.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.09 170.29 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.055 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.72 -127.15 5.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.62 61.49 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -174.82 93.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.741 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 88' ' ' THR . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 13' ' ' LEU . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 105' ' ' TRP . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.919 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.31 168.85 16.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.6 -130.35 10.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -100.18 72.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.64 -19.19 0.3 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.533 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -38.44 120.88 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.151 0.476 . . . . 0.0 111.798 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.837 HG21 HD22 ' A' ' 6' ' ' LEU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 HG22 ' A' ' 8' ' ' THR . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HG2' HD11 ' A' ' 64' ' ' LEU . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.741 HD22 HG21 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD22 HD12 ' A' ' 91' ' ' ILE . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.89 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.89 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.586 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.758 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 71' ' ' VAL . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.868 HG11 ' CE3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.046 HG22 HG22 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 88' ' ' THR . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.676 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.647 ' SD ' HD21 ' A' ' 20' ' ' LEU . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.58 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.466 ' HD2' HD11 ' A' ' 150' ' ' LEU . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.868 ' CE3' HG11 ' A' ' 85' ' ' VAL . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.658 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 133' ' ' PHE . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.669 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.838 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 132' ' ' LYS . 23.5 m -141.71 144.16 26.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -133.91 -51.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.1 131.31 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.148 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.838 0.352 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.66 98.28 2.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.5 -168.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p 56.24 89.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 39' ' ' VAL . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HB2' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.797 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 88' ' ' THR . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.601 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.772 ' CG2' HD22 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.618 ' CD1' HG22 ' A' ' 111' ' ' ILE . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.559 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.836 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.63 143.35 3.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.82 -125.29 6.25 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.181 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -99.94 76.28 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 110.759 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.49 -12.69 2.25 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.062 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.01 106.4 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HD22 ' A' ' 6' ' ' LEU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.596 ' HG3' HG13 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' THR . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.836 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 91' ' ' ILE . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.648 HD11 ' CD1' ' A' ' 123' ' ' TRP . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG23 ' A' ' 83' ' ' VAL . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' HG2' ' A' ' 81' ' ' MET . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.987 HG22 HG22 ' A' ' 12' ' ' VAL . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 59' ' ' LEU . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.895 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.78 ' HB2' HD11 ' A' ' 19' ' ' LEU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.716 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.591 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 150' ' ' LEU . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.746 ' NE2' HG21 ' A' ' 153' ' ' VAL . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.744 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 122' ' ' TYR . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.746 HG21 ' NE2' ' A' ' 134' ' ' HIS . 28.2 m -147.64 148.9 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -136.23 31.88 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.66 111.05 23.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.45 160.81 9.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.565 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.02 76.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.914 0.388 . . . . 0.0 111.124 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -175.47 94.57 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.954 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.937 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.964 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 88' ' ' THR . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.557 ' N ' HD12 ' A' ' 13' ' ' LEU . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.749 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' HG22 ' A' ' 111' ' ' ILE . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.615 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.785 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.55 115.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.09 -120.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.351 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -100.03 23.97 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.33 31.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.053 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -56.69 145.89 27.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.615 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.698 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.954 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.654 ' CG ' HD12 ' A' ' 64' ' ' LEU . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.645 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.787 HD13 HD13 ' A' ' 91' ' ' ILE . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.645 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 91' ' ' ILE . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.7 t60 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.813 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.787 HD13 HD13 ' A' ' 59' ' ' LEU . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 96' ' ' VAL . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.432 ' N ' HD21 ' A' ' 59' ' ' LEU . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 94' ' ' THR . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.569 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.627 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HB2' HD12 ' A' ' 145' ' ' ILE . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.665 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.449 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 150' ' ' LEU . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.964 ' CH2' HD12 ' A' ' 11' ' ' LEU . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.508 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 108' ' ' LEU . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HB3' HG23 ' A' ' 153' ' ' VAL . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.71 ' HB2' HD22 ' A' ' 126' ' ' LEU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.468 ' NE2' HG23 ' A' ' 71' ' ' VAL . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 122' ' ' TYR . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 132' ' ' LYS . 15.4 m -145.26 149.23 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -172.09 -55.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -86.44 155.29 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.071 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.753 0.311 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.48 -28.08 5.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.34 -170.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 111.079 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.12 106.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.671 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.917 HG22 HG23 ' A' ' 45' ' ' ILE . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.814 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.894 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 88' ' ' THR . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.753 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.666 HD11 HG22 ' A' ' 111' ' ' ILE . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.582 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.7 146.26 5.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.74 -125.2 6.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.091 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.19 74.01 1.74 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.5 -12.18 1.35 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.372 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.13 119.44 1.35 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.081 0.441 . . . . 0.0 111.644 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.403 ' CA ' HD22 ' A' ' 20' ' ' LEU . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 6' ' ' LEU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' HG12 ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.917 HG23 HG22 ' A' ' 8' ' ' THR . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.824 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 64' ' ' LEU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD22 HG21 ' A' ' 10' ' ' VAL . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.843 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.968 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.968 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD2' ' A' ' 127' ' ' LEU . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 137' ' ' PHE . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.671 HG22 ' HB2' ' A' ' 7' ' ' TYR . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CE3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.016 HG22 HG22 ' A' ' 12' ' ' VAL . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 94' ' ' THR . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.5 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.821 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.793 ' CD1' HD13 ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.708 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.402 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.549 ' HD2' HD11 ' A' ' 150' ' ' LEU . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.894 ' CH2' HD12 ' A' ' 11' ' ' LEU . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.6 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.838 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.649 ' HB2' HD21 ' A' ' 146' ' ' LEU . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.568 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.83 157.4 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.64 -40.26 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -60.15 -66.02 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.035 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.79 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.67 -171.6 12.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.64 -168.78 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.091 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.6 84.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.859 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.047 HG22 HG22 ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.934 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.934 HG23 HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 103' ' ' PRO . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.846 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.77 153.67 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.02 -127.04 8.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.13 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 78.44 2.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.767 0.317 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.84 -4.89 2.47 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.48 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.846 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.96 144.18 1.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.171 0.485 . . . . 0.0 111.525 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.709 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.793 HG21 HD22 ' A' ' 6' ' ' LEU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 91' ' ' ILE . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.934 HG21 ' HG ' ' A' ' 64' ' ' LEU . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.934 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 68' ' ' GLY . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 ' CE1' ' A' ' 137' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.748 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.606 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.737 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.887 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.047 HG22 HG22 ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 59' ' ' LEU . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.944 ' HB2' HD11 ' A' ' 19' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.877 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.824 HD11 ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.793 ' CD1' HD11 ' A' ' 150' ' ' LEU . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.859 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.588 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.871 ' HB2' HD13 ' A' ' 126' ' ' LEU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 70' ' ' ILE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.752 ' HG2' HD21 ' A' ' 146' ' ' LEU . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.444 ' O ' ' NE2' ' A' ' 142' ' ' GLN . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.793 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 132' ' ' LYS . 9.9 m -144.85 149.36 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.27 -54.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.5 t -88.83 158.65 18.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.102 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.815 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.06 -139.17 2.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.19 -168.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 90.17 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.85 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.96 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.07 HG22 HG22 ' A' ' 88' ' ' THR . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.709 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.709 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.709 ' CD2' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.605 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.863 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.07 142.9 2.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 133.84 -128.26 4.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.272 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -100.27 23.52 9.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.559 0.219 . . . . 0.0 111.322 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.15 18.72 0.09 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.551 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -57.9 148.79 24.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.124 0.462 . . . . 0.0 110.883 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.605 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.631 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' HD11 ' A' ' 64' ' ' LEU . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.966 HG21 ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.966 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.699 HD11 ' CG ' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.744 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.07 HG22 HG22 ' A' ' 12' ' ' VAL . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.932 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.932 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.894 ' HB2' HD11 ' A' ' 19' ' ' LEU . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.887 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.572 ' O ' HG12 ' A' ' 18' ' ' VAL . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.666 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.666 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.6 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.96 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.912 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.744 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.874 ' HG2' HD11 ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.776 HG21 ' OE1' ' A' ' 140' ' ' GLN . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 138' ' ' LYS . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 174.71 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.56 33.33 20.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 38.2 m -83.91 132.05 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.147 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.64 43.44 4.84 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.549 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.12 -168.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p 56.31 87.77 0.05 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.983 HD22 HG21 ' A' ' 39' ' ' VAL . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.743 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.806 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 88' ' ' THR . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.71 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.599 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.828 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.3 139.02 2.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 23' ' ' LYS . . . 137.28 -127.55 4.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.344 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.586 0.231 . . . . 0.0 111.31 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -169.85 22.17 0.09 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.342 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.828 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -57.11 147.36 24.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.95 0.375 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.983 HG21 HD22 ' A' ' 6' ' ' LEU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.821 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 64' ' ' LEU . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 91' ' ' ILE . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.851 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.892 HG21 ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 123' ' ' TRP . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 82' ' ' ASP . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 70' ' ' ILE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 71' ' ' VAL . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' CE3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.932 HG22 HG22 ' A' ' 12' ' ' VAL . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.536 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.812 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 20' ' ' LEU . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.533 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 150' ' ' LEU . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.806 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.673 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.601 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.905 ' HB2' HD13 ' A' ' 126' ' ' LEU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.585 ' CD2' HG11 ' A' ' 153' ' ' VAL . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.498 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.561 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 132' ' ' LYS . 20.2 m -142.25 148.0 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -130.38 -47.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -78.51 125.39 29.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.096 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.882 0.373 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.07 80.02 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.449 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -103.75 81.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.58 92.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 39' ' ' VAL . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.929 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.76 HG21 HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.745 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 88' ' ' THR . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.82 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' C ' HD13 ' A' ' 108' ' ' LEU . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.566 ' N ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.82 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG22 ' A' ' 111' ' ' ILE . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.645 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.49 151.94 6.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.96 -125.47 7.76 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -100.02 80.27 2.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.973 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 141.52 -13.95 2.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.947 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.844 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -44.02 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' THR . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.941 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.929 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.804 HD21 HG13 ' A' ' 61' ' ' VAL . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.859 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.901 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.901 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.746 HD11 ' CD1' ' A' ' 123' ' ' TRP . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.741 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.077 HG22 HG22 ' A' ' 12' ' ' VAL . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' LEU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.778 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' VAL . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.409 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.47 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.746 ' CD1' HD11 ' A' ' 70' ' ' ILE . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.666 ' HB2' HD22 ' A' ' 126' ' ' LEU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.89 ' CD2' HG11 ' A' ' 153' ' ' VAL . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.784 ' HB2' HD11 ' A' ' 146' ' ' LEU . 5.5 tp-100 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.412 ' O ' ' NE2' ' A' ' 142' ' ' GLN . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 138' ' ' LYS . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 122' ' ' TYR . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.89 HG11 ' CD2' ' A' ' 134' ' ' HIS . 20.2 m -145.67 147.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -133.02 -46.9 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 27.7 m -95.58 102.63 14.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.016 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 76.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -60.09 99.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.084 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -177.8 99.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 88' ' ' THR . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.884 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 103' ' ' PRO . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.658 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.48 118.59 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.53 -121.46 1.03 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -100.07 23.81 9.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.684 0.278 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.57 30.64 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.992 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -55.1 147.73 15.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.807 HG21 HD22 ' A' ' 6' ' ' LEU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.754 HG12 HD21 ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 10' ' ' VAL . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.547 HD12 HD21 ' A' ' 19' ' ' LEU . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.93 HG21 ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.93 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.542 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG23 ' CE1' ' A' ' 137' ' ' PHE . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.676 ' OE1' HD22 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.676 HD22 ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 69' ' ' GLN . 38.3 t-80 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.799 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.012 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 59' ' ' LEU . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HB2' HD11 ' A' ' 19' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.789 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.884 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.652 ' HD2' HD11 ' A' ' 150' ' ' LEU . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.921 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.865 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 133' ' ' PHE . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.684 ' HB3' HG23 ' A' ' 153' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 146' ' ' LEU . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.938 ' HB2' HD11 ' A' ' 146' ' ' LEU . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 139' ' ' PHE . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 132' ' ' LYS . 28.5 m -130.56 169.4 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.5 27.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.7 t -78.97 79.75 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.089 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.32 140.52 24.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.94 75.75 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.18 91.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.002 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.879 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.93 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.001 HG22 HG22 ' A' ' 88' ' ' THR . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.581 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' HD13 ' A' ' 108' ' ' LEU . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.629 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.67 119.92 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.07 -120.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.423 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.18 24.0 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.615 0.245 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.25 28.39 0.06 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.357 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.98 149.28 27.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.903 0.351 . . . . 0.0 110.826 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.002 HG21 HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.818 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.755 HD21 HG13 ' A' ' 61' ' ' VAL . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.621 HG23 ' CE1' ' A' ' 137' ' ' PHE . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.856 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 80' ' ' LEU . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.877 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.001 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.947 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.947 ' HD2' HG22 ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 94' ' ' THR . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.666 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.417 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.93 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.828 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 13' ' ' LEU . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.717 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.856 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 70' ' ' ILE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.432 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 140' ' ' GLN . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.708 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.86 161.81 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.75 -33.15 6.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.4 m -87.5 117.9 26.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.162 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.09 -174.09 32.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.51 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.98 -168.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 111.026 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p 56.02 86.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.23 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD22 ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HG22 ' A' ' 88' ' ' THR . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' C ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.758 ' CD2' HD12 ' A' ' 59' ' ' LEU . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 111' ' ' ILE . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.923 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.41 151.74 8.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.56 -130.42 7.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.984 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -100.25 21.55 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.648 0.261 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.58 -1.93 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.314 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.93 153.24 0.31 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.739 0.77 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.838 HG21 HD22 ' A' ' 6' ' ' LEU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 64' ' ' LEU . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.83 HD22 HG21 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.758 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.715 ' CG1' HG21 ' A' ' 88' ' ' THR . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.654 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.897 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.86 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.787 ' HB3' HD22 ' A' ' 64' ' ' LEU . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.99 HG22 HG22 ' A' ' 12' ' ' VAL . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 59' ' ' LEU . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 94' ' ' THR . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.587 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.401 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.408 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.533 ' CD1' HD11 ' A' ' 150' ' ' LEU . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.86 ' CE3' HG11 ' A' ' 85' ' ' VAL . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.699 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 153' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.742 ' HB2' HD22 ' A' ' 126' ' ' LEU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.442 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 75' ' ' VAL . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.778 ' HB2' HD11 ' A' ' 146' ' ' LEU . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 118' ' ' PRO . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 140' ' ' GLN . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 132' ' ' LYS . 6.5 m -145.81 159.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.96 31.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.864 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 23.5 m -151.1 -57.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.149 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.37 163.77 29.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 79' ' ' GLU . . . -138.95 -178.61 5.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.59 101.59 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.993 HD22 HG21 ' A' ' 39' ' ' VAL . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.965 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.803 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.802 ' CD2' HD12 ' A' ' 59' ' ' LEU . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.841 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.01 121.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.07 -122.17 1.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.376 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -100.18 23.08 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.628 0.251 . . . . 0.0 111.201 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -175.45 22.85 0.06 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.43 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -52.39 119.13 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.015 0.408 . . . . 0.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB2' HG13 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 HD22 ' A' ' 6' ' ' LEU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.734 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.606 ' CG ' HD12 ' A' ' 64' ' ' LEU . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.843 HD22 HG21 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.802 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.77 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG22 ' HE2' ' A' ' 138' ' ' LYS . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.763 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CG ' HG21 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.87 HG11 ' CE3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.874 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.024 HG22 HG22 ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG12 ' A' ' 61' ' ' VAL . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 15.1 mm100 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 96' ' ' VAL . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' N ' HD21 ' A' ' 59' ' ' LEU . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 94' ' ' THR . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 20' ' ' LEU . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.428 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.965 ' CH2' HD12 ' A' ' 11' ' ' LEU . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.76 HD13 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.618 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.76 ' CG ' HD13 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.874 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 146' ' ' LEU . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 140' ' ' GLN . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.729 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.14 157.68 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.52 31.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -113.84 147.78 37.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.134 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.767 0.317 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.31 -32.72 2.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.49 92.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.81 99.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.934 HD22 HG21 ' A' ' 39' ' ' VAL . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.93 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.734 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.928 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.116 HG22 HG22 ' A' ' 88' ' ' THR . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.49 121.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.35 -122.29 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.377 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.09 23.43 9.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.71 28.55 0.06 OUTLIER Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.126 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -56.4 149.09 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.848 0.324 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 20' ' ' LEU . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.934 HG21 HD22 ' A' ' 6' ' ' LEU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HG2' HD11 ' A' ' 64' ' ' LEU . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HG21 ' A' ' 10' ' ' VAL . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 19' ' ' LEU . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.856 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.962 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.962 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.59 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 123' ' ' TRP . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.61 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' PHE . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' HG2' ' A' ' 69' ' ' GLN . 18.6 t-80 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.616 HG11 ' CE3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.116 HG22 HG22 ' A' ' 12' ' ' VAL . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HD22 ' A' ' 59' ' ' LEU . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.949 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.949 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.442 ' HE2' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.967 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 18' ' ' VAL . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.833 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.641 HD11 HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.516 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD1' HD11 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.928 ' CH2' HD12 ' A' ' 11' ' ' LEU . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.862 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 111' ' ' ILE . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' CB ' HG23 ' A' ' 153' ' ' VAL . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HB2' HD22 ' A' ' 126' ' ' LEU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 7.4 t60 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.541 ' CE2' HG11 ' A' ' 71' ' ' VAL . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.675 ' CE1' HG23 ' A' ' 70' ' ' ILE . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.673 ' HB2' HD21 ' A' ' 146' ' ' LEU . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.426 HD11 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG23 ' CB ' ' A' ' 132' ' ' LYS . 11.9 m -131.74 142.12 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.96 -55.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -121.06 83.61 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.127 -179.967 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.23 -65.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.574 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.67 -166.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.053 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p 55.96 85.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.622 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.893 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.833 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.882 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.042 HG22 HG22 ' A' ' 88' ' ' THR . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.688 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' N ' HD13 ' A' ' 108' ' ' LEU . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 59' ' ' LEU . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 111' ' ' ILE . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.568 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -161.34 -179.22 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 -138.27 14.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.08 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -99.99 23.82 9.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.756 0.312 . . . . 0.0 110.833 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' C ' ' HB2' ' A' ' 23' ' ' LYS . . . -140.08 -20.88 0.36 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.589 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -35.85 126.04 0.71 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.1 0.45 . . . . 0.0 112.025 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.568 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 6' ' ' LEU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.776 HG12 HD21 ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.908 ' HB2' HG23 ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.908 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.926 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 123' ' ' TRP . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.612 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.622 ' HE2' ' HB2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.48 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.77 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.042 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' A' ' 59' ' ' LEU . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 96' ' ' VAL . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.936 HG23 HG22 ' A' ' 94' ' ' THR . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 103' ' ' PRO . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.426 ' C ' HG12 ' A' ' 18' ' ' VAL . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.882 ' HH2' HD12 ' A' ' 11' ' ' LEU . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.725 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.775 HD13 ' CB ' ' A' ' 133' ' ' PHE . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 153' ' ' VAL . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.775 ' CB ' HD13 ' A' ' 126' ' ' LEU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.87 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 132' ' ' LYS . 27.9 m -142.93 174.86 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.64 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 m -84.93 109.37 18.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.1 -179.946 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.45 103.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.616 ' HB3' ' CG ' ' A' ' 79' ' ' GLU . . . -101.26 176.45 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t 177.77 103.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.026 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.902 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.023 HG22 HG22 ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' C ' HD13 ' A' ' 108' ' ' LEU . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.791 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' A' ' 111' ' ' ILE . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.614 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.85 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.47 138.82 3.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.99 -127.19 3.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.273 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.179 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.4 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.85 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -60.33 148.81 35.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.996 0.398 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 20' ' ' LEU . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.856 HD13 HD21 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.938 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.84 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 91' ' ' ILE . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.914 HG21 ' HG ' ' A' ' 64' ' ' LEU . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.914 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 127' ' ' LEU . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 123' ' ' TRP . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.616 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.715 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.884 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.023 HG22 HG22 ' A' ' 12' ' ' VAL . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.51 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.903 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.903 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.818 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 18' ' ' VAL . 60.5 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.639 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 145' ' ' ILE . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 150' ' ' LEU . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.637 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.555 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 126' ' ' LEU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.671 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 118' ' ' PRO . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 132' ' ' LYS . 23.7 m -144.0 144.98 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.95 -46.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.967 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.8 m -63.84 143.41 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.174 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.833 0.349 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.32 65.29 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.37 -179.64 6.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.06 89.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 39' ' ' VAL . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.855 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.854 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.017 HG22 HG22 ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CE1' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' HD12 ' A' ' 13' ' ' LEU . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.619 ' HB ' HD22 ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 103' ' ' PRO . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.661 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.647 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.74 154.16 9.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -128.31 8.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.053 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -100.12 76.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.727 0.299 . . . . 0.0 110.909 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.42 -7.22 2.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.551 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.3 141.09 1.01 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.261 0.53 . . . . 0.0 111.711 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.647 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.744 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.697 HG21 HD22 ' A' ' 6' ' ' LEU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.655 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 8' ' ' THR . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.855 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 64' ' ' LEU . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.844 ' HB2' HG23 ' A' ' 60' ' ' THR . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.844 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.95 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.95 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.666 HD11 ' CG ' ' A' ' 123' ' ' TRP . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.757 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.6 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 m80 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.017 HG22 HG22 ' A' ' 12' ' ' VAL . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.82 ' HB2' HD11 ' A' ' 19' ' ' LEU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.552 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.481 ' HB2' HD12 ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 116' ' ' MET . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.854 ' CH2' HD12 ' A' ' 11' ' ' LEU . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' LEU . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.708 ' HB2' HD22 ' A' ' 126' ' ' LEU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' HG11 ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.757 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' HD21 ' A' ' 146' ' ' LEU . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.592 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m -144.91 138.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.43 -48.32 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.5 m -99.42 -58.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.109 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.69 -92.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.523 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.86 96.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.77 99.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 39' ' ' VAL . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HE1' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 88' ' ' THR . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.782 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 HG22 ' A' ' 111' ' ' ILE . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.61 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.92 160.75 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 -128.54 9.59 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.221 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -100.12 80.82 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 110.91 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.9 -7.48 2.69 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.311 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.854 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.57 141.51 2.74 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.143 0.471 . . . . 0.0 111.516 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.61 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' CA ' HD22 ' A' ' 20' ' ' LEU . 2.6 p-10 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.732 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 6' ' ' LEU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.812 HG22 HG22 ' A' ' 8' ' ' THR . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.854 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HG2' HD11 ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.855 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.927 HG21 ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.927 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 127' ' ' LEU . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.763 HG23 ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.813 ' CD ' HD22 ' A' ' 80' ' ' LEU . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.625 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.548 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.813 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.527 ' HE1' ' HB ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' VAL . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 45' ' ' ILE . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.587 HG11 ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.058 HG22 HG22 ' A' ' 12' ' ' VAL . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.748 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.622 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.45 ' C ' HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.89 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.743 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.589 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.59 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.42 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD11 ' A' ' 150' ' ' LEU . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.763 ' CE1' HG23 ' A' ' 70' ' ' ILE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.774 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.82 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.0 164.88 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.65 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -78.08 97.46 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.151 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.815 0.341 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.71 1.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.74 -167.94 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.054 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p 56.61 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.976 HD22 HG21 ' A' ' 39' ' ' VAL . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.875 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 88' ' ' THR . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.636 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 103' ' ' PRO . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.598 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.78 140.63 6.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.91 -138.08 13.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.333 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.6 75.27 9.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.335 . . . . 0.0 110.762 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.35 -15.36 1.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.78 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -43.5 94.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.598 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.722 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 8' ' ' THR . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.772 HD22 HG21 ' A' ' 10' ' ' VAL . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 91' ' ' ILE . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.873 HG21 ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.873 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.747 HG23 ' CE1' ' A' ' 137' ' ' PHE . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.57 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.654 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.555 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.688 HG11 ' CE3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.028 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.911 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.911 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' LEU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.82 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.999 HD13 HD21 ' A' ' 128' ' ' LEU . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.688 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 20' ' ' LEU . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 118' ' ' PRO . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 117' ' ' TRP . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.841 ' CD1' HD11 ' A' ' 150' ' ' LEU . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.875 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 133' ' ' PHE . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.999 HD21 HD13 ' A' ' 108' ' ' LEU . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 153' ' ' VAL . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.866 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' HG23 ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.747 ' CE1' HG23 ' A' ' 70' ' ' ILE . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.799 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.841 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 132' ' ' LYS . 16.8 m -144.33 138.55 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.92 -47.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 t -60.3 119.99 8.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.11 179.98 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.848 0.356 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.13 -135.51 2.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -151.03 -168.02 2.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.76 96.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.014 HD22 HG21 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.991 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.569 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.926 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.538 ' N ' HD12 ' A' ' 13' ' ' LEU . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.652 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 33' ' ' ASN . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.572 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.84 -178.21 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.08 -137.41 14.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.042 -179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.13 59.43 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.815 0.341 . . . . 0.0 110.701 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 29' ' ' ALA . . . 179.71 -31.62 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.388 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -22.07 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 31' ' ' ARG . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' N ' HD22 ' A' ' 20' ' ' LEU . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HD22 ' A' ' 6' ' ' LEU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 91' ' ' ILE . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.903 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 123' ' ' TRP . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.811 ' HG3' ' HB3' ' A' ' 3' ' ' ALA . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.553 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.937 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.103 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 59' ' ' LEU . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 94' ' ' THR . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 96' ' ' VAL . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.418 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' LEU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.646 HG23 HG11 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.674 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 126' ' ' LEU . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.926 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.674 ' CE1' ' HE1' ' A' ' 116' ' ' MET . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.548 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 126' ' ' LEU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' NE2' HG23 ' A' ' 71' ' ' VAL . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.584 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.734 ' CG ' HD21 ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 118' ' ' PRO . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.734 HD21 ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.486 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.58 138.99 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.24 36.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.7 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.136 -179.992 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.21 178.78 11.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.55 76.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.866 0.365 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -175.98 95.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 HG21 ' A' ' 39' ' ' VAL . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.95 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.975 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 88' ' ' THR . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.719 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 13' ' ' LEU . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.684 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.531 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.865 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.16 138.66 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.59 -125.7 3.54 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.132 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -100.32 23.45 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.911 -0.17 . . . . 0.0 111.423 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -166.94 17.07 0.08 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.713 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.34 123.52 16.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.263 0.532 . . . . 0.0 110.91 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.543 ' CB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.755 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.943 HG21 HD22 ' A' ' 6' ' ' LEU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.746 HD13 HD21 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.95 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.853 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.885 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.793 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.938 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.597 ' HB2' HG21 ' A' ' 45' ' ' ILE . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.059 HG22 HG22 ' A' ' 12' ' ' VAL . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' NH1' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.775 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.774 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' VAL . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 20' ' ' LEU . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 145' ' ' ILE . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.631 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.975 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.818 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.81 HD13 ' CG ' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.624 ' NE2' HG11 ' A' ' 153' ' ' VAL . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.793 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.591 ' CE1' HG23 ' A' ' 70' ' ' ILE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.728 ' CE ' HG13 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.921 ' HB2' HD11 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.701 HG21 ' CD ' ' A' ' 140' ' ' GLN . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.495 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.494 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.684 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.624 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.4 m -124.24 174.9 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.19 37.16 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 155' ' ' THR . 7.8 t -77.66 92.68 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.127 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.861 0.362 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.89 158.76 8.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.44 -172.08 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p 55.28 87.25 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.987 HD22 HG21 ' A' ' 39' ' ' VAL . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.825 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.764 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.807 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' C ' HD13 ' A' ' 108' ' ' LEU . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' N ' HD13 ' A' ' 108' ' ' LEU . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.778 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.722 HD11 HG22 ' A' ' 111' ' ' ILE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.594 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -141.97 -173.97 3.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 -144.69 17.38 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.929 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.43 25.26 7.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.524 0.202 . . . . 0.0 111.253 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -173.93 35.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.544 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . -41.09 -91.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.006 0.403 . . . . 0.0 110.994 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.727 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.987 HG21 HD22 ' A' ' 6' ' ' LEU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.791 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.825 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 91' ' ' ILE . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 123' ' ' TRP . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.645 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.056 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.962 ' CE2' HG23 ' A' ' 111' ' ' ILE . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.962 HG23 ' CE2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CE3' HG11 ' A' ' 85' ' ' VAL . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.66 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 153' ' ' VAL . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' HD22 ' A' ' 126' ' ' LEU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.877 ' NE2' HG11 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.529 ' HE2' HG13 ' A' ' 75' ' ' VAL . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.638 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.731 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 140' ' ' GLN . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.877 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.2 m -145.47 141.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.19 -53.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.998 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.23 143.44 48.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.97 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.798 0.333 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.19 46.33 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -152.78 95.86 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -177.36 100.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.038 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HG22 ' A' ' 88' ' ' THR . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.817 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 103' ' ' PRO . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.8 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.21 127.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.69 -123.46 1.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.411 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.12 23.66 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -174.93 26.26 0.07 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.306 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.23 144.02 42.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.858 0.329 . . . . 0.0 110.89 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 p-10 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.822 HG21 HD22 ' A' ' 6' ' ' LEU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.925 HD11 HD21 ' A' ' 6' ' ' LEU . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.886 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.872 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.0 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' A' ' 19' ' ' LEU . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.872 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.869 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' CG ' ' A' ' 123' ' ' TRP . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.823 HG11 ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.869 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.97 HG22 HG22 ' A' ' 12' ' ' VAL . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.793 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.625 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 18' ' ' VAL . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 13' ' ' LEU . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.615 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.615 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.424 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.62 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.601 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 108' ' ' LEU . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.715 ' HB2' HD22 ' A' ' 126' ' ' LEU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.612 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 2.4 m80 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HE3' HG21 ' A' ' 75' ' ' VAL . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.664 ' OE1' HG21 ' A' ' 144' ' ' THR . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.664 HG21 ' OE1' ' A' ' 140' ' ' GLN . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 118' ' ' PRO . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.566 HG11 ' CE1' ' A' ' 134' ' ' HIS . 27.7 m -144.34 141.96 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -176.54 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 36.4 m -66.48 90.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.105 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.845 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.855 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.041 HG22 HG22 ' A' ' 88' ' ' THR . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.55 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 HG23 ' A' ' 111' ' ' ILE . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 111' ' ' ILE . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.709 0.29 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.401 ' CA ' HD22 ' A' ' 20' ' ' LEU . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 6' ' ' LEU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.845 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.597 ' HG2' HD11 ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.787 HD22 HG21 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 91' ' ' ILE . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.839 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.969 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.969 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' A' ' 137' ' ' PHE . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.576 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 81' ' ' MET . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' HB2' HG21 ' A' ' 45' ' ' ILE . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 ' CE3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.041 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 59' ' ' LEU . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' LEU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.571 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.805 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.436 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HD2' HD11 ' A' ' 150' ' ' LEU . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.761 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 111' ' ' ILE . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.467 ' CE1' HG23 ' A' ' 71' ' ' VAL . 22.8 t-80 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.677 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.675 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.654 ' HB2' HD11 ' A' ' 146' ' ' LEU . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.623 HD11 ' HD2' ' A' ' 122' ' ' TYR . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.974 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.918 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.998 HG22 HG22 ' A' ' 88' ' ' THR . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.7 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 111' ' ' ILE . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.609 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.687 0.279 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.609 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 20' ' ' LEU . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 10' ' ' VAL . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' THR . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 6' ' ' LEU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.912 HD11 HD21 ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.974 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CG ' HD12 ' A' ' 64' ' ' LEU . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.736 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.675 HD11 ' CG ' ' A' ' 123' ' ' TRP . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.834 ' CB ' HG21 ' A' ' 45' ' ' ILE . 2.5 t-80 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG11 ' CE3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.897 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.998 HG22 HG22 ' A' ' 12' ' ' VAL . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.769 HG22 HG12 ' A' ' 61' ' ' VAL . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.592 HG22 HG23 ' A' ' 96' ' ' VAL . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 94' ' ' THR . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.53 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.961 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.584 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.616 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.628 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.918 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.786 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD23 HD12 ' A' ' 126' ' ' LEU . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 153' ' ' VAL . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.575 ' HB2' HD13 ' A' ' 126' ' ' LEU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.564 ' CD2' HG21 ' A' ' 153' ' ' VAL . 36.0 m170 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.48 ' HE2' HG13 ' A' ' 75' ' ' VAL . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.517 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 134' ' ' HIS . 5.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.953 HD22 HG21 ' A' ' 39' ' ' VAL . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.874 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.872 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.962 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 88' ' ' THR . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.796 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 59' ' ' LEU . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 111' ' ' ILE . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.608 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.884 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.608 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.428 ' CA ' HD22 ' A' ' 20' ' ' LEU . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.953 HG21 HD22 ' A' ' 6' ' ' LEU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HB3' HG12 ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HD21 ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.874 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.773 ' HB2' HG23 ' A' ' 60' ' ' THR . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 103' ' ' PRO . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.806 HD12 HD21 ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.773 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.861 HG21 ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.517 HD11 ' CD1' ' A' ' 123' ' ' TRP . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.694 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' OH ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.933 HG11 ' CE3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.057 HG22 HG22 ' A' ' 12' ' ' VAL . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.675 HD13 HD13 ' A' ' 59' ' ' LEU . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.897 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.897 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HD11 ' A' ' 19' ' ' LEU . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.414 ' C ' HG12 ' A' ' 18' ' ' VAL . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.755 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.443 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.596 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.962 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.777 HD13 ' CG ' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.777 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.694 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.704 ' HB2' HD11 ' A' ' 146' ' ' LEU . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.728 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.821 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.891 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.519 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' C ' HD13 ' A' ' 108' ' ' LEU . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.905 HG11 HG23 ' A' ' 111' ' ' ILE . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.86 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.819 HD11 HG22 ' A' ' 111' ' ' ILE . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.811 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.811 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.958 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.884 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HG21 ' A' ' 10' ' ' VAL . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.724 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.925 HG21 ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.925 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 123' ' ' TRP . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 70' ' ' ILE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.646 HG11 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.029 HG22 HG22 ' A' ' 12' ' ' VAL . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.929 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HB2' HD11 ' A' ' 19' ' ' LEU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.772 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.905 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.633 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.592 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.891 ' CH2' HD12 ' A' ' 11' ' ' LEU . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.787 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.787 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 12.3 m170 -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 146' ' ' LEU . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.865 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 118' ' ' PRO . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.562 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.817 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 88' ' ' THR . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 108' ' ' LEU . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.903 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.626 HD11 ' SD ' ' A' ' 116' ' ' MET . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 8' ' ' THR . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 6' ' ' LEU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.806 ' HB2' HG23 ' A' ' 60' ' ' THR . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.676 HD13 HD13 ' A' ' 91' ' ' ILE . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.804 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG13 ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 66' ' ' LYS . 10.6 t-160 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.738 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.9 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.988 HG22 HG22 ' A' ' 12' ' ' VAL . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.676 HD13 HD13 ' A' ' 59' ' ' LEU . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 94' ' ' THR . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 94' ' ' THR . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' THR . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.438 ' HE1' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.903 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.402 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.584 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.817 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.655 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.744 ' NZ ' HG13 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.587 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.694 ' HG2' HD11 ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.524 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.489 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.666 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 39' ' ' VAL . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.482 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.078 HG22 HG22 ' A' ' 88' ' ' THR . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 13' ' ' LEU . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.653 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.592 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.757 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.669 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 8' ' ' THR . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.96 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.787 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.836 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 10' ' ' VAL . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.915 HG21 ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.915 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.693 HG23 ' HE1' ' A' ' 137' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.681 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 7' ' ' TYR . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.9 t60 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG11 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.078 HG22 HG22 ' A' ' 12' ' ' VAL . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 59' ' ' LEU . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.908 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.819 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.704 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.879 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.789 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.885 HD13 ' CB ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.719 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.885 ' CB ' HD13 ' A' ' 126' ' ' LEU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.585 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.693 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' CE ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.628 ' HB2' HD21 ' A' ' 146' ' ' LEU . 5.8 tp-100 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' A' ' 132' ' ' LYS . 5.9 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.971 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.955 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.834 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.62 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 105' ' ' TRP . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.574 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.751 0.31 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.955 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.834 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.848 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.831 HD13 HD13 ' A' ' 91' ' ' ILE . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.848 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.869 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.869 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.684 HG21 ' CD2' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.626 HG22 ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.754 HG13 ' OD1' ' A' ' 82' ' ' ASP . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HG22 ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.576 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 64' ' ' LEU . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.061 HG22 HG22 ' A' ' 12' ' ' VAL . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.831 HD13 HD13 ' A' ' 59' ' ' LEU . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.652 HG22 HG23 ' A' ' 96' ' ' VAL . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.652 HG23 HG22 ' A' ' 94' ' ' THR . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.513 ' O ' HD12 ' A' ' 19' ' ' LEU . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.662 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.9 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.657 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 150' ' ' LEU . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.932 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.768 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.768 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.674 ' HG2' HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.902 ' HB2' HD11 ' A' ' 146' ' ' LEU . 5.9 tp60 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.902 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.538 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD21 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.936 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.816 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.929 HG22 HG22 ' A' ' 88' ' ' THR . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.924 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.924 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 52' ' ' GLU . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 43' ' ' GLU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.829 HG21 ' CB ' ' A' ' 84' ' ' HIS . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.936 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 64' ' ' LEU . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' CG ' ' HA3' ' A' ' 37' ' ' GLY . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 91' ' ' ILE . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.913 HG21 ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.913 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 127' ' ' LEU . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 123' ' ' TRP . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.494 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.829 ' CB ' HG21 ' A' ' 45' ' ' ILE . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.866 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.495 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.929 HG22 HG22 ' A' ' 12' ' ' VAL . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 59' ' ' LEU . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.865 ' HB2' HD11 ' A' ' 19' ' ' LEU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.837 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 20' ' ' LEU . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.564 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 150' ' ' LEU . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.898 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 116' ' ' MET . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 111' ' ' ILE . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.83 ' HB2' HD13 ' A' ' 126' ' ' LEU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CE1' HG23 ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 73' ' ' GLU . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HE2' HG22 ' A' ' 75' ' ' VAL . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 146' ' ' LEU . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CB ' ' A' ' 132' ' ' LYS . 13.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.741 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 88' ' ' THR . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 13' ' ' LEU . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 105' ' ' TRP . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.919 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.837 HG21 HD22 ' A' ' 6' ' ' LEU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 HG22 ' A' ' 8' ' ' THR . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HG2' HD11 ' A' ' 64' ' ' LEU . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.741 HD22 HG21 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD22 HD12 ' A' ' 91' ' ' ILE . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.89 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.89 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.758 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 71' ' ' VAL . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.868 HG11 ' CE3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.046 HG22 HG22 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 88' ' ' THR . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.676 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.647 ' SD ' HD21 ' A' ' 20' ' ' LEU . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.58 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.466 ' HD2' HD11 ' A' ' 150' ' ' LEU . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.868 ' CE3' HG11 ' A' ' 85' ' ' VAL . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.658 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 133' ' ' PHE . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.669 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 19.4 m170 -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.838 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 132' ' ' LYS . 23.5 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 39' ' ' VAL . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HB2' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.797 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 88' ' ' THR . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.601 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.772 ' CG2' HD22 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.618 ' CD1' HG22 ' A' ' 111' ' ' ILE . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.559 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.836 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HD22 ' A' ' 6' ' ' LEU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.596 ' HG3' HG13 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' THR . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.836 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 91' ' ' ILE . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.648 HD11 ' CD1' ' A' ' 123' ' ' TRP . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG23 ' A' ' 83' ' ' VAL . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' HG2' ' A' ' 81' ' ' MET . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.987 HG22 HG22 ' A' ' 12' ' ' VAL . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 59' ' ' LEU . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.895 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.78 ' HB2' HD11 ' A' ' 19' ' ' LEU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.716 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.591 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 150' ' ' LEU . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.746 ' NE2' HG21 ' A' ' 153' ' ' VAL . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.744 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 122' ' ' TYR . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.746 HG21 ' NE2' ' A' ' 134' ' ' HIS . 28.2 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.954 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.937 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 9' ' ' LEU . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.964 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 88' ' ' THR . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.557 ' N ' HD12 ' A' ' 13' ' ' LEU . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.749 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' HG22 ' A' ' 111' ' ' ILE . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.615 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.785 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.615 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.698 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.954 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.654 ' CG ' HD12 ' A' ' 64' ' ' LEU . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.645 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.787 HD13 HD13 ' A' ' 91' ' ' ILE . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.645 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 91' ' ' ILE . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG3' ' CD2' ' A' ' 84' ' ' HIS . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.3 t-160 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.813 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.787 HD13 HD13 ' A' ' 59' ' ' LEU . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 96' ' ' VAL . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' N ' HD21 ' A' ' 59' ' ' LEU . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 94' ' ' THR . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.569 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.627 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HB2' HD12 ' A' ' 145' ' ' ILE . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.665 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.449 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 150' ' ' LEU . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.964 ' CH2' HD12 ' A' ' 11' ' ' LEU . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.508 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 108' ' ' LEU . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HB3' HG23 ' A' ' 153' ' ' VAL . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.71 ' HB2' HD22 ' A' ' 126' ' ' LEU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.468 ' NE2' HG23 ' A' ' 71' ' ' VAL . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 122' ' ' TYR . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 132' ' ' LYS . 15.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.671 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.917 HG22 HG23 ' A' ' 45' ' ' ILE . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.814 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.894 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 88' ' ' THR . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.753 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.666 HD11 HG22 ' A' ' 111' ' ' ILE . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.582 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.403 ' CA ' HD22 ' A' ' 20' ' ' LEU . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 6' ' ' LEU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' HG12 ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.917 HG23 HG22 ' A' ' 8' ' ' THR . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.824 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 64' ' ' LEU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD22 HG21 ' A' ' 10' ' ' VAL . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.843 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.968 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.968 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD2' ' A' ' 127' ' ' LEU . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 137' ' ' PHE . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.671 HG22 ' HB2' ' A' ' 7' ' ' TYR . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 t-160 -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CE3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.016 HG22 HG22 ' A' ' 12' ' ' VAL . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 94' ' ' THR . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.5 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.821 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.793 ' CD1' HD13 ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.708 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.402 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.549 ' HD2' HD11 ' A' ' 150' ' ' LEU . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.894 ' CH2' HD12 ' A' ' 11' ' ' LEU . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.6 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.838 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.649 ' HB2' HD21 ' A' ' 146' ' ' LEU . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.568 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.859 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.047 HG22 HG22 ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.934 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.934 HG23 HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 103' ' ' PRO . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.846 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.846 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.709 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.793 HG21 HD22 ' A' ' 6' ' ' LEU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 91' ' ' ILE . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.934 HG21 ' HG ' ' A' ' 64' ' ' LEU . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.934 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 68' ' ' GLY . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 ' CE1' ' A' ' 137' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.748 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.606 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' HB2' HG21 ' A' ' 45' ' ' ILE . 15.8 m170 -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.737 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.887 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.047 HG22 HG22 ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 59' ' ' LEU . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.944 ' HB2' HD11 ' A' ' 19' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.877 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.824 HD11 ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.793 ' CD1' HD11 ' A' ' 150' ' ' LEU . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.859 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.588 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.871 ' HB2' HD13 ' A' ' 126' ' ' LEU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 70' ' ' ILE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.752 ' HG2' HD21 ' A' ' 146' ' ' LEU . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.793 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 132' ' ' LYS . 9.9 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.85 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.96 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.07 HG22 HG22 ' A' ' 88' ' ' THR . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.709 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.709 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.709 ' CD2' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.605 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.863 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.605 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.631 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' HD11 ' A' ' 64' ' ' LEU . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.966 HG21 ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.966 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.699 HD11 ' CG ' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.744 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.07 HG22 HG22 ' A' ' 12' ' ' VAL . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.932 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.932 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.894 ' HB2' HD11 ' A' ' 19' ' ' LEU . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.887 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.572 ' O ' HG12 ' A' ' 18' ' ' VAL . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.666 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.666 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.418 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.6 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.96 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.912 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.744 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.874 ' HG2' HD11 ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.776 HG21 ' OE1' ' A' ' 140' ' ' GLN . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 138' ' ' LYS . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.983 HD22 HG21 ' A' ' 39' ' ' VAL . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.743 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.806 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 88' ' ' THR . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.71 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.599 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.828 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.828 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.715 0.293 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.983 HG21 HD22 ' A' ' 6' ' ' LEU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.821 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 64' ' ' LEU . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 91' ' ' ILE . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.851 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.892 HG21 ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 123' ' ' TRP . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 82' ' ' ASP . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 70' ' ' ILE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 71' ' ' VAL . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' CE3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.932 HG22 HG22 ' A' ' 12' ' ' VAL . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.536 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.812 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 20' ' ' LEU . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.533 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 150' ' ' LEU . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.806 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.673 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.601 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.905 ' HB2' HD13 ' A' ' 126' ' ' LEU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.585 ' CD2' HG11 ' A' ' 153' ' ' VAL . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.498 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.561 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 132' ' ' LYS . 20.2 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 39' ' ' VAL . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.929 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.76 HG21 HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.745 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 88' ' ' THR . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.82 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' C ' HD13 ' A' ' 108' ' ' LEU . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.566 ' N ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.82 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG22 ' A' ' 111' ' ' ILE . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.645 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.844 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' THR . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.941 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.929 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.804 HD21 HG13 ' A' ' 61' ' ' VAL . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.859 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.901 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.901 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.746 HD11 ' CD1' ' A' ' 123' ' ' TRP . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.741 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.077 HG22 HG22 ' A' ' 12' ' ' VAL . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' LEU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.778 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' VAL . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.409 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.47 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.746 ' CD1' HD11 ' A' ' 70' ' ' ILE . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.666 ' HB2' HD22 ' A' ' 126' ' ' LEU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.89 ' CD2' HG11 ' A' ' 153' ' ' VAL . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.784 ' HB2' HD11 ' A' ' 146' ' ' LEU . 12.1 tp60 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 138' ' ' LYS . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 122' ' ' TYR . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.89 HG11 ' CD2' ' A' ' 134' ' ' HIS . 20.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 88' ' ' THR . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.884 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 103' ' ' PRO . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.658 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.807 HG21 HD22 ' A' ' 6' ' ' LEU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.754 HG12 HD21 ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 10' ' ' VAL . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.547 HD12 HD21 ' A' ' 19' ' ' LEU . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.93 HG21 ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.93 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG23 ' CE1' ' A' ' 137' ' ' PHE . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.676 ' OE1' HD22 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.676 HD22 ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.492 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 4.5 t60 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.799 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE1' ' CD2' ' A' ' 84' ' ' HIS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.012 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 59' ' ' LEU . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HB2' HD11 ' A' ' 19' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.789 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.884 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.652 ' HD2' HD11 ' A' ' 150' ' ' LEU . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.921 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.865 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 133' ' ' PHE . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.684 ' HB3' HG23 ' A' ' 153' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 146' ' ' LEU . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.938 ' HB2' HD11 ' A' ' 146' ' ' LEU . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 139' ' ' PHE . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 132' ' ' LYS . 28.5 m . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.002 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.879 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.93 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.001 HG22 HG22 ' A' ' 88' ' ' THR . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.581 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' HD13 ' A' ' 108' ' ' LEU . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.629 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.62 0.248 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.002 HG21 HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.818 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.755 HD21 HG13 ' A' ' 61' ' ' VAL . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.621 HG23 ' CE1' ' A' ' 137' ' ' PHE . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.856 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 80' ' ' LEU . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.877 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.001 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.947 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.947 ' HD2' HG22 ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 94' ' ' THR . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.666 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.417 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.93 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.828 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 13' ' ' LEU . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.717 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.856 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 70' ' ' ILE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.432 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 140' ' ' GLN . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.708 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.102 0.477 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD22 ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HG22 ' A' ' 88' ' ' THR . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' C ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.758 ' CD2' HD12 ' A' ' 59' ' ' LEU . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 111' ' ' ILE . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.923 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.67 0.271 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.838 HG21 HD22 ' A' ' 6' ' ' LEU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 64' ' ' LEU . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.83 HD22 HG21 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.758 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.715 ' CG1' HG21 ' A' ' 88' ' ' THR . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.654 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.897 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.86 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.787 ' HB3' HD22 ' A' ' 64' ' ' LEU . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.99 HG22 HG22 ' A' ' 12' ' ' VAL . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 59' ' ' LEU . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 94' ' ' THR . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.587 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.401 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.408 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.533 ' CD1' HD11 ' A' ' 150' ' ' LEU . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.86 ' CE3' HG11 ' A' ' 85' ' ' VAL . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.699 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 153' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.742 ' HB2' HD22 ' A' ' 126' ' ' LEU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' HG21 ' A' ' 153' ' ' VAL . 20.8 m170 -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.442 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 75' ' ' VAL . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.778 ' HB2' HD11 ' A' ' 146' ' ' LEU . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 118' ' ' PRO . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 140' ' ' GLN . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 134' ' ' HIS . 6.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.993 HD22 HG21 ' A' ' 39' ' ' VAL . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.965 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.803 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.802 ' CD2' HD12 ' A' ' 59' ' ' LEU . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.841 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.702 0.287 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB2' HG13 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 HD22 ' A' ' 6' ' ' LEU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.734 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.606 ' CG ' HD12 ' A' ' 64' ' ' LEU . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.843 HD22 HG21 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.802 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.77 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HG2' ' CG ' ' A' ' 84' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG22 ' HE2' ' A' ' 138' ' ' LYS . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.763 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CG ' HG21 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.87 HG11 ' CE3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.874 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.024 HG22 HG22 ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG12 ' A' ' 61' ' ' VAL . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 8.9 mm-40 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 96' ' ' VAL . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' N ' HD21 ' A' ' 59' ' ' LEU . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 94' ' ' THR . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 20' ' ' LEU . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.428 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.965 ' CH2' HD12 ' A' ' 11' ' ' LEU . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.76 HD13 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.618 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.76 ' CG ' HD13 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.874 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 146' ' ' LEU . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 140' ' ' GLN . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.729 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.934 HD22 HG21 ' A' ' 39' ' ' VAL . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.93 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.734 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.928 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.116 HG22 HG22 ' A' ' 88' ' ' THR . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 20' ' ' LEU . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.934 HG21 HD22 ' A' ' 6' ' ' LEU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HG2' HD11 ' A' ' 64' ' ' LEU . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HG21 ' A' ' 10' ' ' VAL . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 19' ' ' LEU . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.856 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.962 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.962 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 123' ' ' TRP . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.61 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' PHE . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 2.1 t60 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.616 HG11 ' CE3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.116 HG22 HG22 ' A' ' 12' ' ' VAL . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HD22 ' A' ' 59' ' ' LEU . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.949 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.949 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.442 ' HE2' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.967 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 18' ' ' VAL . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.833 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.641 HD11 HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.516 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD1' HD11 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.928 ' CH2' HD12 ' A' ' 11' ' ' LEU . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.862 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 111' ' ' ILE . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' CB ' HG23 ' A' ' 153' ' ' VAL . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HB2' HD22 ' A' ' 126' ' ' LEU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 71' ' ' VAL . 20.7 t-80 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.541 ' CE2' HG11 ' A' ' 71' ' ' VAL . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.675 ' CE1' HG23 ' A' ' 70' ' ' ILE . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.673 ' HB2' HD21 ' A' ' 146' ' ' LEU . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.426 HD11 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG23 ' CB ' ' A' ' 132' ' ' LYS . 11.9 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.622 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.893 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.833 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.882 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.042 HG22 HG22 ' A' ' 88' ' ' THR . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.688 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' N ' HD13 ' A' ' 108' ' ' LEU . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.776 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 59' ' ' LEU . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 111' ' ' ILE . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.568 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.568 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 6' ' ' LEU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.776 HG12 HD21 ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.908 ' HB2' HG23 ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.908 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.926 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 123' ' ' TRP . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.612 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.622 ' HE2' ' HB2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.48 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.77 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.042 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' A' ' 59' ' ' LEU . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 96' ' ' VAL . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.936 HG23 HG22 ' A' ' 94' ' ' THR . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 103' ' ' PRO . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.426 ' C ' HG12 ' A' ' 18' ' ' VAL . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.882 ' HH2' HD12 ' A' ' 11' ' ' LEU . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.725 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.775 HD13 ' CB ' ' A' ' 133' ' ' PHE . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 153' ' ' VAL . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.775 ' CB ' HD13 ' A' ' 126' ' ' LEU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.87 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 132' ' ' LYS . 27.9 m . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.028 0.442 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.902 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.023 HG22 HG22 ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' C ' HD13 ' A' ' 108' ' ' LEU . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.791 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' A' ' 111' ' ' ILE . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.614 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.85 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.85 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.69 0.281 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 20' ' ' LEU . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.856 HD13 HD21 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.938 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.84 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 91' ' ' ILE . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.914 HG21 ' HG ' ' A' ' 64' ' ' LEU . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.914 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 127' ' ' LEU . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 123' ' ' TRP . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.715 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.884 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.023 HG22 HG22 ' A' ' 12' ' ' VAL . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.51 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.903 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.903 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.818 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 18' ' ' VAL . 47.1 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.639 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 145' ' ' ILE . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 150' ' ' LEU . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.637 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.555 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 126' ' ' LEU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 14.0 m170 -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.671 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 118' ' ' PRO . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 132' ' ' LYS . 23.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 39' ' ' VAL . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.855 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.854 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.017 HG22 HG22 ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CE1' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' HD12 ' A' ' 13' ' ' LEU . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.619 ' HB ' HD22 ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 103' ' ' PRO . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.661 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.647 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.647 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.744 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.697 HG21 HD22 ' A' ' 6' ' ' LEU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.655 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 8' ' ' THR . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.855 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 64' ' ' LEU . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.844 ' HB2' HG23 ' A' ' 60' ' ' THR . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.844 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.95 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.95 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.666 HD11 ' CG ' ' A' ' 123' ' ' TRP . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.757 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.6 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.5 m-70 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.017 HG22 HG22 ' A' ' 12' ' ' VAL . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.82 ' HB2' HD11 ' A' ' 19' ' ' LEU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.552 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.481 ' HB2' HD12 ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 116' ' ' MET . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.854 ' CH2' HD12 ' A' ' 11' ' ' LEU . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' LEU . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.708 ' HB2' HD22 ' A' ' 126' ' ' LEU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' HG11 ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.757 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' HD21 ' A' ' 146' ' ' LEU . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.592 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 39' ' ' VAL . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HE1' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 88' ' ' THR . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.782 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 HG22 ' A' ' 111' ' ' ILE . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.61 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.854 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.733 0.301 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.61 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' CA ' HD22 ' A' ' 20' ' ' LEU . 9.2 p30 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.732 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 6' ' ' LEU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.812 HG22 HG22 ' A' ' 8' ' ' THR . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.854 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HG2' HD11 ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.855 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.927 HG21 ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.927 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 127' ' ' LEU . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.763 HG23 ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.813 ' CD ' HD22 ' A' ' 80' ' ' LEU . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.625 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.548 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.813 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.527 ' HE1' ' HB ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 83' ' ' VAL . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 45' ' ' ILE . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.587 HG11 ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.058 HG22 HG22 ' A' ' 12' ' ' VAL . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.748 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.622 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.45 ' C ' HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.89 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.743 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.589 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.59 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.42 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD11 ' A' ' 150' ' ' LEU . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.763 ' CE1' HG23 ' A' ' 70' ' ' ILE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.774 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.82 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.976 HD22 HG21 ' A' ' 39' ' ' VAL . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.875 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 88' ' ' THR . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.636 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 103' ' ' PRO . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.598 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.78 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.598 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.722 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 8' ' ' THR . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.772 HD22 HG21 ' A' ' 10' ' ' VAL . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 91' ' ' ILE . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.873 HG21 ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.873 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.747 HG23 ' CE1' ' A' ' 137' ' ' PHE . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.57 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.654 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.555 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.688 HG11 ' CE3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.028 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.911 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.911 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' LEU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.82 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.999 HD13 HD21 ' A' ' 128' ' ' LEU . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.688 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 20' ' ' LEU . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 118' ' ' PRO . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 117' ' ' TRP . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.841 ' CD1' HD11 ' A' ' 150' ' ' LEU . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.875 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 133' ' ' PHE . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.999 HD21 HD13 ' A' ' 108' ' ' LEU . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 153' ' ' VAL . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.866 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' HG23 ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.747 ' CE1' HG23 ' A' ' 70' ' ' ILE . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.799 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.841 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 132' ' ' LYS . 16.8 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.014 HD22 HG21 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.991 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.569 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.926 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.538 ' N ' HD12 ' A' ' 13' ' ' LEU . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.652 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 33' ' ' ASN . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.572 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 31' ' ' ARG . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' N ' HD22 ' A' ' 20' ' ' LEU . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HD22 ' A' ' 6' ' ' LEU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 91' ' ' ILE . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.903 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 123' ' ' TRP . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.636 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.553 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.937 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.103 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 59' ' ' LEU . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 94' ' ' THR . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 96' ' ' VAL . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.418 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' LEU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.646 HG23 HG11 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.674 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 126' ' ' LEU . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.926 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.674 ' CE1' ' HE1' ' A' ' 116' ' ' MET . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.548 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 126' ' ' LEU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' NE2' HG23 ' A' ' 71' ' ' VAL . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.584 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.734 ' CG ' HD21 ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 118' ' ' PRO . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.734 HD21 ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.486 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 HG21 ' A' ' 39' ' ' VAL . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.95 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.975 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 88' ' ' THR . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.719 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 13' ' ' LEU . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.684 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.531 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.865 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.646 0.26 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.543 ' CB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.755 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.943 HG21 HD22 ' A' ' 6' ' ' LEU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.746 HD13 HD21 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.95 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.853 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.885 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.793 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.938 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.597 ' HB2' HG21 ' A' ' 45' ' ' ILE . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.059 HG22 HG22 ' A' ' 12' ' ' VAL . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' NH1' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.775 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.774 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' VAL . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 20' ' ' LEU . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 145' ' ' ILE . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.631 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.975 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.818 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.81 HD13 ' CG ' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.624 ' NE2' HG11 ' A' ' 153' ' ' VAL . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.793 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.591 ' CE1' HG23 ' A' ' 70' ' ' ILE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.728 ' CE ' HG13 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.921 ' HB2' HD11 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.701 HG21 ' CD ' ' A' ' 140' ' ' GLN . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.495 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.494 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.684 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.624 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.4 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.987 HD22 HG21 ' A' ' 39' ' ' VAL . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.825 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.764 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.807 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' C ' HD13 ' A' ' 108' ' ' LEU . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' N ' HD13 ' A' ' 108' ' ' LEU . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.778 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.722 HD11 HG22 ' A' ' 111' ' ' ILE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.594 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.38 0.133 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.727 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.987 HG21 HD22 ' A' ' 6' ' ' LEU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.791 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.825 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 91' ' ' ILE . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 123' ' ' TRP . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.645 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.056 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.962 ' CE2' HG23 ' A' ' 111' ' ' ILE . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.962 HG23 ' CE2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CE3' HG11 ' A' ' 85' ' ' VAL . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.66 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 153' ' ' VAL . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' HD22 ' A' ' 126' ' ' LEU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.877 ' NE2' HG11 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.529 ' HE2' HG13 ' A' ' 75' ' ' VAL . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.638 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.731 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 140' ' ' GLN . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.877 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.2 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.073 0.463 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HG22 ' A' ' 88' ' ' THR . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.817 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 103' ' ' PRO . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.8 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.3 p30 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.822 HG21 HD22 ' A' ' 6' ' ' LEU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.925 HD11 HD21 ' A' ' 6' ' ' LEU . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.886 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.872 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' A' ' 19' ' ' LEU . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.872 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.869 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HB3' ' ND1' ' A' ' 134' ' ' HIS . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' CG ' ' A' ' 123' ' ' TRP . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.562 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.823 HG11 ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.869 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.97 HG22 HG22 ' A' ' 12' ' ' VAL . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.793 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.625 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 18' ' ' VAL . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 13' ' ' LEU . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.615 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.615 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.424 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.62 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.601 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 108' ' ' LEU . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.715 ' HB2' HD22 ' A' ' 126' ' ' LEU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.701 ' CD2' HG11 ' A' ' 153' ' ' VAL . 11.7 m170 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HE3' HG21 ' A' ' 75' ' ' VAL . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.664 ' OE1' HG21 ' A' ' 144' ' ' THR . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.664 HG21 ' OE1' ' A' ' 140' ' ' GLN . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 118' ' ' PRO . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 134' ' ' HIS . 27.7 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.826 0.346 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.57 -178.0 35.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.2 -176.02 2.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 111.059 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.72 91.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.262 0.554 . . . . 0.0 111.044 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 81' ' ' MET . 24.8 mmt-85 -67.41 96.18 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.64 115.89 24.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.513 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.512 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.845 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.1 p -125.64 171.67 10.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.4 tt -154.84 108.82 2.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.958 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.62 125.27 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 121.621 0.724 . . . . 0.0 112.025 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.855 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.23 112.83 15.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.513 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.041 HG22 HG22 ' A' ' 88' ' ' THR . 15.2 t -81.29 68.58 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.227 0.537 . . . . 0.0 111.262 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.78 117.96 30.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.949 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.55 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -104.84 157.37 34.33 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.117 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.3 Cg_endo -65.17 33.34 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.498 2.132 . . . . 0.0 112.92 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -160.45 -42.68 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.488 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.29 161.22 38.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.318 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 HG23 ' A' ' 111' ' ' ILE . 4.0 p -129.82 155.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.5 113.97 20.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.728 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 111' ' ' ILE . 11.7 mt -115.55 140.77 48.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.53 126.35 8.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.932 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.2 ttm -113.43 142.44 45.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 mtpt -87.84 146.83 25.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -91.92 -32.83 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 110.344 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.8 119.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.777 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.02 -113.2 0.73 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.379 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 10.4 p90 -100.24 74.88 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.77 23.94 2.94 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.101 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -55.7 93.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.817 0.309 . . . . 0.0 111.11 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.14 17.86 7.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.579 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -132.31 134.82 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.23 152.75 18.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.537 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.401 ' CA ' HD22 ' A' ' 20' ' ' LEU . 22.9 p30 -177.55 162.88 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 111.005 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.48 168.88 11.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.36 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -100.0 98.33 9.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.254 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.69 158.28 23.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.08 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.39 146.73 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.205 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 2.8 ptmt -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 0.0 111.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 6' ' ' LEU . 3.8 t -75.47 111.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.548 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -46.57 171.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -68.05 65.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.05 43.49 0.48 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.999 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.1 pt-20 -126.68 173.02 9.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -100.25 143.18 30.75 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.21 -33.64 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.18 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.52 -28.62 61.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.98 -36.2 36.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.617 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -36.88 67.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.508 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.845 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.73 -31.47 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.597 ' HG2' HD11 ' A' ' 64' ' ' LEU . 25.1 mtt180 -77.45 -53.85 7.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -61.88 -34.2 75.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.36 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -84.19 -19.44 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.787 HD22 HG21 ' A' ' 10' ' ' VAL . 18.8 tp -72.19 -47.21 52.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.0 tt0 -60.68 -25.04 66.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -82.54 -23.21 34.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -76.42 -43.91 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 t -135.99 25.73 3.3 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.846 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.62 14.45 7.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.481 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 91' ' ' ILE . 13.3 mt -103.1 112.73 25.71 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.067 0.46 . . . . 0.0 110.354 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.839 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.28 136.58 37.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.55 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.969 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.5 m -105.85 139.7 26.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 111.97 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -20.08 46.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.08 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 101.1 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.634 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.969 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -67.07 -172.46 0.2 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 110.091 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.07 101.2 4.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.596 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.6 ptmt -61.7 131.41 49.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.249 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 127' ' ' LEU . 27.2 m -120.37 -48.99 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.94 173.19 27.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.035 -1.078 . . . . 0.0 113.25 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 3.0 mt-30 -131.7 114.44 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.61 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' A' ' 137' ' ' PHE . 53.0 mt -101.27 150.02 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.817 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.576 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -127.61 149.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.795 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 11.1 m-85 -129.37 118.07 21.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.1 tt0 -101.84 133.73 46.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.234 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CZ ' ' O ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -97.01 129.26 44.5 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.24 0.543 . . . . 0.0 111.089 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -74.89 123.7 31.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.892 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -19.37 53.81 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.415 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 27.5 mt-10 -114.6 140.99 25.98 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.57 -37.17 7.56 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.444 2.096 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.1 tt0 -59.29 165.6 2.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -144.76 -163.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.321 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.6 mtp -147.23 111.76 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 0.0 110.882 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.66 102.93 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 81' ' ' MET . 21.4 t -106.05 122.1 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.863 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' HB2' HG21 ' A' ' 45' ' ' ILE . 12.3 m80 -93.16 148.63 21.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.564 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 ' CE3' ' A' ' 123' ' ' TRP . 58.7 t -107.3 135.46 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.042 0.449 . . . . 0.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -139.25 131.7 28.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.921 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.7 m -118.44 117.17 28.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.041 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -97.18 -173.8 2.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.194 0.521 . . . . 0.0 111.76 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -160.47 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.791 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 99.36 11.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.272 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 59' ' ' LEU . 50.1 pt -102.8 178.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 110.994 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -132.92 -67.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.231 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.92 -164.18 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.606 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.44 51.47 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-O 120.5 0.19 . . . . 0.0 111.166 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.41 65.43 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.386 2.058 . . . . 0.0 109.235 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.41 61.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.611 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 7.0 pt-20 -46.77 111.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.831 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -87.49 -177.19 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.27 -9.0 57.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.391 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.4 -28.92 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.117 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.13 159.07 27.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.0 111.182 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' MET . 2.7 ttm180 -161.18 95.7 1.37 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' LEU . 76.4 Cg_endo -74.59 160.38 41.41 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.568 2.178 . . . . 0.0 112.664 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.11 119.7 9.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.699 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.888 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -86.51 117.27 25.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.323 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -127.73 -166.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.916 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -88.62 156.04 19.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.571 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -75.09 -2.64 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.629 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -118.16 20.09 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.882 0.372 . . . . 0.0 110.143 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -143.99 21.87 1.76 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.405 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.805 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.01 125.08 91.28 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.906 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 59.2 Cg_endo -89.76 97.88 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.479 2.119 . . . . 0.0 113.401 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -26.1 59.9 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.29 27.77 3.57 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.3 mtm -134.27 -72.98 0.48 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.436 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -157.0 171.21 7.74 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 111.332 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 90.9 Cg_endo -85.44 14.89 2.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.088 2.525 . . . . 0.0 113.248 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -126.11 -22.64 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.713 0.292 . . . . 0.0 111.459 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.8 m-20 -45.02 -52.49 8.83 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -60.19 -17.3 40.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HD2' HD11 ' A' ' 150' ' ' LEU . 61.9 m-85 -84.73 -32.68 23.35 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.7 p-90 -109.25 -2.71 17.74 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-85 -76.34 -52.05 2.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 111.337 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 84.4 Cg_exo -46.82 -36.19 19.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.02 2.48 . . . . 0.0 113.822 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.761 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -79.6 -35.07 40.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.73 -54.52 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.533 0.682 . . . . 0.0 109.537 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 111' ' ' ILE . 7.4 mt -58.44 -28.9 65.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -85.03 -9.67 57.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.98 41.9 1.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.63 159.17 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 38.1 mttt -104.09 135.66 45.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.28 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 111.382 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.467 ' CE1' HG23 ' A' ' 71' ' ' VAL . 22.8 t-80 -144.69 124.92 13.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.254 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.81 148.85 17.12 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 119.934 -1.126 . . . . 0.0 113.354 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.05 112.62 18.94 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.677 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.9 m-85 -113.95 127.54 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.675 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.61 129.62 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 m-85 -108.01 145.62 33.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.065 0.46 . . . . 0.0 111.684 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.654 ' HB2' HD11 ' A' ' 146' ' ' LEU . 35.3 tp60 -84.15 -1.31 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . 173.08 -47.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.79 -31.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.48 -21.98 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 16.4 m -95.06 137.94 33.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.861 0.362 . . . . 0.0 111.294 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 62.9 mt -110.16 140.12 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.697 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.3 mt -120.91 -13.48 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.14 136.06 14.59 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.128 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 30.5 p90 -139.43 131.43 27.85 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.569 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.36 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.5 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.623 HD11 ' HD2' ' A' ' 122' ' ' TYR . 4.9 mp -133.76 124.23 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -131.41 119.69 22.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.66 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.43 141.27 36.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.52 167.87 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.143 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -169.64 -42.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -101.9 -178.63 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.474 ' H ' HG22 ' A' ' 155' ' ' THR . 21.4 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.95 118.31 0.82 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.558 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.21 86.34 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.106 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.47 97.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.162 0.506 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 4.9 mmt-85 -57.5 93.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.324 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -86.57 116.63 24.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.274 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.87 -178.78 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.355 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.974 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.3 p -125.57 168.92 13.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.776 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 9' ' ' LEU . 2.7 tt -156.28 109.41 2.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.315 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.12 124.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.572 0.701 . . . . 0.0 112.045 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.918 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.26 112.99 15.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.619 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.998 HG22 HG22 ' A' ' 88' ' ' THR . 21.0 t -81.28 83.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.128 0.49 . . . . 0.0 111.578 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -109.6 117.97 35.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.934 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mt-30 -104.77 157.13 34.82 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.117 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.6 Cg_endo -65.08 31.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.479 2.119 . . . . 0.0 113.075 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.7 pt20 -160.41 -39.85 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.777 0.323 . . . . 0.0 110.688 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -142.13 161.35 38.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.5 p -131.43 157.29 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.3 OUTLIER -121.29 122.03 38.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 111' ' ' ILE . 6.5 mt -127.24 133.07 50.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 125.48 8.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.682 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.609 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.3 ttm -111.54 142.27 44.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 0.0 110.569 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.2 OUTLIER -83.26 146.63 28.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -27.46 16.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.842 0.353 . . . . 0.0 110.517 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.37 153.31 5.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.22 -127.68 8.77 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.178 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.11 81.4 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.15 -3.46 3.71 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.339 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.69 120.1 2.46 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.996 0.398 . . . . 0.0 111.56 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 22.79 53.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.971 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -136.23 128.1 29.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.661 0.267 . . . . 0.0 110.679 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.609 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.29 150.75 20.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.42 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 20' ' ' LEU . 9.4 t-20 -178.51 151.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 110.988 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -49.02 173.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.486 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 10' ' ' VAL . 2.0 m-85 -105.31 95.1 5.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.902 0.382 . . . . 0.0 110.361 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.81 161.61 49.7 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.899 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' THR . . . -156.64 130.57 2.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.243 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -76.8 137.06 39.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 111.569 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 6' ' ' LEU . 1.7 t -82.2 98.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.096 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -47.4 166.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.31 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.62 87.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.29 47.17 1.46 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.322 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -125.53 172.67 9.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -112.52 139.01 48.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.156 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.912 HD11 HD21 ' A' ' 6' ' ' LEU . 5.9 mt -48.22 -32.17 3.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.5 tt0 -76.77 -29.54 56.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -80.11 -43.34 21.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.182 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.17 -33.11 82.04 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.783 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.974 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.23 -39.74 62.87 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CG ' HD12 ' A' ' 64' ' ' LEU . 35.9 mtt180 -69.17 -56.92 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.054 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.64 -35.93 71.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.37 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.32 -23.91 30.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.614 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -66.86 -51.0 60.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.736 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.5 tt0 -59.89 -26.46 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.643 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.52 -22.49 35.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.715 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -75.44 -44.28 45.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 5.9 t -142.77 30.86 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.78 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 52.38 14.81 2.43 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.61 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -100.15 108.58 20.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.34 177.33 6.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.653 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.0 m -142.33 138.21 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 0.0 111.786 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.86 -19.53 48.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.57 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.4 mt -58.79 177.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.17 101.23 4.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.059 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.6 ptmt -62.62 125.17 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 127' ' ' LEU . 18.7 m -118.45 -49.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.88 169.99 23.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.396 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 50.7 tt0 -131.74 114.55 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.369 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.675 HD11 ' CG ' ' A' ' 123' ' ' TRP . 5.0 mt -103.39 146.84 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 28.0 t -129.13 149.3 33.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.698 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 56.2 m-85 -126.19 118.12 24.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.082 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.54 115.96 31.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.282 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -85.23 136.21 33.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.19 0.519 . . . . 0.0 111.102 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -82.64 108.07 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.785 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.42 -18.66 50.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.287 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.47 108.58 56.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.568 0.223 . . . . 0.0 110.755 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.47 -32.72 11.64 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.398 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -75.04 173.79 10.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -146.87 -165.46 2.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.299 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -146.81 111.47 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.61 102.6 11.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.297 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 83' ' ' VAL . 13.0 p -113.39 116.78 53.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.834 ' CB ' HG21 ' A' ' 45' ' ' ILE . 2.5 t-80 -79.7 165.02 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.685 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG11 ' CE3' ' A' ' 123' ' ' TRP . 79.7 t -116.83 134.86 59.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.897 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -134.2 125.67 28.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.687 -179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.3 m -116.45 117.85 31.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.998 HG22 HG22 ' A' ' 12' ' ' VAL . 13.5 t -92.48 -172.57 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.501 . . . . 0.0 111.576 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.66 -45.92 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.999 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.769 HG22 HG12 ' A' ' 61' ' ' VAL . 8.3 pt -103.71 177.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.745 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 34.2 mm-40 -105.27 73.6 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.912 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.47 89.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.311 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.592 HG22 HG23 ' A' ' 96' ' ' VAL . 97.0 m -160.26 56.41 0.81 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.52 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' SER . 65.8 Cg_endo -75.83 73.46 4.77 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.096 1.864 . . . . 0.0 110.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 94' ' ' THR . 2.5 t -77.34 64.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.584 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.9 pt-20 -42.32 107.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.244 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.58 -173.67 4.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.88 -8.43 56.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.64 -38.61 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.53 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -114.18 159.37 20.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.16 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 7.5 ttt180 -158.94 99.89 1.63 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.553 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 41.4 Cg_endo -66.36 155.12 71.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.326 2.017 . . . . 0.0 112.171 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 17.8 m -142.87 119.56 11.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.658 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.961 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -90.36 124.82 35.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 60.3 m-85 -140.01 -170.48 2.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.657 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.2 mt-30 -89.08 162.15 16.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.927 0.394 . . . . 0.0 110.941 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.8 pt? -80.14 0.97 29.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.661 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -121.06 22.65 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.906 0.384 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -148.08 22.32 1.09 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.584 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.99 127.15 89.91 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.974 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.473 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.2 Cg_endo -92.39 99.03 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.506 2.138 . . . . 0.0 112.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -78.81 -18.2 54.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.251 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -24.51 62.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.455 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 1.4 m-20 -98.63 26.17 5.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.616 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.9 mtm -132.99 -71.69 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 11.7 m95 -158.34 161.43 28.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.01 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 88.0 Cg_endo -79.75 13.74 2.04 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.853 2.369 . . . . 0.0 113.144 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.4 p30 -124.33 -19.71 5.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.628 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.0 m-20 -51.37 -50.05 60.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.419 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 2.4 t -57.82 -17.52 16.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -85.46 -38.99 18.0 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.918 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.9 p-90 -101.16 -9.97 20.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.786 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.71 -46.39 3.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.601 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 79.0 Cg_exo -48.07 -38.38 32.0 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.455 2.103 . . . . 0.0 112.942 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -75.26 -29.66 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.154 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD23 HD12 ' A' ' 126' ' ' LEU . 1.1 mt -64.06 -48.28 76.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 0.0 109.882 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mt -62.41 -28.88 70.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -83.75 2.4 38.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.545 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.97 30.79 18.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.755 0.312 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -118.22 159.13 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 153' ' ' VAL . 18.7 mtmt -109.9 125.01 52.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.575 ' HB2' HD13 ' A' ' 126' ' ' LEU . 13.5 m-85 -138.11 156.77 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.676 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.564 ' CD2' HG21 ' A' ' 153' ' ' VAL . 36.0 m170 -117.68 125.16 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.4 132.96 10.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.305 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.4 m-85 -113.0 110.64 20.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 19.1 m-85 -110.16 130.98 55.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.48 ' HE2' HG13 ' A' ' 75' ' ' VAL . 1.3 tptt -88.54 130.0 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.3 m-30 -104.06 164.06 11.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.14 0.495 . . . . 0.0 111.805 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.8 tp60 -120.29 19.77 12.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.303 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 154.41 -57.27 0.41 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.586 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -177.68 -36.3 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -121.72 8.86 10.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 34.0 m -119.19 134.11 55.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 54.3 mt -110.19 144.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.461 . . . . 0.0 111.042 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.9 mt -123.41 -15.39 7.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.103 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 141.32 19.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 120.723 0.297 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -139.54 128.76 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.428 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.517 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.02 145.37 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.511 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.94 124.41 26.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.988 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.426 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 21.7 mmt180 -126.37 160.2 31.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.52 148.48 23.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.771 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 134' ' ' HIS . 5.8 m -144.02 148.64 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -177.8 37.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.2 m -109.63 111.65 23.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.14 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.65 -83.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.26 -167.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 p 56.61 89.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.236 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.65 95.83 0.08 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.253 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.953 HD22 HG21 ' A' ' 39' ' ' VAL . 1.3 tt -86.72 117.7 25.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.341 0.591 . . . . 0.0 110.511 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 6.0 m-85 -122.5 -179.22 4.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.748 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.874 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 62.4 p -130.77 150.04 52.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.491 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.1 tt -136.28 109.27 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.566 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.872 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -109.17 127.63 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.597 0.713 . . . . 0.0 112.713 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.962 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.37 112.92 15.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.307 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 88' ' ' THR . 4.9 t -89.16 87.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.058 0.456 . . . . 0.0 111.439 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.69 158.38 15.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.962 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.55 157.08 78.12 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.13 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.7 Cg_endo -66.95 24.72 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.445 2.097 . . . . 0.0 113.108 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLN . 39.9 mt-30 -160.53 -41.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -133.91 161.14 35.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.39 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.796 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -126.74 154.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.732 0.301 . . . . 0.0 110.722 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 59' ' ' LEU . 16.1 tp -112.1 107.42 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.48 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 111' ' ' ILE . 6.5 mt -110.43 135.28 51.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.001 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.37 123.08 5.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.188 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.608 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 22.1 ttm -113.67 142.17 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.697 0.284 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -89.77 146.99 24.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -88.86 -32.83 17.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.801 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.04 160.66 24.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.75 9.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.272 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -100.0 78.4 2.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.62 -13.41 1.56 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.161 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.884 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.81 141.4 1.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.968 0.384 . . . . 0.0 111.624 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.65 13.99 61.93 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 17.8 mtt180 -126.21 152.28 46.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.533 0.206 . . . . 0.0 110.51 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.608 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.07 152.62 26.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.542 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.428 ' CA ' HD22 ' A' ' 20' ' ' LEU . 27.0 p30 179.27 163.2 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.925 0.393 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -59.82 176.19 3.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.152 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.7 m-85 -101.42 98.77 9.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -57.68 -174.83 0.38 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.279 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 173.75 162.44 25.6 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 9.1 ptmt -133.31 141.6 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.892 0.377 . . . . 0.0 111.512 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.953 HG21 HD22 ' A' ' 6' ' ' LEU . 1.6 t -82.23 99.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.458 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.45 166.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.25 94.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 51.41 3.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.167 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HB3' HG12 ' A' ' 39' ' ' VAL . 1.5 tt0 -126.02 172.82 9.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.9 p -108.86 140.59 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.329 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HD21 ' A' ' 6' ' ' LEU . 2.2 mp -51.05 -31.72 11.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 5.7 tt0 -76.41 -25.54 54.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.61 -38.83 21.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.898 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.41 -36.2 88.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.45 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.874 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.14 -39.55 54.8 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -66.13 -54.55 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -62.06 -34.09 75.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.181 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -84.25 -19.51 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -77.24 -51.0 11.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.773 ' HB2' HG23 ' A' ' 60' ' ' THR . 8.0 tt0 -58.72 -31.03 67.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.98 -23.32 33.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 mm-40 -76.97 -43.9 33.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 103' ' ' PRO . 12.4 p -131.4 20.16 4.78 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.865 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.0 14.03 9.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.441 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.806 HD12 HD21 ' A' ' 19' ' ' LEU . 8.5 mt -109.21 109.09 19.95 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.773 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.26 167.77 14.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.299 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.861 HG21 ' HG ' ' A' ' 64' ' ' LEU . 19.8 m -135.47 140.12 45.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.91 -21.29 44.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.349 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 96.31 0.02 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.758 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.861 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -62.4 -178.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -135.09 101.28 4.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.02 127.61 32.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 127' ' ' LEU . 22.8 m -124.56 -49.47 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.474 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -137.37 128.55 4.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.512 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 40.0 tt0 -106.52 114.27 28.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.517 HD11 ' CD1' ' A' ' 123' ' ' TRP . 7.7 mt -105.26 150.08 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.321 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -120.19 149.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.486 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 5.4 m-85 -127.23 118.06 23.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 111.321 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.3 tt0 -102.36 122.63 44.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.116 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.42 130.68 43.51 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.351 0.596 . . . . 0.0 111.11 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.694 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -76.29 121.32 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.75 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.38 -21.22 46.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.108 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.25 108.67 62.18 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.557 0.218 . . . . 0.0 110.626 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.78 -42.24 19.6 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.11 . . . . 0.0 112.471 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -66.73 169.91 7.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' OH ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -141.64 -164.34 1.76 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.329 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.5 ttp -145.37 111.27 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.871 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -103.04 102.91 12.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -111.66 117.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.018 0.437 . . . . 0.0 112.166 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.99 147.87 31.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.514 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.933 HG11 ' CE3' ' A' ' 123' ' ' TRP . 15.3 t -110.8 102.24 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -99.13 136.29 39.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.255 -179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 44.2 t -121.44 117.19 26.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.057 HG22 HG22 ' A' ' 12' ' ' VAL . 9.2 t -98.29 -170.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.175 0.512 . . . . 0.0 111.697 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -160.09 -45.51 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.842 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.31 98.36 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.675 HD13 HD13 ' A' ' 59' ' ' LEU . 31.8 pt -103.33 178.79 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.388 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -138.66 -66.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.207 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.27 -178.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.79 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.897 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -112.34 161.58 25.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.499 0.19 . . . . 0.0 111.335 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.897 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.1 Cg_exo -67.94 62.66 0.96 Allowed 'Trans proline' 0 CA--C 1.509 -0.772 0 C-N-CA 122.571 2.181 . . . . 0.0 109.768 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 94' ' ' THR . 16.3 t -76.97 60.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.521 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.1 pt-20 -42.91 118.75 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.071 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -87.51 -177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.15 -15.08 62.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -127.55 20.63 6.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.57 156.62 36.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.021 0.438 . . . . 0.0 111.167 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' MET . 6.5 ttt180 -170.82 101.7 0.42 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.435 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HD11 ' A' ' 19' ' ' LEU . 59.7 Cg_endo -70.82 144.51 48.58 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.183 1.922 . . . . 0.0 112.054 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.58 119.48 23.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.453 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 7.7 m95 -82.98 103.87 12.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.614 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.89 -161.76 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.345 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.414 ' C ' HG12 ' A' ' 18' ' ' VAL . 3.5 mt-30 -99.31 145.21 27.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.755 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -71.15 -10.45 59.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.337 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.14 19.82 14.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -147.08 23.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.79 126.82 90.44 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.02 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.84 98.71 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.507 2.138 . . . . 0.0 113.069 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -76.22 -18.13 59.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.508 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.19 -24.46 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.31 25.74 6.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.4 mtm -133.61 -72.58 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.522 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.408 ' CE3' ' OD2' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -156.68 166.87 15.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.205 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.443 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.3 Cg_endo -84.96 13.59 2.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.033 2.488 . . . . 0.0 113.057 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.408 ' OD2' ' CE3' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -122.8 -20.3 5.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.509 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.596 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.5 m-20 -52.46 -48.33 65.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.443 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 9.5 t -60.21 -17.1 39.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.868 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 11.1 m-85 -84.51 -31.38 24.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.962 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.6 p-90 -110.46 -9.17 14.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.601 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.0 m-85 -70.45 -51.84 12.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 122.426 -0.171 . . . . 0.0 111.376 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.0 Cg_endo -61.22 -23.26 76.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.24 1.96 . . . . 0.0 112.415 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.777 HD13 ' CG ' ' A' ' 133' ' ' PHE . 6.2 mt -83.16 -31.77 26.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 109.915 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -62.67 -57.62 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.493 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.84 -25.55 20.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.72 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 42.8 tp60 -83.8 2.89 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 52.85 36.63 22.06 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.836 0.35 . . . . 0.0 111.326 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -119.3 157.8 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.661 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HD2' HG11 ' A' ' 156' ' ' VAL . 4.5 mtmt -110.56 138.37 47.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.777 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.7 OUTLIER -149.46 171.07 17.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 111.567 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -135.29 124.9 25.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.366 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -125.62 148.69 17.01 Favored Glycine 0 C--O 1.221 -0.664 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.208 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -121.15 110.93 16.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.7 m-30 -108.98 126.23 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 111.82 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.694 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.56 131.28 35.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 m-85 -104.78 164.02 12.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.704 ' HB2' HD11 ' A' ' 146' ' ' LEU . 32.9 tp60 -105.44 -4.79 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.77 -62.46 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.687 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -158.96 -38.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -127.99 15.38 6.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 20.2 m -119.27 133.66 55.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.29 . . . . 0.0 110.957 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 60.2 mt -110.13 137.06 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.481 . . . . 0.0 111.441 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.2 mt -119.4 -11.33 9.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.801 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -154.03 134.24 13.3 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.475 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 24.2 p90 -139.3 123.13 17.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.58 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.28 143.37 47.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.728 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.3 mp -133.96 124.85 27.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -127.02 119.71 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.795 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.8 141.7 28.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.333 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.76 161.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -141.94 31.29 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -130.1 102.1 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 132' ' ' LYS . 10.7 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.024 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.788 0.328 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.21 170.49 23.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.516 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.37 62.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.148 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 p -174.99 93.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.329 0.585 . . . . 0.0 111.214 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 30.5 mmt180 -65.17 94.61 0.15 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.312 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.91 118.41 26.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.257 0.551 . . . . 0.0 110.845 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 19.2 m-30 -122.57 -178.87 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.886 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.8 p -126.26 163.24 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.55 108.94 4.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.088 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.821 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.09 125.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.557 0.694 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.891 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.4 mt -127.19 112.79 15.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.291 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.029 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -82.13 72.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.201 0.524 . . . . 0.0 111.321 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.84 117.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.816 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.8 mt-30 -105.87 157.39 34.81 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' C ' HD13 ' A' ' 108' ' ' LEU . 23.8 Cg_exo -63.95 30.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.68 2.253 . . . . 0.0 112.952 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 24.9 mt-30 -159.55 -42.17 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.321 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -142.17 161.12 38.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.394 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.905 HG11 HG23 ' A' ' 111' ' ' ILE . 4.2 p -128.84 156.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.86 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.44 115.28 22.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.945 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.819 HD11 HG22 ' A' ' 111' ' ' ILE . 23.3 mt -117.87 138.84 51.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 124.39 7.31 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.889 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 43.5 ttm -109.55 142.48 40.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mmmt -88.92 146.51 24.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 2.7 mttp -91.73 -31.03 15.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.811 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -172.25 107.32 0.2 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.897 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.37 -117.85 0.65 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -100.01 23.71 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.01 32.09 0.04 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.837 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.811 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -54.66 103.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.693 0.282 . . . . 0.0 111.091 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.35 20.71 10.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.447 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 27.8 mtt-85 -132.65 129.91 39.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.684 0.278 . . . . 0.0 110.397 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.51 152.92 20.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.406 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.24 164.42 2.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 167.95 9.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.206 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.74 100.07 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.459 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.18 160.25 13.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.943 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.2 -123.51 1.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.254 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -166.73 139.99 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.958 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -75.38 107.82 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -48.7 175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 64.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.22 42.89 0.38 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.241 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.52 172.99 9.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 47' ' ' ASP . 59.3 p -100.76 141.0 34.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.83 0.348 . . . . 0.0 110.777 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.43 -33.01 10.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.069 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.28 -27.36 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' THR . 38.2 m-20 -80.61 -38.06 30.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.28 -35.38 69.71 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.397 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.884 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.17 -33.49 61.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 11.6 mtp-105 -76.01 -54.59 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -34.86 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.412 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.3 -21.1 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.697 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HG21 ' A' ' 10' ' ' VAL . 19.3 tp -70.33 -48.02 58.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.9 tt0 -60.96 -26.56 67.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.787 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.56 -23.42 34.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.21 -43.96 27.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 65.5 m -134.3 25.91 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.873 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 52.77 16.34 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.509 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.724 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.7 mt -107.56 105.47 15.37 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.279 0.562 . . . . 0.0 110.782 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.34 152.59 22.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.637 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.925 HG21 ' HG ' ' A' ' 64' ' ' LEU . 29.1 m -121.54 141.45 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.4 m-20 -79.95 -20.53 45.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.268 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.57 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.595 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.925 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.1 mp -61.3 -175.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.213 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -135.08 101.24 4.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.596 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -62.27 135.49 57.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.2 m -123.15 -47.83 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.884 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.6 178.79 26.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.008 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.8 tt0 -131.62 114.38 14.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 123' ' ' TRP . 28.7 mt -100.33 134.24 40.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 111.234 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 51.7 t -120.62 149.23 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.699 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CE1' HG22 ' A' ' 70' ' ' ILE . 3.9 m-85 -128.76 118.21 22.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 0.0 110.969 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.56 128.85 44.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.441 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.99 134.18 35.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.295 0.569 . . . . 0.0 110.938 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.89 108.41 14.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.832 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.73 -20.21 44.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.294 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -106.5 117.54 56.79 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.518 0.199 . . . . 0.0 110.772 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.0 -45.24 37.62 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.473 2.115 . . . . 0.0 112.44 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -58.32 169.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -146.7 -167.36 2.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.501 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.2 mtp -142.6 111.46 6.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.6 t0 -106.85 102.58 11.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.818 0.342 . . . . 0.0 110.314 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.8 p -111.23 116.76 53.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 111.515 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -79.23 150.32 31.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.473 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.646 HG11 ' CE3' ' A' ' 123' ' ' TRP . 62.0 t -105.12 137.24 35.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 13.8 m-85 -139.24 142.74 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.971 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.7 m -130.64 117.18 19.11 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.029 HG22 HG22 ' A' ' 12' ' ' VAL . 6.7 t -96.03 -173.23 2.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.193 0.52 . . . . 0.0 111.547 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -160.06 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.83 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.86 99.15 11.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.944 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 60' ' ' THR . 41.9 pt -103.03 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -142.69 -62.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.087 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.71 -176.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.724 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.929 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -113.11 151.45 44.21 Favored Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 111.325 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 94' ' ' THR . 39.1 Cg_endo -72.12 64.98 3.44 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.88 1.72 . . . . 0.0 109.093 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 94' ' ' THR . 2.4 t -76.49 62.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.495 -178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.4 110.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.878 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -175.18 5.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.36 -10.21 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.476 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.96 -38.07 5.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 110.963 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.44 158.22 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.014 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -162.0 92.7 1.35 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.494 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HB2' HD11 ' A' ' 19' ' ' LEU . 62.2 Cg_endo -71.55 160.7 47.65 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.397 2.064 . . . . 0.0 112.585 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.15 119.55 9.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.674 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.772 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.3 m95 -85.77 109.04 18.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -117.25 -167.42 1.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -92.36 149.9 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.715 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -68.72 -8.0 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.726 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -116.32 19.18 14.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.076 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -143.27 22.15 1.88 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.455 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.905 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -72.94 125.64 90.98 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.777 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -91.04 98.53 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.492 2.128 . . . . 0.0 113.343 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -75.87 -18.35 59.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.264 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -24.76 59.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.98 0.419 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.18 27.26 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.518 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.6 mtm -135.55 -82.35 0.41 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 6.6 m95 -145.97 165.36 21.0 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 145' ' ' ILE . 98.0 Cg_endo -82.0 17.03 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.108 2.538 . . . . 0.0 113.271 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.22 -21.25 3.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.756 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.633 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.3 m-20 -48.47 -49.62 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 55.4 p -58.94 -17.27 23.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.592 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.9 m-85 -84.9 -38.27 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.891 ' CH2' HD12 ' A' ' 11' ' ' LEU . 55.2 p-90 -103.38 -3.56 25.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.7 m-85 -76.06 -53.01 2.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.582 0.23 . . . . 0.0 110.986 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 52.0 Cg_exo -55.21 -28.55 62.25 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.606 2.204 . . . . 0.0 112.621 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.787 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.1 mt -81.43 -34.77 31.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.44 -56.36 22.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.528 0.68 . . . . 0.0 109.533 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.02 -25.59 45.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.915 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 27.4 tp60 -83.89 2.52 38.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.407 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 58.99 23.14 11.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -103.58 159.08 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 3.8 mptt -115.52 131.77 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.787 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.42 170.61 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.025 0.441 . . . . 0.0 111.35 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 12.3 m170 -124.25 125.11 43.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.606 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -115.47 125.02 6.51 Favored Glycine 0 C--O 1.226 -0.363 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.254 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.1 m-85 -109.47 117.37 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 11.5 m-85 -118.81 132.56 56.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 146' ' ' LEU . 9.6 ttmt -88.55 128.55 35.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.2 m-85 -108.06 163.98 12.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 0.0 112.347 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.865 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.3 tp-100 -135.79 81.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.951 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.62 -64.84 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.461 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.38 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 -12.56 8.21 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.4 m -83.3 135.19 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.215 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 118' ' ' PRO . 30.3 mt -110.61 140.21 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.433 . . . . 0.0 110.986 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.4 OUTLIER -120.32 -16.64 8.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.96 140.23 18.56 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.288 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 23.0 p90 -139.65 133.78 31.1 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.17 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.562 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 145.17 51.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 110.667 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.0 mp -134.1 114.65 13.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.886 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.88 119.63 32.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.69 141.03 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.028 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.25 161.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.83 -33.2 9.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -103.27 156.16 17.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.084 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.8 0.333 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.59 52.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 -175.46 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 111.004 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.42 84.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 111.231 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.84 95.71 0.08 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.254 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.89 118.91 26.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.259 0.552 . . . . 0.0 110.643 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.0 m-85 -122.77 -179.0 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.788 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 22.6 p -126.03 166.51 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.033 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.6 tt -156.24 108.96 2.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.06 123.39 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 112.374 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.817 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.32 112.8 15.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.609 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 88' ' ' THR . 18.4 t -78.23 87.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.075 0.464 . . . . 0.0 111.818 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.57 117.9 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.737 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -105.96 157.38 34.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.296 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.2 Cg_endo -65.61 31.01 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.626 2.217 . . . . 0.0 112.878 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 108' ' ' LEU . 18.6 mt-30 -160.44 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.708 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 4.6 mtt-85 -141.67 161.33 38.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -132.13 155.05 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.903 HD21 ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -120.01 113.77 21.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.251 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.626 HD11 ' SD ' ' A' ' 116' ' ' MET . 3.0 mt -113.59 135.56 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.98 125.05 8.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.222 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 38.7 ttm -113.62 142.25 46.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 110.535 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.86 146.73 24.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -90.08 -32.0 16.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.626 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.17 115.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.3 -119.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.08 23.78 9.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.67 0.271 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.45 30.77 0.05 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -54.53 146.8 15.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.742 0.306 . . . . 0.0 111.018 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.38 23.45 26.71 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.793 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 21.9 mtp180 -132.86 135.62 45.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.627 0.251 . . . . 0.0 110.638 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -89.29 153.5 20.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 17.0 p30 177.94 151.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.98 170.86 3.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.348 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -97.86 103.65 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.13 174.45 45.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.226 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 8' ' ' THR . . . 177.72 118.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.202 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 8.7 ptmt -59.04 146.39 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 6' ' ' LEU . 6.9 t -75.55 113.05 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.637 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.6 168.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.374 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.96 75.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.27 45.59 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.943 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.81 172.84 10.03 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.4 p -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.116 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 6' ' ' LEU . 2.1 mp -50.72 -33.46 11.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.311 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -74.4 -26.77 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.46 -37.57 25.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.752 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.94 -35.24 65.15 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.479 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.26 -39.77 62.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.5 mtp180 -67.91 -56.81 7.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.042 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -58.2 -35.3 71.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.22 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.51 -24.01 29.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.482 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.6 tp -65.97 -52.27 51.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.806 ' HB2' HG23 ' A' ' 60' ' ' THR . 3.0 tt0 -61.25 -25.39 67.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.619 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -82.36 -21.68 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.534 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -77.73 -44.17 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.6 7.61 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.45 -9.58 54.33 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.25 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.676 HD13 HD13 ' A' ' 91' ' ' ILE . 4.6 mt -78.76 106.15 10.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -90.38 176.94 6.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.377 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.804 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.1 m -141.03 138.36 34.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 0.0 111.743 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -79.76 -19.05 49.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.091 179.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.94 89.69 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.757 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.2 mt -54.32 177.26 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -135.06 101.22 4.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.981 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -62.13 126.97 29.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 127' ' ' LEU . 17.3 m -128.5 -48.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.815 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -135.22 127.26 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.81 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 2.0 tt0 -104.3 114.31 28.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 34.1 mt -106.54 138.57 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.162 0.506 . . . . 0.0 111.831 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 38.2 t -112.04 149.32 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.491 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 3.9 m-85 -125.54 118.03 24.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.072 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -102.1 125.63 48.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -87.63 131.79 34.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG13 ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.15 112.68 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.791 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.77 -19.81 51.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.287 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.89 140.96 21.59 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 120.623 0.249 . . . . 0.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.47 -45.88 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.42 2.08 . . . . 0.0 112.2 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.4 tt0 -60.48 174.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.33 -165.57 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -146.15 111.28 5.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 61.3 t0 -103.97 102.8 12.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.6 p -113.64 116.8 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 66' ' ' LYS . 10.6 t-160 -77.51 151.71 34.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.365 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.738 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 9.7 t -116.22 104.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.345 0.593 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.9 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -99.03 134.93 41.17 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.091 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.9 p -121.27 117.57 27.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.988 HG22 HG22 ' A' ' 12' ' ' VAL . 8.7 t -94.68 -179.48 4.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.198 0.523 . . . . 0.0 111.865 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -144.51 -46.99 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.841 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.57 96.46 10.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.945 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.676 HD13 HD13 ' A' ' 59' ' ' LEU . 3.2 pt -103.51 171.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.143 0.497 . . . . 0.0 111.846 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 93' ' ' GLY . 70.9 mt-30 -104.06 76.03 1.32 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.973 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.69 89.56 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.041 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 94' ' ' THR . 90.4 m -160.19 53.89 0.56 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 94' ' ' THR . 71.2 Cg_endo -77.0 73.21 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.111 1.874 . . . . 0.0 110.23 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' THR . 2.0 t -77.77 63.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.572 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.9 OUTLIER -42.52 104.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.061 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -88.43 -173.05 4.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.83 -10.23 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.69 -40.71 5.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.779 0.323 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.438 ' HE1' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.78 160.15 15.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.821 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 22' ' ' MET . 25.4 ttt180 -164.15 94.22 1.01 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 74.1 Cg_endo -74.1 160.21 43.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.529 2.153 . . . . 0.0 112.661 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.53 124.12 14.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.666 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.903 ' CD2' HD21 ' A' ' 19' ' ' LEU . 6.9 m95 -88.58 125.29 34.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.549 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 12.7 m-85 -143.51 -171.6 3.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 15.8 tt0 -89.2 160.62 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.6 pt? -77.25 -1.09 27.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.94 21.93 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -145.32 20.11 1.55 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -73.33 125.9 90.46 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.812 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.05 97.71 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.545 2.164 . . . . 0.0 113.369 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.14 -18.32 53.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.927 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -65.61 -31.16 72.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.28 29.69 4.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.092 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 3.5 mtp -125.74 -83.61 0.63 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.32 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.402 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -150.88 171.37 6.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.005 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 145' ' ' ILE . 86.4 Cg_endo -85.43 16.08 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.008 2.472 . . . . 0.0 112.985 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.02 -21.93 2.62 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.584 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 3.9 m-20 -50.06 -51.86 39.08 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 24.8 p -58.18 -17.24 17.41 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HD2' HD11 ' A' ' 150' ' ' LEU . 77.0 m-85 -84.68 -34.05 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.817 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.61 -2.75 18.53 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -76.33 -49.26 3.08 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.183 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 51.2 Cg_exo -53.92 -34.42 76.24 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.835 2.357 . . . . 0.0 113.536 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -79.55 -33.75 41.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.307 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.655 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.83 -54.44 44.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.713 0.768 . . . . 0.0 109.041 178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.9 -25.6 20.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.528 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 26.1 mt-30 -89.33 2.76 53.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.344 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.18 34.25 22.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.903 0.382 . . . . 0.0 111.36 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 159.16 19.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -103.59 140.33 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.629 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.5 171.0 17.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.548 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 9.3 m80 -137.17 125.02 22.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.424 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -125.52 132.79 8.11 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.452 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 4.2 m-85 -111.12 115.37 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 148' ' ' TYR . 4.7 m-85 -115.63 127.26 55.07 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.744 ' NZ ' HG13 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.74 123.15 32.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.587 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.1 m-85 -110.13 158.32 18.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.694 ' HG2' HD11 ' A' ' 146' ' ' LEU . 3.2 mm-40 -79.83 -9.81 59.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.355 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.88 -56.9 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.96 28.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 20.1 m-20 -158.89 -48.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 111.064 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 5.7 m -82.94 137.05 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.524 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 63.2 mt -110.09 139.56 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.464 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.7 OUTLIER -122.3 -11.04 8.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.747 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.99 135.28 14.09 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.594 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 41.0 p90 -139.2 128.83 24.56 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.504 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.489 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -121.76 144.98 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.248 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.666 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.4 mp -134.26 124.56 26.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -128.61 151.82 49.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 147.44 26.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.855 0.359 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 m -142.2 147.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -148.4 -50.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.6 m -68.13 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.151 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.55 -161.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.01 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.37 86.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' MET . 21.5 mmt180 -67.8 95.57 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.407 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 39' ' ' VAL . 2.6 tt -87.09 117.06 25.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.228 0.537 . . . . 0.0 110.508 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.482 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.3 m-85 -122.45 -179.43 4.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.545 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.7 p -125.47 171.61 10.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -155.46 108.98 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.071 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -113.74 125.58 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 112.198 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.5 mt -127.15 112.61 15.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.078 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.078 HG22 HG22 ' A' ' 88' ' ' THR . 12.1 t -80.62 89.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -110.57 117.91 34.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.101 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 13' ' ' LEU . 66.3 mt-30 -101.81 157.27 34.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.043 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.2 29.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.504 2.136 . . . . 0.0 113.194 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.3 mm-40 -160.56 -38.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.14 161.15 38.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 111.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.9 p -129.78 156.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.4 tp -118.82 108.81 15.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.653 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.7 mt -103.88 136.09 44.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.63 120.92 6.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.207 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.592 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 33.2 ttm -109.65 142.22 41.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.63 0.252 . . . . 0.0 110.395 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.2 mtpt -87.56 146.61 25.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -91.67 -32.3 15.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.757 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -162.7 164.24 26.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.16 -130.13 10.12 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.18 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.24 83.34 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.66 0.2 3.65 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.457 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.63 146.64 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.168 0.484 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.01 24.55 20.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -133.24 132.77 41.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.711 0.291 . . . . 0.0 110.621 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.669 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -82.46 153.49 25.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.5 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.0 t30 -179.29 145.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.67 172.45 2.1 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.053 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -101.82 98.6 8.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.192 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -85.67 162.41 35.98 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.917 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 8' ' ' THR . . . -160.02 121.54 1.05 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.416 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 11.5 ptmt -70.85 140.46 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.312 . . . . 0.0 111.105 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.96 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.42 110.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.712 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -48.13 174.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -69.32 64.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.225 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.23 43.02 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.73 173.06 9.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 p -100.31 141.4 33.21 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.787 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.28 -33.51 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.97 -28.6 61.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.72 -35.59 44.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.521 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.65 -34.09 45.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.861 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.836 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.82 -32.92 62.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.652 0.263 . . . . 0.0 110.306 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -83.97 -46.79 11.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.36 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.35 79.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 19.6 mm-40 -84.0 -19.43 34.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.041 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 10' ' ' VAL . 15.2 tp -69.2 -48.15 62.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.504 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.6 -26.15 66.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -82.53 -21.85 35.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.55 -43.99 19.77 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.6 m -131.68 22.98 4.66 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.899 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.14 14.04 10.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.5 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -107.51 107.91 18.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.883 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.01 170.08 12.61 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.236 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.915 HG21 ' HG ' ' A' ' 64' ' ' LEU . 30.9 m -138.23 142.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 0.0 111.762 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -79.9 -20.6 45.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.8 96.41 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.778 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.915 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -59.42 -173.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -135.0 101.26 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.937 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.58 134.28 56.64 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 127' ' ' LEU . 31.2 m -124.94 -48.4 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.117 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -150.28 177.53 28.31 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.264 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.59 121.67 24.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.693 HG23 ' HE1' ' A' ' 137' ' ' PHE . 68.9 mt -103.74 145.41 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.559 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 136' ' ' TYR . 17.3 t -129.08 149.19 33.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 66.5 m-85 -135.63 120.38 18.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.399 . . . . 0.0 111.351 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -99.57 131.72 45.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -96.66 131.88 42.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.38 119.31 25.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.832 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.5 -20.67 49.45 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.309 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -111.54 112.35 54.16 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.62 -37.08 26.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.449 2.099 . . . . 0.0 112.388 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.681 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -59.84 172.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.5 -166.13 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.355 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.0 mtp -144.9 111.69 5.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.017 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -102.71 102.69 12.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.266 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 7' ' ' TYR . 12.6 t -106.9 116.77 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.742 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.9 t60 -83.27 151.54 25.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG11 ' CE3' ' A' ' 123' ' ' TRP . 87.1 t -109.4 135.57 47.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.022 0.439 . . . . 0.0 110.341 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 m-85 -139.28 142.02 37.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.5 m -128.03 117.33 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.078 HG22 HG22 ' A' ' 12' ' ' VAL . 7.4 t -96.8 -173.91 2.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 111.378 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -160.04 -46.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.917 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 98.71 10.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.878 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 59' ' ' LEU . 33.3 pt -103.21 178.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.911 0.386 . . . . 0.0 111.311 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -138.25 -66.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.081 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -52.54 -178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.628 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.908 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -111.67 161.46 25.44 Favored Pre-proline 0 CA--C 1.516 -0.36 0 CA-C-O 120.602 0.239 . . . . 0.0 111.323 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.908 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.0 Cg_exo -67.99 62.71 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.638 2.225 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' THR . 3.7 t -76.92 59.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.607 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -46.03 115.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m -87.29 -174.27 4.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -73.4 -6.76 48.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.83 -34.34 5.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.731 0.3 . . . . 0.0 111.285 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.47 159.41 18.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.229 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.8 ttm180 -163.46 95.38 1.06 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.309 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.819 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.1 Cg_endo -72.82 160.23 46.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.423 2.082 . . . . 0.0 112.722 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.18 120.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.508 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.704 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.9 m95 -86.7 117.0 25.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.8 m-85 -133.74 -167.96 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.0 mt-30 -82.82 164.75 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -90.65 4.94 49.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.543 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.38 25.03 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.906 0.384 . . . . 0.0 110.021 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -151.57 22.02 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.82 126.65 90.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -92.81 98.75 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.496 2.131 . . . . 0.0 113.027 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.89 -18.24 51.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -30.06 70.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -99.58 28.61 4.54 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.078 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -124.42 -81.05 0.63 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.018 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -156.78 174.4 4.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.811 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 85.7 Cg_endo -86.37 17.29 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.969 2.446 . . . . 0.0 113.14 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.3 p-10 -129.16 -26.8 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.9 m-20 -43.68 -58.0 2.9 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 4.2 t -57.93 -19.05 27.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 21.9 m-85 -85.66 -21.8 28.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.879 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.3 p-90 -121.92 -11.56 8.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.789 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.18 -50.0 3.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.411 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 121' ' ' SER . 76.2 Cg_exo -50.77 -30.55 29.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.293 1.996 . . . . 0.0 112.414 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.885 HD13 ' CB ' ' A' ' 133' ' ' PHE . 5.3 mt -78.38 -32.92 49.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.16 0.505 . . . . 0.0 109.968 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -63.25 -53.38 53.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.042 179.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.6 -31.26 69.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -72.1 -10.03 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt 68.58 36.35 2.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -127.44 159.13 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.805 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.719 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.1 mptt -96.69 138.82 33.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.885 ' CB ' HD13 ' A' ' 126' ' ' LEU . 21.0 m-85 -145.92 171.11 15.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.155 0.502 . . . . 0.0 111.217 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -144.87 125.05 13.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.288 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.94 129.17 6.93 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.791 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.585 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.64 119.5 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.693 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.5 m-85 -121.44 137.51 54.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' CE ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.6 133.28 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.2 164.15 11.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.16 0.505 . . . . 0.0 111.879 -178.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.628 ' HB2' HD21 ' A' ' 146' ' ' LEU . 5.8 tp-100 -120.88 15.22 11.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.61 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.94 -57.19 0.38 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.647 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.412 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 2.3 mt-30 -176.5 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -123.18 9.03 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 29.6 m -119.2 132.57 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.332 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.79 143.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -122.32 -14.15 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.294 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.03 137.74 16.11 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.478 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 38.6 p90 -139.58 135.59 33.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.75 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.582 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.61 144.11 51.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.205 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.82 122.84 23.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.155 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -134.71 125.19 26.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 1.5 tt0 -74.51 142.23 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.912 0.386 . . . . 0.0 110.751 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' A' ' 132' ' ' LYS . 5.9 m -125.97 167.99 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -177.4 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -62.48 128.67 37.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.099 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.835 0.35 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.14 -56.28 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.96 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 p 56.68 90.38 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.302 0.572 . . . . 0.0 111.225 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.3 mmp_? -66.04 96.28 0.31 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.128 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.971 HD22 HG21 ' A' ' 39' ' ' VAL . 2.5 tt -86.52 119.36 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.383 0.611 . . . . 0.0 110.599 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.8 m-85 -122.38 -178.82 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.728 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.955 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.1 p -126.63 169.51 13.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.334 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.4 tt -156.15 109.06 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.25 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.834 HG21 HD22 ' A' ' 53' ' ' LEU . 1.7 p -111.48 124.03 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.504 0.668 . . . . 0.0 112.023 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.19 112.92 15.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.643 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 88' ' ' THR . 18.6 t -80.4 106.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 111.329 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -134.89 118.18 16.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.218 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.62 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -104.77 157.3 34.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.628 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.14 31.48 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.692 2.262 . . . . 0.0 113.646 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLN . 16.2 pt20 -160.65 -40.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.745 0.307 . . . . 0.0 111.072 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 1.8 mmt85 -137.84 161.69 35.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.259 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -138.08 153.77 27.48 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.612 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 105' ' ' TRP . 22.1 tp -121.45 129.38 52.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -121.98 142.03 50.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.036 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.93 122.42 7.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.924 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.574 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.6 ttm -113.29 142.2 46.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.796 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -87.49 146.77 25.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -91.7 -33.01 15.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.634 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.35 156.26 14.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.97 -127.72 8.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.086 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.14 79.88 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.982 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.11 1.31 2.93 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.623 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -46.2 143.63 2.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.311 0.555 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.52 22.21 30.76 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.77 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.2 ttm180 -128.82 135.6 49.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.584 0.23 . . . . 0.0 110.615 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -91.96 153.48 19.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.505 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 8.1 t30 -178.24 144.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.282 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.1 -178.91 0.55 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.215 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -110.25 90.4 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.023 0.439 . . . . 0.0 110.236 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 8' ' ' THR . . . -98.59 148.04 18.72 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.849 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.57 -161.06 9.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -131.05 139.55 49.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -75.37 107.49 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.7 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.72 176.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -69.26 64.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.213 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.42 43.56 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.17 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.55 173.05 9.72 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 61.8 p -101.23 141.21 34.45 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.76 0.314 . . . . 0.0 110.962 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -51.03 -31.14 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 31.3 tt0 -75.69 -26.98 58.07 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.57 -35.25 30.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.383 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.59 -37.38 58.09 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.419 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.955 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.67 -34.47 62.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.103 0.478 . . . . 0.0 109.768 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -75.0 -55.48 5.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.761 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.37 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.255 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.37 -23.29 30.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.505 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.834 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -66.59 -49.77 65.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.668 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.848 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.0 tt0 -61.14 -25.15 66.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.662 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -82.36 -22.08 35.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -77.11 -44.17 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -142.22 32.55 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.772 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 51.5 15.44 1.94 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.787 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.831 HD13 HD13 ' A' ' 91' ' ' ILE . 5.1 mt -101.33 108.65 20.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.966 0.412 . . . . 0.0 110.23 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.848 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.51 177.08 6.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.869 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.6 m -141.5 139.35 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 0.0 111.792 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.2 t0 -79.89 -17.34 53.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 174.79 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.824 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.869 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mt -56.5 -177.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -134.94 101.29 4.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.695 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.08 128.64 37.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.684 HG21 ' CD2' ' A' ' 127' ' ' LEU . 31.8 m -117.85 -49.24 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.096 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -151.72 178.13 29.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.272 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -130.86 119.41 22.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.626 HG22 ' CE1' ' A' ' 72' ' ' PHE . 23.6 mt -104.06 134.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.068 0.461 . . . . 0.0 111.51 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.754 HG13 ' OD1' ' A' ' 82' ' ' ASP . 11.6 t -116.29 149.22 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.734 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HG22 ' A' ' 70' ' ' ILE . 6.8 m-85 -132.94 125.95 30.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 111.204 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.82 133.41 49.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -96.62 131.05 43.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.274 0.559 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -78.02 117.28 23.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.766 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.34 -20.49 50.28 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.208 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -107.92 140.93 22.1 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.591 0.234 . . . . 0.0 110.752 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 -43.72 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.392 2.061 . . . . 0.0 112.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.9 tt0 -61.0 175.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -149.77 -165.32 2.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.202 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.9 ttp -146.15 111.4 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.651 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.18 102.51 12.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.377 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.9 p -109.84 116.69 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.234 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -77.85 163.89 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.807 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.576 HG11 ' CE3' ' A' ' 123' ' ' TRP . 69.4 t -116.87 134.91 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.103 0.478 . . . . 0.0 110.324 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 64' ' ' LEU . 13.4 m-85 -136.32 133.23 36.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.996 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.1 t -122.26 117.35 25.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.061 HG22 HG22 ' A' ' 12' ' ' VAL . 10.0 t -95.43 178.84 5.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 111.687 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -146.16 -46.6 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.141 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.63 95.3 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.292 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.831 HD13 HD13 ' A' ' 59' ' ' LEU . 1.4 pt -103.83 176.02 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.171 0.51 . . . . 0.0 111.656 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 93' ' ' GLY . 1.9 mt-30 -105.2 74.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.839 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.93 89.88 0.01 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.153 -0.93 . . . . 0.0 114.464 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.652 HG22 HG23 ' A' ' 96' ' ' VAL . 98.9 m -160.39 55.87 0.74 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 0.0 110.374 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' SER . 60.8 Cg_endo -74.83 73.14 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.094 1.862 . . . . 0.0 110.12 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.652 HG23 HG22 ' A' ' 94' ' ' THR . 3.1 t -77.4 63.16 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.549 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.0 pt-20 -41.48 110.06 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.061 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -87.52 -172.96 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.09 -8.42 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.493 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.0 -39.66 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.763 0.316 . . . . 0.0 110.946 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.84 159.31 16.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 54.4 ttt180 -161.99 98.23 1.19 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.416 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.1 Cg_endo -73.27 156.64 50.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.375 2.05 . . . . 0.0 112.528 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.513 ' O ' HD12 ' A' ' 19' ' ' LEU . 40.1 m -143.78 119.58 10.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.452 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.662 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.3 m95 -86.52 132.66 33.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.686 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 57.4 m-85 -148.05 -168.83 3.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.618 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 18' ' ' VAL . 32.9 tt0 -87.44 165.12 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -85.14 8.74 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -125.44 25.89 6.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.837 0.351 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -152.12 20.29 0.67 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.204 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.27 127.21 89.45 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.871 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -93.01 98.65 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.45 2.1 . . . . 0.0 113.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.74 -18.07 48.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -30.16 71.03 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.3 25.64 6.73 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.218 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.657 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -120.77 -77.75 0.59 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.876 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -160.94 173.97 4.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.889 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.8 Cg_endo -85.89 18.05 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.302 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -129.77 -27.57 2.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.742 0.306 . . . . 0.0 111.283 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 7.0 m-20 -43.67 -57.89 2.96 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 0.7 OUTLIER -56.87 -17.83 10.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 150' ' ' LEU . 71.7 m-85 -85.49 -29.43 24.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.3 p-90 -115.53 -11.03 11.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.932 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -75.97 -50.74 3.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.507 -179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' SER . 52.4 Cg_exo -52.64 -30.19 44.57 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.148 1.899 . . . . 0.0 112.077 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.768 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.0 mt -78.84 -33.35 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.93 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -60.36 -53.57 56.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.665 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -59.93 -30.95 69.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.835 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -72.59 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.387 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt 69.2 34.14 3.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -121.41 159.15 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.98 134.37 54.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.768 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.65 170.97 17.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.473 . . . . 0.0 111.241 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.65 125.22 41.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.39 126.92 7.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.284 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -109.76 119.2 38.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.6 m-85 -122.66 134.74 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.674 ' HG2' HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -88.85 132.03 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 145' ' ' ILE . 2.0 m-85 -108.15 163.2 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.307 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.902 ' HB2' HD11 ' A' ' 146' ' ' LEU . 5.9 tp60 -138.84 80.33 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.05 -78.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.756 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -160.26 -42.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -127.99 25.26 5.94 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 44.1 m -115.72 132.49 56.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.566 0.222 . . . . 0.0 110.871 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 139' ' ' PHE . 25.5 mt -110.46 137.67 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.902 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -116.26 -15.75 11.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.696 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.01 137.75 16.13 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.473 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 37.1 p90 -139.58 133.72 31.13 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.538 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.66 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.01 116.28 15.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.875 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -123.58 119.74 30.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -85.84 141.03 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.99 159.95 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.55 -47.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -91.75 164.82 13.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.037 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.85 -124.39 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 -172.04 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 111.111 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p 55.59 88.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.192 0.52 . . . . 0.0 111.194 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.8 mmt85 -62.41 95.05 0.06 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD21 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -86.73 116.33 24.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.135 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.6 m-85 -122.6 -178.8 4.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.452 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.936 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 30.3 p -127.99 166.75 17.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.046 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.0 tt -156.0 109.64 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.816 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -112.28 127.1 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.524 0.678 . . . . 0.0 112.299 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.06 112.74 15.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.963 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.929 HG22 HG22 ' A' ' 88' ' ' THR . 11.8 t -82.78 83.27 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.064 0.459 . . . . 0.0 111.873 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -98.58 158.55 15.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.642 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -136.39 156.98 76.24 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.22 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 25.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.517 2.145 . . . . 0.0 112.9 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 6.0 pt20 -160.56 -38.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.48 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -138.89 159.62 41.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.596 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.6 p -128.06 158.0 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.64 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 103' ' ' PRO . 23.0 tp -121.46 114.75 21.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -111.3 139.9 46.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.864 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.14 125.26 8.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.615 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 32' ' ' TRP . 34.8 ttm -108.84 142.31 39.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.763 0.316 . . . . 0.0 110.647 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.09 147.16 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -88.33 -34.18 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.901 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.924 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.92 151.34 7.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.68 -125.76 7.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.098 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -100.18 71.55 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.767 0.318 . . . . 0.0 110.769 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.64 -18.93 0.59 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.215 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.924 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -40.26 129.05 2.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.971 0.386 . . . . 0.0 111.755 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.59 -4.46 81.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.5 mtp-105 -113.93 157.67 22.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.742 0.271 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' CE2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.9 152.35 26.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.471 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 2.4 p-10 -177.77 159.5 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.06 -174.92 3.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.119 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.61 88.93 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 110.353 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.25 142.46 15.99 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.712 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 52' ' ' GLU . . . -143.08 146.52 17.37 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.364 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -72.04 154.12 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 43' ' ' GLU . 2.6 t -88.08 102.41 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.225 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -42.49 153.97 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.633 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -47.71 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 48.53 4.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.029 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' VAL . 16.8 tt0 -125.88 171.86 10.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.4 p -109.0 142.79 39.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.829 HG21 ' CB ' ' A' ' 84' ' ' HIS . 4.6 mt -47.54 -30.84 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.367 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 7.8 tt0 -78.32 -29.38 47.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 44' ' ' THR . 5.1 m-20 -81.12 -36.97 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.464 . . . . 0.0 109.952 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.03 59.03 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.72 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.936 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -35.6 60.22 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 64' ' ' LEU . 27.0 mtt180 -70.93 -54.78 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.941 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.374 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' CG ' ' HA3' ' A' ' 37' ' ' GLY . 4.8 mm-40 -84.3 -19.49 33.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 10' ' ' VAL . 20.1 tp -73.77 -48.74 29.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.6 tt0 -60.72 -27.38 67.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.819 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.78 -22.69 34.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -82.09 -43.86 17.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 p -128.53 21.05 6.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.79 16.11 7.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.266 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 91' ' ' ILE . 16.2 mt -108.98 114.2 27.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.49 136.5 36.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.474 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.913 HG21 ' HG ' ' A' ' 64' ' ' LEU . 20.1 m -106.0 139.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 112.083 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.95 -20.58 45.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.015 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.64 96.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.787 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.913 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.46 -174.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.79 101.31 4.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.646 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -59.3 132.73 54.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.124 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 127' ' ' LEU . 18.1 m -122.0 -49.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.135 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.43 165.54 27.07 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.398 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' CG ' ' NE2' ' A' ' 84' ' ' HIS . 4.1 mp0 -125.48 114.54 18.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 123' ' ' TRP . 78.3 mt -102.45 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.341 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 134' ' ' HIS . 6.3 t -129.11 149.1 33.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.448 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE2' ' CZ ' ' A' ' 139' ' ' PHE . 91.5 m-85 -131.03 118.11 20.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.945 0.402 . . . . 0.0 111.195 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 2.1 tp10 -103.27 127.58 50.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.393 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.12 135.48 39.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.255 0.55 . . . . 0.0 111.088 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -80.56 118.54 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.762 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 -19.67 53.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.295 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -109.17 109.17 60.66 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.25 -37.16 18.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.458 2.106 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.494 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.3 tt0 -65.13 168.11 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -143.79 -163.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -147.13 111.54 5.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -106.96 102.9 12.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.166 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.8 p -114.09 116.82 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 0.0 111.484 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.829 ' CB ' HG21 ' A' ' 45' ' ' ILE . 7.4 t-80 -78.47 158.43 28.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.578 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.866 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.1 t -114.15 134.6 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.249 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.495 ' HB3' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -133.41 137.21 45.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.263 -178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.6 p -123.35 117.28 24.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.929 HG22 HG22 ' A' ' 12' ' ' VAL . 1.6 t -99.79 -173.31 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.135 0.493 . . . . 0.0 111.922 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.27 -44.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.59 98.48 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 59' ' ' LEU . 46.9 pt -103.21 178.81 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -132.83 -68.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.932 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.24 -168.56 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -118.98 164.42 21.15 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 120.369 0.128 . . . . 0.0 110.886 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.5 Cg_exo -65.85 65.59 0.42 Allowed 'Trans proline' 0 CA--C 1.506 -0.886 0 C-N-CA 122.332 2.022 . . . . 0.0 109.474 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 94' ' ' THR . 8.7 t -76.45 62.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.387 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 3.4 mp0 -41.59 114.69 0.55 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.948 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.43 -176.21 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.018 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -69.88 -11.77 61.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.409 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.22 20.88 5.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.647 0.26 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.53 161.81 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 6.9 ttt85 -176.71 95.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.528 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.865 ' HB2' HD11 ' A' ' 19' ' ' LEU . 88.6 Cg_endo -75.29 153.23 40.29 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.534 2.156 . . . . 0.0 112.496 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -140.1 128.04 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.837 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.8 122.95 36.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.1 m-85 -136.65 -167.12 2.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -81.91 158.76 23.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -88.57 13.26 12.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.544 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.91 23.3 7.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 0.0 110.07 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -155.28 27.59 0.4 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.498 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 127.85 89.14 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -92.97 98.34 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.376 2.051 . . . . 0.0 113.293 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.96 -18.04 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.781 179.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -63.29 -31.71 72.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -100.91 33.53 2.78 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.759 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 20' ' ' LEU . 9.8 ttp -129.61 -66.21 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.065 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -170.4 166.18 5.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.503 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 94.7 Cg_endo -83.95 15.22 2.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.732 2.288 . . . . 0.0 113.046 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 12.2 m-20 -132.62 -5.2 3.26 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.564 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 20.7 m-20 -62.79 -48.88 77.2 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 t -54.91 -16.94 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.656 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 150' ' ' LEU . 12.6 m-85 -83.2 -38.25 22.54 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.898 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -102.87 -4.92 24.15 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 116' ' ' MET . 1.4 m-85 -75.82 -49.21 3.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 10.9 Cg_endo -55.16 -30.98 73.71 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.322 2.014 . . . . 0.0 113.342 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -79.52 -34.15 41.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.036 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.62 -55.45 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.663 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 111' ' ' ILE . 5.8 mt -61.94 -30.59 71.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.003 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -78.72 -3.79 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 64.29 30.61 13.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.862 0.363 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -121.98 159.18 27.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 18.6 mtmm -107.73 133.02 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.184 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.83 ' HB2' HD13 ' A' ' 126' ' ' LEU . 27.4 m-85 -142.93 159.19 42.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CE1' HG23 ' A' ' 71' ' ' VAL . 12.8 t-80 -119.37 125.21 48.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.752 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -119.78 130.98 8.7 Favored Glycine 0 C--O 1.226 -0.362 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.457 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 73' ' ' GLU . 3.8 t80 -112.73 112.99 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 13.3 m-85 -114.76 130.64 56.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.45 . . . . 0.0 111.714 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HE2' HG22 ' A' ' 75' ' ' VAL . 5.9 tptt -88.52 133.71 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-30 -106.69 163.93 12.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.974 0.416 . . . . 0.0 111.372 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 146' ' ' LEU . 6.5 tp-100 -115.31 5.68 14.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.01 -48.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 176.67 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.628 0.251 . . . . 0.0 111.554 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.81 -19.27 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 23.0 m -91.74 137.2 32.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 139' ' ' PHE . 52.2 mt -110.14 144.06 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 140' ' ' GLN . 4.3 mt -122.51 -16.0 7.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.354 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -154.09 141.27 19.47 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.696 0.284 . . . . 0.0 111.221 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -139.8 131.57 27.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.59 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.62 145.62 51.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.51 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -133.65 121.89 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -125.48 159.82 31.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.2 148.32 24.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.847 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CB ' ' A' ' 132' ' ' LYS . 13.1 m -145.3 157.14 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -144.82 -48.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.09 170.29 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.055 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.72 -127.15 5.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.62 61.49 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -174.82 93.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.353 0.596 . . . . 0.0 111.203 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.62 94.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.172 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.63 118.65 26.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.549 0.69 . . . . 0.0 110.782 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE1' ' CB ' ' A' ' 38' ' ' LYS . 2.0 m-85 -122.31 -178.83 3.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.583 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 68.6 p -129.36 166.52 19.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.392 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -154.17 108.84 3.07 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.904 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.741 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.17 122.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.488 0.661 . . . . 0.0 112.252 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.97 112.73 15.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.311 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 88' ' ' THR . 11.0 t -77.37 100.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.088 0.47 . . . . 0.0 111.533 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.81 117.91 25.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.934 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 13' ' ' LEU . 36.8 mt-30 -104.98 157.3 34.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.174 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.79 31.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.539 2.159 . . . . 0.0 113.092 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 2.9 pt20 -160.45 -39.63 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 110.691 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -142.12 160.94 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -131.89 156.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.777 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 105' ' ' TRP . 14.9 tp -121.44 118.58 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.858 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -108.93 151.33 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.757 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.62 115.69 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.044 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mtp -95.01 142.55 27.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.505 0.193 . . . . 0.0 110.525 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -86.71 146.67 26.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.09 -36.67 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.411 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.919 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.31 168.85 16.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 0.0 111.323 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.6 -130.35 10.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -100.18 72.11 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.683 0.278 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.64 -19.19 0.3 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.533 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -38.44 120.88 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.151 0.476 . . . . 0.0 111.798 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.29 -5.31 80.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.916 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -105.42 144.75 31.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 110.397 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -97.32 152.78 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 4.7 t-20 178.69 145.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.52 -172.04 0.24 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.661 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -111.03 89.91 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.265 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -84.58 147.41 23.07 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -129.42 -156.78 8.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.288 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 4.6 pttt -150.15 141.33 23.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.837 HG21 HD22 ' A' ' 6' ' ' LEU . 1.1 t -87.1 99.14 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -53.48 174.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.061 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.8 86.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.986 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.91 48.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.549 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -126.13 172.84 9.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 47' ' ' ASP . 73.5 p -109.8 139.95 44.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.916 0.388 . . . . 0.0 110.267 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 HG22 ' A' ' 8' ' ' THR . 3.6 mt -50.6 -33.5 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.265 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt0 -76.54 -24.6 53.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.083 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 1.5 m-20 -82.39 -42.01 19.19 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.973 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.05 91.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.425 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.67 -35.69 60.3 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HG2' HD11 ' A' ' 64' ' ' LEU . 10.0 mtt85 -72.46 -54.08 10.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -61.68 -34.35 75.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.355 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.06 -19.55 34.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.019 0.438 . . . . 0.0 110.493 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.741 HD22 HG21 ' A' ' 10' ' ' VAL . 19.0 tp -73.89 -49.35 25.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.843 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.834 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.8 tt0 -60.66 -27.04 67.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.867 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -82.55 -22.03 35.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -77.79 -43.78 29.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.47 24.88 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.943 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.52 13.87 12.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.58 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD22 HD12 ' A' ' 91' ' ' ILE . 13.1 mt -102.39 112.73 25.56 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.316 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.66 136.63 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.606 -179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.89 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -105.24 138.8 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.948 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.9 m-20 -80.05 -17.83 51.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.967 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.26 94.43 0.01 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.89 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.7 mp -59.44 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.68 101.2 4.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.684 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.2 135.07 55.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 127' ' ' LEU . 32.9 m -128.39 -47.77 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.221 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -140.17 167.31 25.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.163 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 4.7 tt0 -129.69 115.29 17.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.781 0.324 . . . . 0.0 110.321 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.684 HD11 ' CD1' ' A' ' 123' ' ' TRP . 36.5 mt -103.67 133.69 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.468 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 25.6 t -114.22 149.47 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.507 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.6 m-85 -126.55 118.26 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -97.53 122.7 40.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.215 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -88.7 132.09 34.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.336 0.588 . . . . 0.0 111.068 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -79.38 108.32 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.836 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.35 -20.16 45.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.35 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.7 118.41 56.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.579 0.228 . . . . 0.0 110.695 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.83 -48.83 18.98 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.409 2.072 . . . . 0.0 112.373 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.758 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.94 178.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.058 0.456 . . . . 0.0 111.201 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -150.86 -166.49 2.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.299 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 9.0 tmm? -147.17 111.12 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.39 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 71' ' ' VAL . 7.5 t0 -106.36 102.7 12.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.749 0.309 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.6 p -107.36 116.59 51.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.859 0.361 . . . . 0.0 111.307 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t60 -71.31 157.06 38.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.868 HG11 ' CE3' ' A' ' 123' ' ' TRP . 98.4 t -116.91 104.34 16.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -104.97 149.08 26.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 25.8 p -134.06 117.57 16.78 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.046 HG22 HG22 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -100.43 -174.88 2.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.164 0.507 . . . . 0.0 111.836 -178.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 88' ' ' THR . 4.8 p-10 -160.37 -43.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.648 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.72 99.16 10.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.9 178.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.106 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -133.83 -65.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.317 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.15 -151.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.488 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -135.45 165.66 34.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 O-C-N 122.905 -0.173 . . . . 0.0 111.082 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CD ' ' OG1' ' A' ' 94' ' ' THR . 17.2 Cg_exo -67.26 65.79 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.438 2.092 . . . . 0.0 109.849 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 94' ' ' THR . 33.8 t -76.37 63.19 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.103 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 4.9 mp0 -38.35 117.97 0.67 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.052 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.51 -174.08 4.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.9 -9.88 59.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.374 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.3 23.51 3.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.249 . . . . 0.0 111.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -152.77 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.954 0.407 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -171.57 100.69 0.39 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.366 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' LEU . 74.0 Cg_endo -73.64 146.64 39.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.465 2.11 . . . . 0.0 112.821 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.6 m -136.53 121.66 19.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.676 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -90.73 127.72 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 38.5 m-85 -146.32 -170.76 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.051 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.6 mp0 -78.86 160.37 27.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -84.83 3.54 37.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.558 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.4 21.05 11.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.676 0.274 . . . . 0.0 110.501 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -144.78 19.76 1.65 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.972 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.59 127.95 87.86 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.031 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.9 Cg_endo -93.41 99.04 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.528 2.152 . . . . 0.0 112.898 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.23 -18.21 46.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.854 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -64.38 -28.28 69.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.13 27.93 6.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.24 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.647 ' SD ' HD21 ' A' ' 20' ' ' LEU . 1.9 mtp -123.45 -81.63 0.64 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.972 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -153.18 172.48 5.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.571 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 74.0 Cg_endo -86.36 16.33 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.817 2.345 . . . . 0.0 113.17 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -128.16 -25.37 3.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.476 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.58 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 13.1 m-20 -44.48 -57.07 3.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 46.1 p -58.18 -17.31 17.89 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.466 ' HD2' HD11 ' A' ' 150' ' ' LEU . 84.0 m-85 -84.97 -22.29 29.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.868 ' CE3' HG11 ' A' ' 85' ' ' VAL . 68.2 p-90 -119.57 -29.4 5.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.658 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.13 -50.47 87.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.369 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 12.0 Cg_endo -56.54 -23.66 49.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.745 1.63 . . . . 0.0 111.663 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 133' ' ' PHE . 16.9 mt -81.15 -34.17 32.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.669 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.39 -57.1 14.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.518 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -25.2 23.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.551 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -83.96 2.62 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.318 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.96 30.19 13.6 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.892 0.377 . . . . 0.0 111.249 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.53 153.33 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.956 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 153' ' ' VAL . 1.9 mtmp? -106.21 128.28 53.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.1 m-85 -140.68 157.61 45.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 19.4 m170 -120.33 125.13 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.666 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.13 129.94 8.63 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.355 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -109.41 112.51 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.4 m-85 -115.73 132.51 56.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.39 129.5 35.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE1' HG12 ' A' ' 145' ' ' ILE . 3.4 m-85 -107.23 163.87 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.838 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp-100 -135.35 82.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.797 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.68 -70.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.491 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -176.96 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.29 20.6 9.7 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 23.6 m -119.39 132.26 55.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.609 0.243 . . . . 0.0 111.002 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 27.3 mt -110.49 132.75 58.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.119 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.2 OUTLIER -112.74 -14.26 13.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.624 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 137.66 16.22 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.777 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 43.4 p90 -139.44 128.47 23.7 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.566 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -123.74 146.03 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.023 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.1 mp -133.61 122.93 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 28.8 mmm180 -125.81 159.96 31.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -98.56 149.08 23.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.749 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 132' ' ' LYS . 23.5 m -141.71 144.16 26.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -133.91 -51.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.1 131.31 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.148 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.838 0.352 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.66 98.28 2.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.5 -168.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 p 56.24 89.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.192 0.52 . . . . 0.0 111.33 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -73.97 96.26 2.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.285 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 39' ' ' VAL . 4.0 tt -87.09 116.4 25.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.414 0.626 . . . . 0.0 110.829 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HB2' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -122.45 -179.35 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.797 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 69.8 p -126.16 171.28 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.407 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -156.13 108.69 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.777 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -110.74 124.54 67.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.513 0.673 . . . . 0.0 112.199 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.947 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.15 112.7 15.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.512 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 88' ' ' THR . 5.5 t -80.47 69.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -94.79 117.9 30.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.969 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -106.54 157.47 34.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.032 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.601 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.4 Cg_endo -64.95 32.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.476 2.117 . . . . 0.0 112.943 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLN . 10.1 mt-30 -160.48 -41.58 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -142.25 161.18 38.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.299 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.772 ' CG2' HD22 ' A' ' 13' ' ' LEU . 4.3 p -131.02 155.13 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.4 tp -121.38 112.18 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.609 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.618 ' CD1' HG22 ' A' ' 111' ' ' ILE . 7.4 mt -112.07 137.71 49.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.07 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.19 128.32 9.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.6 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.559 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.0 ttm -112.37 142.55 44.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -84.48 146.89 27.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.08 -31.5 16.24 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.639 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.836 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.63 143.35 3.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.82 -125.29 6.25 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.181 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -99.94 76.28 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 110.759 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.49 -12.69 2.25 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.062 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.01 106.4 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.11 3.86 35.87 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.983 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 9.7 mtt180 -124.41 152.82 42.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.791 0.296 . . . . 0.0 110.398 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -108.63 152.63 24.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.738 0.304 . . . . 0.0 110.616 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.4 p30 -176.6 160.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 0.0 111.0 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -57.44 169.63 3.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.389 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -100.44 100.33 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -77.62 163.91 51.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.047 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 111.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.279 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.1 pttt -67.97 140.87 56.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HD22 ' A' ' 6' ' ' LEU . 22.0 t -80.08 107.47 12.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.821 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.35 170.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.225 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.31 64.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 37.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.194 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.596 ' HG3' HG13 ' A' ' 39' ' ' VAL . 4.0 pt-20 -126.8 173.08 9.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.1 p -100.11 142.32 31.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.13 0.49 . . . . 0.0 111.05 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' THR . 7.4 mt -49.98 -33.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.101 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -76.11 -26.32 56.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.895 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 18.2 m-20 -78.8 -37.88 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.437 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.38 -33.81 55.68 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.89 -33.7 62.08 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 21.2 ptt180 -83.4 -48.49 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -36.08 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.625 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.2 -22.0 31.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.114 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 10' ' ' VAL . 15.0 tp -67.81 -49.97 59.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.747 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.836 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.1 tt0 -58.32 -27.46 64.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.847 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -82.62 -22.11 34.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -82.11 -44.02 17.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 p -128.16 21.09 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.884 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.17 14.12 5.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.357 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 91' ' ' ILE . 11.9 mt -110.96 110.87 21.62 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.229 0.537 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.39 173.17 9.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.341 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.3 m -138.87 139.2 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.952 0.406 . . . . 0.0 111.732 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m-20 -79.89 -18.09 51.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.11 92.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.574 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -56.18 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.03 101.19 4.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.507 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.3 139.09 58.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.107 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 33.3 m -129.05 -47.44 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.889 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.03 171.0 26.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.959 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -131.78 114.43 14.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.636 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.648 HD11 ' CD1' ' A' ' 123' ' ' TRP . 46.6 mt -101.09 142.52 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.789 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 136' ' ' TYR . 96.2 t -129.19 146.21 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 61.8 m-85 -122.6 117.9 26.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -99.5 125.01 45.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.795 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -82.41 131.97 35.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 111.157 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -78.26 108.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.797 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.32 48.73 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.326 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -106.39 143.35 26.81 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.278 . . . . 0.0 110.786 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -46.69 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.499 2.132 . . . . 0.0 112.316 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.8 tt0 -56.59 163.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.99 -163.77 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.12 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG23 ' A' ' 83' ' ' VAL . 27.3 ttm -147.21 114.53 6.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -101.97 102.46 13.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' HG2' ' A' ' 81' ' ' MET . 25.4 t -107.18 117.12 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.148 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HB2' HG21 ' A' ' 45' ' ' ILE . 2.4 t-80 -79.98 147.73 31.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 ' CE3' ' A' ' 123' ' ' TRP . 48.7 t -114.61 104.18 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.173 0.511 . . . . 0.0 110.714 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.2 m-85 -107.4 150.18 27.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.352 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.2 p -136.91 117.36 13.72 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.987 HG22 HG22 ' A' ' 12' ' ' VAL . 1.2 t -97.24 -179.57 4.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.295 0.569 . . . . 0.0 111.945 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -153.24 -45.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.568 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.32 97.91 11.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.891 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 59' ' ' LEU . 35.1 pt -103.25 178.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 111.493 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -137.67 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.124 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -175.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.845 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.895 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.93 161.42 30.89 Favored Pre-proline 0 CA--C 1.516 -0.329 0 CA-C-O 120.53 0.205 . . . . 0.0 111.269 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.2 Cg_exo -68.17 62.79 1.04 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.602 2.202 . . . . 0.0 109.645 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 94' ' ' THR . 11.6 t -76.88 59.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.689 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.5 pt-20 -45.07 119.13 1.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.962 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -87.53 -178.67 6.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.28 -13.19 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -11.86 9.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.03 162.57 23.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 111.094 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -174.6 99.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.667 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.78 ' HB2' HD11 ' A' ' 19' ' ' LEU . 95.7 Cg_endo -76.66 161.31 34.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.422 2.081 . . . . 0.0 112.591 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.9 t -145.14 124.15 12.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -88.2 115.64 25.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.534 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -127.64 -168.04 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -89.99 156.38 18.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -75.89 -1.7 26.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.682 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -119.09 21.83 12.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.9 20.68 1.45 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.583 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.716 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.27 126.39 90.2 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.992 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.29 98.42 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.531 2.154 . . . . 0.0 113.115 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.32 -18.32 58.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -73.77 -22.46 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.405 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.33 24.04 9.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 2.0 mtm -131.69 -73.48 0.53 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.346 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.5 OUTLIER -152.13 165.07 18.3 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 0.0 111.242 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 89.2 Cg_endo -83.39 15.88 2.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.102 2.535 . . . . 0.0 113.477 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -133.06 -6.83 3.06 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.591 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -60.38 -43.87 96.2 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 84.7 p -60.31 -16.75 37.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.818 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 150' ' ' LEU . 35.1 m-85 -84.4 -36.19 22.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.947 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.6 p-90 -104.24 -6.28 21.08 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.619 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -73.12 -50.15 6.77 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 11.7 Cg_endo -56.35 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.565 2.176 . . . . 0.0 113.721 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -80.67 -31.61 36.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.261 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -59.33 -55.09 39.2 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.647 0.737 . . . . 0.0 109.211 178.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mt -58.51 -30.69 67.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.802 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -78.2 -10.32 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.399 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt 68.27 51.6 0.69 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.94 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -134.46 159.14 42.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.683 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 30.6 mttp -104.02 135.87 44.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.723 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -149.52 171.09 17.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.073 0.463 . . . . 0.0 111.298 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.746 ' NE2' HG21 ' A' ' 153' ' ' VAL . 53.4 m-70 -139.82 124.77 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.291 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -118.23 139.73 14.87 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.331 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 71' ' ' VAL . 6.8 m-85 -120.87 110.75 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 70' ' ' ILE . 19.8 m-85 -110.62 134.0 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.999 0.428 . . . . 0.0 111.651 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 2.4 mmtp -88.36 119.69 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.1 m-85 -103.31 143.67 32.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.624 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.744 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.7 tp60 -82.63 -2.7 54.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.808 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 176.82 -47.09 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.403 ' O ' ' CE2' ' A' ' 139' ' ' PHE . 0.0 OUTLIER 174.56 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.598 0.237 . . . . 0.0 111.516 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.06 -25.32 7.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.641 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 17.5 m -92.59 135.06 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.187 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 ' HG2' ' A' ' 118' ' ' PRO . 51.5 mt -110.04 143.57 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.887 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.0 mt -125.44 -15.5 6.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.36 141.73 19.64 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.689 0.28 . . . . 0.0 111.004 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 34.1 p90 -139.54 131.61 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.651 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -126.98 145.97 50.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.285 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 122' ' ' TYR . 4.4 mp -133.85 125.53 28.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -122.25 147.29 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.23 147.32 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.746 HG21 ' NE2' ' A' ' 134' ' ' HIS . 28.2 m -147.64 148.9 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -136.23 31.88 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.66 111.05 23.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.45 160.81 9.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.565 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.02 76.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.914 0.388 . . . . 0.0 111.124 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -175.47 94.57 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' MET . 31.0 mmt-85 -62.35 95.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.318 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.954 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.66 118.26 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.388 0.613 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 20.4 m-30 -122.47 -178.62 3.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.932 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.937 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 18.0 p -124.95 166.12 16.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.159 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 9' ' ' LEU . 2.8 tt -153.73 108.69 3.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -108.23 124.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.484 0.659 . . . . 0.0 112.081 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.964 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.05 113.0 15.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.403 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 88' ' ' THR . 16.8 t -81.71 76.05 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.093 0.473 . . . . 0.0 111.486 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.32 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.767 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.557 ' N ' HD12 ' A' ' 13' ' ' LEU . 40.3 mt-30 -105.19 157.29 34.66 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.327 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' C ' HD13 ' A' ' 108' ' ' LEU . 37.1 Cg_endo -65.41 32.8 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.204 . . . . 0.0 113.02 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.7 pt20 -160.5 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.5 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -142.18 161.08 38.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.749 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.42 154.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.786 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 105' ' ' TRP . 5.9 tp -121.12 115.1 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.251 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' HG22 ' A' ' 111' ' ' ILE . 1.9 mt -113.09 139.53 48.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 123.92 7.8 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.197 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.615 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.8 ttm -113.6 142.14 46.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 mtpt -89.05 146.78 24.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 mttt -90.28 -31.8 16.81 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.655 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.785 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.55 115.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.09 -120.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.351 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -100.03 23.97 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.33 31.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.053 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -56.69 145.89 27.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.757 0.313 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.16 22.48 29.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.708 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.6 mmt180 -132.73 136.67 46.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.576 0.227 . . . . 0.0 110.509 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.615 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -88.24 153.59 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.919 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.4 t-20 -178.14 142.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.745 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.35 -178.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.294 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.698 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -108.29 94.04 4.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.412 . . . . 0.0 110.345 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.8 148.63 17.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.698 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.66 -128.41 2.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.375 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -160.23 140.44 11.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.954 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 t -78.05 108.18 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -49.31 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.205 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -69.79 64.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.284 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.17 42.69 0.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.205 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.63 173.13 9.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.8 p -100.39 141.27 33.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.46 -33.1 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -74.52 -27.86 60.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' THR . 10.6 m-20 -79.53 -36.29 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.406 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.21 -32.88 59.76 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.53 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.72 -33.69 60.32 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.654 ' CG ' HD12 ' A' ' 64' ' ' LEU . 11.9 mtp-105 -74.37 -54.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.025 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -34.38 75.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.442 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 5.4 mm-40 -84.41 -19.39 33.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -74.66 -49.38 21.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.645 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.4 tt0 -57.66 -28.85 64.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 12.7 pt-20 -82.78 -24.93 33.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -68.85 -43.97 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.32 27.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.758 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 59.31 9.35 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.534 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.787 HD13 HD13 ' A' ' 91' ' ' ILE . 4.9 mt -93.44 108.52 20.19 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.988 0.423 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.645 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.44 177.11 6.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.474 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 91' ' ' ILE . 16.5 m -142.41 136.84 28.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.122 0.487 . . . . 0.0 111.842 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 4.0 t0 -79.91 -18.45 50.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.124 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.37 90.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.748 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.5 mt -54.62 172.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -135.22 101.39 4.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.685 0.278 . . . . 0.0 110.99 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.18 139.68 58.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 127' ' ' LEU . 34.1 m -128.24 -47.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.021 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.48 159.2 27.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.095 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG3' ' CD2' ' A' ' 84' ' ' HIS . 3.3 tt0 -117.59 119.44 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.252 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 123' ' ' TRP . 21.2 mt -110.27 134.7 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.511 . . . . 0.0 111.611 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 136' ' ' TYR . 37.5 t -115.89 149.35 18.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.199 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 70' ' ' ILE . 7.0 m-85 -134.34 139.46 45.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -121.57 131.15 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.57 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 3.0 t80 -82.8 137.65 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG21 HD13 ' A' ' 146' ' ' LEU . 0.5 OUTLIER -71.69 126.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.978 0.418 . . . . 0.0 111.203 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.66 13.8 80.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.242 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 34.1 mm-40 -137.27 125.94 14.86 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.944 0.372 . . . . 0.0 110.93 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.61 -44.83 44.37 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.479 2.12 . . . . 0.0 112.418 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.5 tt0 -51.62 163.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -147.71 -168.37 3.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 11.8 ttp -147.57 111.59 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.779 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 31.9 t0 -102.44 102.96 13.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.301 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.1 p -112.09 116.73 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.3 t-160 -74.25 155.89 37.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.3 t -116.89 107.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.224 0.535 . . . . 0.0 110.939 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.813 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -104.81 147.76 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.9 m -136.94 117.34 13.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -91.82 -172.18 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 111.889 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -152.65 -43.81 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.84 93.93 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.173 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.787 HD13 HD13 ' A' ' 59' ' ' LEU . 1.7 pt -103.77 177.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.073 0.464 . . . . 0.0 111.552 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 93' ' ' GLY . 45.6 mm-40 -103.56 74.32 1.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.914 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.26 90.05 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.233 -0.894 . . . . 0.0 114.293 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 96' ' ' VAL . 92.1 m -160.4 54.79 0.63 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.922 0.392 . . . . 0.0 110.485 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.432 ' N ' HD21 ' A' ' 59' ' ' LEU . 61.5 Cg_endo -75.29 73.14 4.59 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.117 1.878 . . . . 0.0 110.161 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 94' ' ' THR . 2.4 t -77.48 63.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.465 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.4 pt-20 -41.5 106.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.82 -175.53 5.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.118 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -72.7 -9.87 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.249 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.41 -37.05 6.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 110.963 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.47 160.66 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.8 ttm180 -164.43 93.73 0.98 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.548 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.6 Cg_endo -72.03 160.33 47.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.573 2.182 . . . . 0.0 112.587 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.26 123.75 12.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.54 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.569 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.7 m95 -90.17 124.2 34.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 27.4 m-85 -140.91 -167.08 2.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.951 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.8 mp0 -86.22 159.37 19.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 13' ' ' LEU . 1.9 pt? -78.09 -2.45 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.581 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.82 20.47 13.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -140.87 18.23 2.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.799 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.627 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -73.36 124.36 90.41 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.686 179.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -92.22 97.0 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.645 2.23 . . . . 0.0 113.566 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -74.87 -18.48 60.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.024 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -67.97 -27.71 66.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.151 0.5 . . . . 0.0 109.663 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.23 29.61 4.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.414 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.3 mtp -131.43 -81.53 0.52 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.347 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 9.0 m95 -151.91 163.37 23.81 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.689 0.281 . . . . 0.0 111.17 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HB2' HD12 ' A' ' 145' ' ' ILE . 91.5 Cg_endo -78.08 11.73 2.24 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.833 2.355 . . . . 0.0 113.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.5 p30 -121.68 -26.25 4.93 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.943 0.401 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.665 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 42.7 m-20 -44.48 -52.75 7.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.449 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -60.0 -17.28 37.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 150' ' ' LEU . 32.4 m-85 -84.72 -30.37 24.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.964 ' CH2' HD12 ' A' ' 11' ' ' LEU . 62.0 p-90 -112.6 -5.0 14.02 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.2 m-85 -76.35 -51.34 2.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 111.048 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 83.2 Cg_exo -46.55 -37.57 20.32 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.034 2.489 . . . . 0.0 113.763 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -78.25 -32.42 49.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.508 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.57 -52.35 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.438 0.637 . . . . 0.0 109.408 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 108' ' ' LEU . 6.5 mt -59.99 -28.74 67.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.735 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 8.6 tp60 -85.1 2.47 43.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.429 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.8 21.54 11.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 111.322 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -107.16 159.2 16.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.855 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HB3' HG23 ' A' ' 153' ' ' VAL . 9.1 mptt -107.78 129.87 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.71 ' HB2' HD22 ' A' ' 126' ' ' LEU . 16.4 m-85 -138.19 165.79 25.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.994 0.426 . . . . 0.0 111.048 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.468 ' NE2' HG23 ' A' ' 71' ' ' VAL . 6.0 t60 -127.39 125.33 40.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 70' ' ' ILE . . . -125.32 133.21 8.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.563 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CE2' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -112.5 118.5 35.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 16.9 m-85 -119.0 123.14 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 111.731 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -88.51 128.1 35.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.3 p90 -103.61 158.57 16.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 112.005 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 146' ' ' LEU . 14.0 tp60 -97.38 -27.38 14.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.541 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.82 -45.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.249 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.31 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.751 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -113.19 -20.31 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.495 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.7 m -90.42 134.95 34.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.815 0.34 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 118' ' ' PRO . 70.5 mt -109.99 135.79 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -116.07 -10.68 11.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.99 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.1 OUTLIER -153.81 134.18 13.46 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.991 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 148' ' ' TYR . 31.6 p90 -139.29 131.42 28.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.844 0.354 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.71 145.21 51.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 122' ' ' TYR . 1.6 mp -133.34 122.5 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -126.79 158.52 36.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.72 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 7.1 pt-20 -100.14 148.43 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 132' ' ' LYS . 15.4 m -145.26 149.23 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -172.09 -55.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -86.44 155.29 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.071 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.753 0.311 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.48 -28.08 5.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.34 -170.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 111.079 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.12 106.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.162 0.506 . . . . 0.0 111.087 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.01 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.476 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -86.87 115.04 24.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.348 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.671 ' HB2' HG22 ' A' ' 83' ' ' VAL . 8.2 m-85 -122.54 -179.29 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.917 HG22 HG23 ' A' ' 45' ' ' ILE . 26.9 p -126.84 165.4 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.228 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -150.74 109.03 3.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.814 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.51 125.07 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.518 0.675 . . . . 0.0 111.945 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.894 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.8 mt -127.26 112.95 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 88' ' ' THR . 14.4 t -80.85 72.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.146 0.498 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.33 117.88 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.1 mt-30 -104.27 157.27 34.4 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.173 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.8 Cg_endo -65.24 32.54 0.1 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.972 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 1.5 mm100 -160.37 -41.48 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.811 0.338 . . . . 0.0 110.6 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 5.0 mtt85 -142.15 161.27 38.44 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.753 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.6 p -131.67 153.31 38.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.1 tp -121.43 112.83 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.666 HD11 HG22 ' A' ' 111' ' ' ILE . 9.9 mt -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.14 128.12 9.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.608 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.582 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 42.6 ttm -111.16 142.4 43.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -83.23 147.12 28.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.41 -35.25 16.13 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.886 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.7 146.26 5.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.0 111.291 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.74 -125.2 6.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.091 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.19 74.01 1.74 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.5 -12.18 1.35 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.372 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.13 119.44 1.35 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.081 0.441 . . . . 0.0 111.644 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.9 51.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.675 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.69 131.47 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.594 0.235 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -94.37 152.59 18.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.334 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.403 ' CA ' HD22 ' A' ' 20' ' ' LEU . 41.2 t30 -177.63 163.64 1.93 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.24 169.29 7.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.228 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.93 99.62 10.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.355 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -101.76 153.53 18.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.956 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.94 123.17 1.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.194 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -49.63 146.5 4.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 0.0 111.261 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 6' ' ' LEU . 5.7 t -75.32 112.98 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 4.7 mt-30 -42.51 163.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.544 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.05 86.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.192 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.37 46.25 4.13 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.007 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' HG12 ' A' ' 39' ' ' VAL . 1.9 pt-20 -126.61 173.07 9.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -103.34 144.3 31.55 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.425 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.917 HG23 HG22 ' A' ' 8' ' ' THR . 4.2 mt -48.0 -31.68 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.124 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 3.2 tt0 -72.5 -34.22 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -39.93 36.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.968 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.02 60.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.537 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.824 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.36 -29.86 60.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 64' ' ' LEU . 65.3 mtt180 -79.44 -54.76 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -61.18 -34.21 74.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.492 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.25 -20.65 31.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.669 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD22 HG21 ' A' ' 10' ' ' VAL . 18.2 tp -70.31 -48.19 57.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.843 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.7 tt0 -62.15 -26.3 68.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.588 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.64 -21.95 34.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -78.5 -43.97 25.64 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -135.88 26.76 3.31 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.767 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 53.89 16.25 5.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.552 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 19' ' ' LEU . 6.6 mt -106.71 105.05 14.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.261 0.553 . . . . 0.0 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.86 152.63 22.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.666 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.968 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.9 m -121.22 141.84 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.989 0.423 . . . . 0.0 111.817 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.0 t70 -79.95 -20.85 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.61 96.57 0.02 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.968 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -61.98 -177.15 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -135.18 101.18 4.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 18.0 pttt -61.15 140.03 57.98 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG21 ' CD2' ' A' ' 127' ' ' LEU . 34.5 m -126.05 -46.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.855 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -149.8 177.49 27.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.092 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -131.59 116.47 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 137' ' ' PHE . 75.6 mt -99.63 146.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.279 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.04 147.91 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.344 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 61.7 m-85 -134.78 118.59 17.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.276 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.6 127.79 43.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.304 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -96.55 130.76 43.66 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.276 0.56 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -78.09 117.6 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 -18.82 56.86 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -107.58 109.11 62.36 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.513 0.196 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.76 -27.06 7.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.471 2.114 . . . . 0.0 112.409 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -73.16 171.38 13.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -142.88 -165.39 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 3.1 mtp -145.02 111.77 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.27 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -107.4 102.74 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.671 HG22 ' HB2' ' A' ' 7' ' ' TYR . 21.6 t -110.73 116.9 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.012 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.7 t-160 -83.25 142.93 30.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CE3' ' A' ' 123' ' ' TRP . 46.6 t -101.81 137.43 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.561 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 16.1 m-85 -139.37 145.71 39.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.927 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 5.6 m -133.64 117.36 16.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.016 HG22 HG22 ' A' ' 12' ' ' VAL . 6.0 t -97.27 -172.53 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.185 0.517 . . . . 0.0 111.664 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -160.12 -45.79 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.788 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 99.23 11.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.082 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' THR . 38.9 pt -102.95 178.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.762 0.315 . . . . 0.0 111.279 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -142.39 -62.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -53.82 -172.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.91 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.48 152.83 48.61 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.589 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 94' ' ' THR . 37.3 Cg_endo -73.08 65.68 4.21 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 121.905 1.736 . . . . 0.0 108.87 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 94' ' ' THR . 3.8 t -76.2 64.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.713 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -43.7 113.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.939 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.36 -176.2 5.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.69 -11.03 60.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.499 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.48 15.05 8.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.582 0.23 . . . . 0.0 111.401 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.5 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -154.58 160.96 41.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' MET . 24.9 ttt85 -173.11 104.57 0.32 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.535 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.821 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.5 Cg_endo -76.95 159.93 33.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.479 2.119 . . . . 0.0 112.519 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 7.6 t -145.14 119.68 9.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.749 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.793 ' CD1' HD13 ' A' ' 19' ' ' LEU . 10.0 m95 -86.37 117.1 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 7.2 m-85 -128.63 -169.47 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -89.33 156.56 18.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.7 pt? -74.57 -2.22 24.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.702 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.67 20.71 12.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -145.35 21.68 1.53 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.523 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.708 HG23 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 126.02 90.52 Favored Pre-proline 0 N--CA 1.466 0.343 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.867 179.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.9 Cg_endo -90.34 97.93 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.434 2.089 . . . . 0.0 113.432 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -75.53 -18.22 59.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.486 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -25.96 59.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -96.47 27.6 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.727 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.514 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.5 mtm -134.71 -74.1 0.47 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.572 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.402 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -155.16 171.52 7.11 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.509 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.5 Cg_endo -86.65 16.48 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.403 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -128.15 -21.83 3.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.705 0.288 . . . . 0.0 111.547 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.0 m-20 -45.91 -52.45 11.51 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -58.86 -16.89 19.47 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.549 ' HD2' HD11 ' A' ' 150' ' ' LEU . 64.2 m-85 -84.48 -35.63 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.894 ' CH2' HD12 ' A' ' 11' ' ' LEU . 43.8 p-90 -104.4 -12.86 16.32 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.285 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 1.7 m-85 -66.12 -52.18 40.78 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 17.5 Cg_endo -58.95 -27.85 85.93 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 0.0 112.726 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.838 HD13 ' CG ' ' A' ' 133' ' ' PHE . 5.3 mt -81.18 -31.45 34.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.95 0.405 . . . . 0.0 110.248 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.6 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -63.2 -54.7 33.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.364 0.602 . . . . 0.0 109.496 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -58.78 -24.51 61.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.704 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.1 mt-30 -82.33 2.89 30.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.312 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 54.18 34.14 19.54 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -117.08 155.05 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.469 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 5.4 mtmm -108.8 132.92 53.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.838 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -149.48 169.6 20.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.177 0.513 . . . . 0.0 111.361 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 10.8 m170 -125.64 125.04 42.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.316 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.14 127.17 7.65 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.079 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -111.63 117.95 34.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 70' ' ' ILE . 2.4 m-85 -121.53 135.23 55.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 112.066 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.74 133.74 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.432 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -103.28 164.16 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.061 0.458 . . . . 0.0 111.513 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.649 ' HB2' HD21 ' A' ' 146' ' ' LEU . 37.4 tp60 -117.89 6.68 12.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.754 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.46 -51.42 0.29 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.446 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.06 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -121.31 -9.13 9.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 41.3 m -104.02 135.74 44.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.561 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 59.7 mt -109.95 144.15 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.708 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 140' ' ' GLN . 8.2 mt -122.36 -15.0 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.276 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -154.09 137.91 16.21 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 16.3 p90 -139.73 135.45 33.14 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.416 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.64 144.67 51.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.746 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.568 HD23 ' CE2' ' A' ' 133' ' ' PHE . 5.1 mp -133.97 121.53 21.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -136.61 119.86 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.9 141.14 34.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.755 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.83 157.4 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.64 -40.26 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -60.15 -66.02 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.035 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.79 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.67 -171.6 12.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.64 -168.78 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.091 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p 55.6 84.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.277 0.561 . . . . 0.0 111.199 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' MET . 27.7 mmm180 -60.83 97.28 0.05 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.262 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.23 118.86 25.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.614 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 7.4 m-85 -122.44 -178.9 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.721 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 31.6 p -125.06 167.89 14.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.2 tt -153.5 109.15 3.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.91 127.52 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.68 0.753 . . . . 0.0 112.436 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.859 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.2 mt -127.03 112.7 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.725 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.047 HG22 HG22 ' A' ' 88' ' ' THR . 21.3 t -82.34 96.87 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.295 0.569 . . . . 0.0 111.853 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.934 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -101.58 158.22 16.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.824 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.1 156.95 77.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 14' ' ' GLN . 36.4 Cg_endo -65.47 20.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.319 2.012 . . . . 0.0 113.478 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.8 mt-30 -160.93 -41.95 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.965 0.412 . . . . 0.0 110.858 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -127.55 161.29 29.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.934 HG23 HD22 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -129.6 140.24 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 103' ' ' PRO . 27.6 tp -105.57 113.5 27.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -108.81 155.83 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.21 125.41 8.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 39.4 ttm -113.73 142.34 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.702 0.287 . . . . 0.0 110.737 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -84.94 147.06 26.93 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 -32.0 17.43 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.938 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.846 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -165.77 153.67 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.961 0.41 . . . . 0.0 111.345 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.02 -127.04 8.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.13 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 78.44 2.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.767 0.317 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.84 -4.89 2.47 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.48 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.846 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.96 144.18 1.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.171 0.485 . . . . 0.0 111.525 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.7 24.11 56.6 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.7 mtp85 -139.15 140.9 38.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.67 0.235 . . . . 0.0 110.591 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -93.02 153.02 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -178.57 143.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -50.07 168.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.332 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.709 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -99.59 99.39 10.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.6 167.34 38.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.028 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -172.22 119.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.295 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 12.7 pttt -58.92 149.63 26.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.793 HG21 HD22 ' A' ' 6' ' ' LEU . 10.9 t -80.08 110.31 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.653 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -44.27 166.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.415 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.11 79.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 46.84 1.85 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.967 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.65 172.97 9.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.1 p -98.44 143.02 29.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.16 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -50.85 -33.44 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.196 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.64 -26.65 60.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -81.59 -37.05 28.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.566 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.62 -34.87 62.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.343 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.15 -35.78 61.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtp180 -72.56 -54.75 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.056 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -60.82 -34.9 75.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.308 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.2 -20.2 32.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.687 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 10' ' ' VAL . 18.9 tp -70.66 -47.12 61.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.693 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 6.8 tt0 -61.46 -25.75 67.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.63 -21.94 34.88 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -79.62 -43.95 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -134.33 25.03 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.86 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.31 14.51 8.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.679 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 91' ' ' ILE . 12.8 mt -103.78 112.69 25.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.9 136.61 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.596 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.934 HG21 ' HG ' ' A' ' 64' ' ' LEU . 18.3 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.047 0.451 . . . . 0.0 111.946 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.99 -17.34 53.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.206 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -179.77 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.934 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -61.14 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 1.7 t-80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -60.75 132.56 54.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 68' ' ' GLY . 35.5 m -124.37 -48.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.051 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.06 171.18 26.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.062 -1.065 . . . . 0.0 113.038 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -131.76 115.85 16.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 0.0 110.568 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 ' CE1' ' A' ' 137' ' ' PHE . 36.8 mt -105.27 150.0 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 111.062 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 136' ' ' TYR . 60.1 t -127.81 149.3 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.359 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.0 m-85 -126.82 127.34 44.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.84 0.352 . . . . 0.0 111.234 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 26.3 tt0 -104.51 122.36 45.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.081 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -82.77 129.9 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.871 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.748 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -72.83 119.92 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.54 -15.37 58.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.157 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -111.33 122.75 36.78 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 117.018 0.409 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.63 -37.73 90.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.415 2.077 . . . . 0.0 112.125 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -62.77 175.39 0.84 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.397 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -150.78 -171.63 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.218 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.606 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -144.55 110.93 5.56 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -101.03 107.29 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -110.01 116.7 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.912 0.387 . . . . 0.0 111.334 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' HB2' HG21 ' A' ' 45' ' ' ILE . 15.8 m170 -75.25 161.58 29.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.68 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.737 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.2 t -116.95 133.64 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.122 0.487 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.887 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -135.56 142.8 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.798 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.7 m -129.48 117.58 20.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.047 HG22 HG22 ' A' ' 12' ' ' VAL . 13.9 t -97.72 -172.4 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.199 0.523 . . . . 0.0 111.698 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.38 -44.26 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.75 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.61 99.54 11.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.08 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 59' ' ' LEU . 47.4 pt -102.73 178.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 111.043 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -69.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.264 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.29 -166.39 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.652 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -119.29 164.89 19.05 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.389 0.138 . . . . 0.0 111.066 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.45 64.33 0.77 Allowed 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.436 2.09 . . . . 0.0 109.457 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 94' ' ' THR . 8.0 t -76.64 61.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.678 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.18 116.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.868 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.4 m -87.53 -179.69 6.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.8 -15.95 56.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.54 21.12 7.18 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.233 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.54 155.14 34.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 111.215 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' MET . 9.3 ttt-85 -169.14 106.34 0.48 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.944 ' HB2' HD11 ' A' ' 19' ' ' LEU . 98.0 Cg_endo -80.47 156.92 22.11 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.374 2.05 . . . . 0.0 112.947 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 129.53 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.424 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.877 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.7 m95 -96.5 113.84 25.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.985 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -122.02 -164.6 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.794 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.43 164.46 13.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.824 HD11 ' O ' ' A' ' 14' ' ' GLN . 17.3 mt -72.38 -23.78 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.418 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.86 18.13 22.24 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -131.71 14.86 4.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.686 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -73.53 124.0 89.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.614 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 44.2 Cg_endo -92.76 97.87 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.579 2.186 . . . . 0.0 113.315 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.81 -18.06 45.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -66.12 -26.3 67.38 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 109.959 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.18 27.0 4.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.558 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 6.2 mtm -137.91 -161.08 1.13 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.451 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 166.31 2.42 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.758 0.313 . . . . 0.0 111.107 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 84.0 Cg_endo -84.97 14.75 2.39 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.064 2.509 . . . . 0.0 113.211 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.4 m-20 -122.7 -16.78 7.09 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.347 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.4 m-20 -45.59 -55.72 5.98 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.9 t -57.37 -17.53 13.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.793 ' CD1' HD11 ' A' ' 150' ' ' LEU . 30.0 m-85 -85.1 -44.42 13.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.859 ' CH2' HD12 ' A' ' 11' ' ' LEU . 59.0 p-90 -95.12 -1.96 50.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.588 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 2.1 m-85 -76.44 -50.67 2.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.319 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 75.4 Cg_exo -49.26 -35.28 33.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.013 2.475 . . . . 0.0 113.576 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.1 OUTLIER -78.2 -34.27 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.048 0.452 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.65 -54.62 43.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.728 179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -28.18 68.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.759 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 3.6 tp60 -84.85 2.47 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.472 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.2 23.03 11.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.735 0.302 . . . . 0.0 111.292 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -109.04 159.14 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.82 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -108.36 129.72 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.871 ' HB2' HD13 ' A' ' 126' ' ' LEU . 16.9 m-85 -139.82 160.36 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -128.05 125.06 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.755 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.98 147.83 17.54 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.563 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.7 t80 -121.04 110.75 16.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 70' ' ' ILE . 29.3 m-85 -113.01 127.53 56.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.78 128.37 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 11.4 m-85 -111.88 161.36 16.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 111.814 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.752 ' HG2' HD21 ' A' ' 146' ' ' LEU . 1.8 mm-40 -85.04 -41.2 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.0 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 74' ' ' PHE . . . -148.66 -38.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.297 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.85 -31.29 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.64 -23.36 9.78 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 8.8 m -92.29 135.57 33.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.398 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 139' ' ' PHE . 64.7 mt -110.04 141.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.155 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.752 HD21 ' HG2' ' A' ' 140' ' ' GLN . 3.4 mt -123.1 -13.88 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.115 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -153.94 135.99 14.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.913 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.499 ' CD1' ' CE1' ' A' ' 122' ' ' TYR . 51.0 p90 -139.39 130.41 26.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.637 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.66 51.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.517 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.793 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -133.4 124.39 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 31.9 mtt180 -123.97 158.95 30.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 4.5 pt-20 -99.36 148.05 24.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 132' ' ' LYS . 9.9 m -144.85 149.36 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.27 -54.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.5 t -88.83 158.65 18.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.102 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.815 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.06 -139.17 2.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.19 -168.31 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.23 90.17 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.224 0.535 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.2 mmm180 -61.75 97.35 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.127 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.0 116.13 24.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.401 0.619 . . . . 0.0 110.628 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 7.6 m-85 -122.61 -178.9 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.728 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.85 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 67.9 p -127.1 169.43 13.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.14 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -152.4 109.06 3.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.398 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -111.26 120.69 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.705 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.96 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.12 113.0 15.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.07 HG22 HG22 ' A' ' 88' ' ' THR . 12.0 t -81.97 99.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.174 0.511 . . . . 0.0 111.361 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.709 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.61 118.0 24.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.043 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -104.56 157.13 34.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.947 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.2 Cg_endo -64.83 32.19 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.505 2.137 . . . . 0.0 113.108 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 8.0 mt-30 -160.56 -39.06 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -142.24 161.14 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.709 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.6 p -134.05 150.02 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.7 tp -121.29 117.55 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.522 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.709 ' CD2' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -114.96 144.66 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.968 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.64 124.87 7.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.605 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -113.61 142.2 46.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.702 0.286 . . . . 0.0 110.595 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -89.57 146.71 24.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 -27.6 21.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.863 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -169.07 142.9 2.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.938 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 133.84 -128.26 4.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.272 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -100.27 23.52 9.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.559 0.219 . . . . 0.0 111.322 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.15 18.72 0.09 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.551 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -57.9 148.79 24.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.124 0.462 . . . . 0.0 110.883 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.45 30.23 58.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.899 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.1 mtt-85 -143.43 146.19 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.605 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.73 152.64 22.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.595 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 p-10 -177.62 160.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.391 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.58 168.28 6.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.157 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.631 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -99.97 100.19 11.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.362 . . . . 0.0 110.118 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -75.54 161.6 52.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.177 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.93 117.08 0.75 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.28 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 12.7 pttt -75.3 143.07 43.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 0.0 111.321 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.86 108.73 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.597 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.06 174.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.303 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -68.52 65.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.8 44.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.07 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.67 173.11 9.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' ASP . 69.7 p -100.78 143.04 31.42 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.896 0.379 . . . . 0.0 111.055 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HD21 ' A' ' 6' ' ' LEU . 2.8 mp -50.11 -33.66 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.225 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.98 -28.46 61.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -80.08 -36.92 34.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.735 179.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.84 64.43 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.372 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.6 -31.53 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' HD11 ' A' ' 64' ' ' LEU . 14.2 mtt85 -78.4 -53.82 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.006 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -61.65 -34.42 75.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.443 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.17 -19.51 33.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.604 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 10' ' ' VAL . 15.6 tp -72.45 -47.66 47.08 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.5 tt0 -61.03 -27.11 68.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.86 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.54 -22.08 35.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.1 mt-10 -77.08 -43.91 32.57 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -136.58 24.93 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.819 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.32 14.18 12.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.571 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.18 108.4 19.75 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.279 0.562 . . . . 0.0 110.615 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -91.52 144.06 25.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.078 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.966 HG21 ' HG ' ' A' ' 64' ' ' LEU . 23.4 m -114.76 139.84 38.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.98 0.419 . . . . 0.0 111.779 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 40.8 t0 -79.92 -19.03 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.261 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.6 95.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.781 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.966 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -60.69 -172.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -134.88 101.19 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.638 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 1.4 pttp -61.08 135.77 57.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.275 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 127' ' ' LEU . 35.6 m -122.44 -47.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.854 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -153.23 168.17 31.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.069 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -116.54 119.96 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 0.0 110.327 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.699 HD11 ' CG ' ' A' ' 123' ' ' TRP . 34.1 mt -106.94 128.62 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.061 0.457 . . . . 0.0 111.311 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.744 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 39.3 t -109.38 149.4 12.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.253 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 12.4 m-85 -131.45 127.75 38.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.83 125.52 52.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 2.8 t80 -84.71 138.28 32.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.582 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -70.14 131.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.654 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.72 10.48 58.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.599 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 4.1 mm-40 -130.1 120.39 19.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 117.214 0.507 . . . . 0.0 111.147 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.58 -42.64 60.72 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.404 2.07 . . . . 0.0 112.193 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 4.2 tt0 -58.27 168.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -148.34 -165.44 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.177 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 17.3 ttp -147.53 111.1 4.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -97.84 102.72 14.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.806 0.336 . . . . 0.0 110.353 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -109.41 116.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HB2' HG21 ' A' ' 45' ' ' ILE . 10.0 m80 -77.22 159.39 29.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.552 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' CE3' ' A' ' 123' ' ' TRP . 78.6 t -114.39 133.28 60.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.125 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 15.0 m-85 -138.28 142.39 39.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.027 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 18.0 p -129.62 117.53 20.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.07 HG22 HG22 ' A' ' 12' ' ' VAL . 4.6 t -98.52 -174.28 2.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 0.0 111.768 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -160.34 -44.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.24 98.77 10.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.276 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.0 pt -103.02 178.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -137.09 -64.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.66 -164.03 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.703 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.932 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.81 160.18 52.64 Favored Pre-proline 0 CA--C 1.517 -0.319 0 CA-C-O 120.456 0.17 . . . . 0.0 111.26 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.932 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.8 Cg_exo -68.17 63.36 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.517 2.145 . . . . 0.0 109.639 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 94' ' ' THR . 3.0 t -76.73 60.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.621 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.3 pt-20 -45.52 113.19 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.131 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -87.44 -176.88 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -68.16 -12.56 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -111.42 -27.18 8.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.624 0.249 . . . . 0.0 111.432 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.37 160.48 22.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.432 . . . . 0.0 111.302 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -169.56 93.25 0.53 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.894 ' HB2' HD11 ' A' ' 19' ' ' LEU . 83.3 Cg_endo -75.63 157.49 40.12 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.362 2.041 . . . . 0.0 112.86 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -142.16 130.83 22.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.464 179.504 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.887 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.1 m95 -94.86 122.2 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.5 m-85 -133.4 -165.08 1.57 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.764 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.572 ' O ' HG12 ' A' ' 18' ' ' VAL . 19.4 mt-30 -87.71 164.09 16.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.812 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.1 pt? -88.73 9.24 25.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.517 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -125.6 25.16 7.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.799 0.333 . . . . 0.0 110.281 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -155.86 24.26 0.38 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.688 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.1 127.41 89.37 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.174 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.45 98.92 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.666 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -79.1 -18.21 53.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.32 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -22.45 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.15 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.39 23.43 7.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.858 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.666 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -128.82 -72.1 0.62 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -158.35 172.1 6.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.961 0.41 . . . . 0.0 111.123 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HG2' HD11 ' A' ' 145' ' ' ILE . 82.5 Cg_endo -86.05 16.52 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.212 2.608 . . . . 0.0 113.351 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 3.5 p-10 -126.91 -23.15 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.6 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.5 m-20 -45.15 -56.9 4.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 28.3 p -56.11 -18.25 9.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 9.7 m-85 -85.48 -28.46 25.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.96 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.5 p-90 -114.66 -10.5 12.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.912 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.49 -47.97 3.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 74.6 Cg_exo -49.79 -36.7 43.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.512 2.141 . . . . 0.0 113.196 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -78.06 -32.65 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.268 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -57.41 -51.63 68.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.565 0.697 . . . . 0.0 109.225 178.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.11 -31.08 64.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.042 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.96 -6.87 59.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 42.93 2.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -122.33 159.13 28.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 9.1 mttt -104.86 137.1 43.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -149.47 171.09 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.257 0.551 . . . . 0.0 111.557 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 69' ' ' GLN . 1.4 m80 -131.48 124.89 31.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.987 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -124.42 125.61 5.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.602 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.744 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.6 m-85 -107.69 115.21 29.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 31.0 m-85 -116.38 122.06 43.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.964 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -88.54 134.42 33.87 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 2.0 p90 -119.02 163.98 16.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.874 ' HG2' HD11 ' A' ' 146' ' ' LEU . 57.2 mt-30 -98.69 -29.15 13.19 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.425 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.42 -67.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.753 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -171.64 24.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.557 0.217 . . . . 0.0 111.173 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 118' ' ' PRO . 8.6 m-20 -160.39 -39.91 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.408 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.776 HG21 ' OE1' ' A' ' 140' ' ' GLN . 30.9 m -83.11 133.53 35.05 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.268 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 138' ' ' LYS . 56.5 mt -110.23 137.29 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -112.21 -16.37 13.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.973 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.4 OUTLIER -149.55 134.25 17.72 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 43.6 p90 -138.98 116.63 11.4 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.891 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -115.85 146.01 42.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 110.951 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 133' ' ' PHE . 3.7 mp -134.33 123.18 23.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.77 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -128.2 119.68 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.963 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.11 141.17 28.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 174.71 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.56 33.33 20.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 38.2 m -83.91 132.05 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.147 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.64 43.44 4.84 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.549 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.12 -168.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 p 56.31 87.77 0.05 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.71 97.08 0.09 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.164 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.983 HD22 HG21 ' A' ' 39' ' ' VAL . 2.8 tt -86.16 120.38 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.487 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.6 m-85 -122.43 -178.89 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.055 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -135.67 131.56 35.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.386 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -116.03 109.01 16.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.77 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.743 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.06 128.33 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.557 0.694 . . . . 0.0 112.415 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.806 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.91 112.74 15.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.205 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HG22 ' A' ' 88' ' ' THR . 13.5 t -81.06 115.5 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.982 0.42 . . . . 0.0 111.559 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -127.81 158.54 37.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.256 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 1.1 mt-30 -128.97 157.04 77.01 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.52 21.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.365 2.044 . . . . 0.0 113.6 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.4 pt20 -160.83 -40.62 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.003 0.43 . . . . 0.0 110.669 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 14' ' ' GLN . 6.5 ptt85 -130.57 160.8 33.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.377 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.71 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.5 p -127.13 158.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 110.784 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 15.4 tp -121.36 110.63 16.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.29 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -103.49 176.74 5.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.35 121.19 3.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.044 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.599 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 41.8 ttm -113.15 142.35 45.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.633 0.254 . . . . 0.0 110.848 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG3' ' HE3' ' A' ' 101' ' ' MET . 0.1 OUTLIER -87.45 146.77 25.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -89.67 -30.88 17.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.858 0.361 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.828 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.3 139.02 2.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.897 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 23' ' ' LYS . . . 137.28 -127.55 4.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.344 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.586 0.231 . . . . 0.0 111.31 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -169.85 22.17 0.09 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.342 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.828 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -57.11 147.36 24.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.95 0.375 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.85 24.75 27.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.853 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mpt_? -136.49 135.04 38.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.1 OUTLIER -84.29 153.19 23.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.508 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -175.38 143.31 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -53.23 176.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.302 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HB2' HG13 ' A' ' 10' ' ' VAL . 1.5 m-85 -102.68 96.06 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.082 0.468 . . . . 0.0 109.81 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -56.58 -168.4 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.31 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . 166.72 158.17 11.01 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 138.74 49.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.321 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.983 HG21 HD22 ' A' ' 6' ' ' LEU . 2.5 t -75.36 106.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 176.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.333 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.63 65.72 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.129 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.37 44.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.3 pt-20 -126.63 173.35 9.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 p -100.61 142.31 32.26 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.165 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 6' ' ' LEU . 3.3 mp -49.74 -33.43 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.91 -28.72 60.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.69 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.04 -37.13 39.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.647 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.98 65.02 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.583 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.821 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.98 -33.62 59.76 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -73.74 -53.34 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ttt85 -62.22 -33.74 75.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.04 -19.48 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.673 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 64' ' ' LEU . 24.4 tp -76.01 -48.03 22.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.0 tt0 -59.44 -24.91 63.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.96 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.58 -23.83 34.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -75.15 -44.11 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 t -135.86 24.15 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.742 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.97 12.08 10.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.385 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 91' ' ' ILE . 12.3 mt -102.72 110.9 22.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.851 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -91.32 156.57 17.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.629 179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.892 HG21 ' HG ' ' A' ' 64' ' ' LEU . 31.0 m -123.6 141.06 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.075 0.464 . . . . 0.0 111.963 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 46.1 m-20 -80.38 -19.02 47.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.125 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.02 97.04 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.644 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -62.05 -174.31 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.876 0.369 . . . . 0.0 110.098 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -134.96 101.11 4.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.563 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.87 135.28 53.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.032 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 127' ' ' LEU . 23.5 m -129.59 -47.57 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.011 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -137.09 169.05 24.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.974 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 5.6 mp0 -131.57 114.45 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.758 0.313 . . . . 0.0 110.341 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 123' ' ' TRP . 53.1 mt -98.94 148.48 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.0 111.369 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 82' ' ' ASP . 17.5 t -129.09 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.545 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CE1' HG22 ' A' ' 70' ' ' ILE . 5.3 m-85 -131.48 118.19 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.996 0.427 . . . . 0.0 111.164 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -99.82 123.52 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.14 135.18 33.39 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.41 107.49 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.765 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.02 47.03 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.214 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -107.38 117.2 56.57 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.544 0.211 . . . . 0.0 110.674 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.5 -48.16 19.97 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.448 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.8 tt0 -58.91 168.35 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -142.55 -166.29 2.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.1 ttp -145.61 111.08 5.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.686 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 71' ' ' VAL . 2.7 t70 -105.72 102.6 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -111.84 116.93 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.376 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -72.77 159.88 33.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.871 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' CE3' ' A' ' 123' ' ' TRP . 26.2 t -116.78 102.55 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.148 0.499 . . . . 0.0 110.253 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 66' ' ' LYS . 7.8 m-85 -103.79 150.75 23.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.165 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 40.8 t -135.01 117.29 15.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.932 HG22 HG22 ' A' ' 12' ' ' VAL . 1.4 t -98.53 -173.16 2.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.116 0.484 . . . . 0.0 111.685 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -160.12 -45.15 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.781 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 98.75 10.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.025 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.8 pt -103.07 176.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.894 0.378 . . . . 0.0 111.302 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.03 -64.84 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.7 -162.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.777 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.62 157.75 67.3 Favored Pre-proline 0 CA--C 1.514 -0.417 0 CA-C-O 120.518 0.199 . . . . 0.0 111.493 -179.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 94' ' ' THR . 20.1 Cg_exo -66.33 66.11 0.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.475 2.116 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 94' ' ' THR . 2.6 t -76.35 61.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.47 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 9.7 pt-20 -46.94 112.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.974 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 t -87.55 -177.55 5.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.28 -11.67 61.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -35.85 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.634 0.254 . . . . 0.0 111.245 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.536 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -112.02 160.89 17.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.318 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -166.49 96.11 0.73 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 -179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.8 Cg_endo -74.52 161.86 39.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.443 2.096 . . . . 0.0 112.663 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.34 127.56 15.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.812 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.4 m95 -94.34 119.59 33.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -135.11 -162.97 1.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 2.6 mp0 -85.06 153.66 22.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.798 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -77.8 -1.24 30.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.651 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -119.88 20.25 12.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.847 0.356 . . . . 0.0 110.056 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.24 21.5 1.9 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.814 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.18 127.93 89.7 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.95 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 68.2 Cg_endo -91.81 98.58 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.401 2.067 . . . . 0.0 113.137 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.26 -17.97 57.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.846 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -60.52 -29.46 69.12 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' A' ' 32' ' ' TRP . 2.3 m-20 -100.78 28.93 4.82 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 20' ' ' LEU . 14.9 mtp -134.91 -174.54 3.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.51 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -51.1 165.78 0.36 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.463 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 91.1 Cg_endo -85.2 16.21 2.03 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.906 2.404 . . . . 0.0 113.154 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -127.5 -17.02 4.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.615 0.245 . . . . 0.0 111.479 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.533 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.1 m-20 -48.07 -53.9 14.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 11.6 t -61.09 -16.88 49.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 150' ' ' LEU . 79.7 m-85 -85.03 -21.12 29.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.806 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.1 p-90 -121.54 -32.09 3.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.455 ' N ' ' CD ' ' A' ' 125' ' ' PRO . 0.2 OUTLIER -50.75 -48.75 82.49 Favored Pre-proline 0 N--CA 1.463 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.105 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 53.1 Cg_exo -51.95 -24.82 20.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.298 1.998 . . . . 0.0 111.978 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' A' ' 133' ' ' PHE . 10.4 mt -81.97 -35.84 28.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.146 0.498 . . . . 0.0 109.696 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.673 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.87 -58.28 9.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.633 178.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -52.07 -28.9 19.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.113 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -82.15 -9.72 59.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.83 42.89 1.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.858 0.361 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -130.45 159.17 37.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.601 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -107.48 130.07 54.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.905 ' HB2' HD13 ' A' ' 126' ' ' LEU . 25.9 m-85 -143.05 156.39 44.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.585 ' CD2' HG11 ' A' ' 153' ' ' VAL . 19.9 m170 -118.01 128.59 54.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.74 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.62 128.09 7.3 Favored Glycine 0 C--O 1.225 -0.438 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.33 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.498 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -110.45 115.24 29.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.5 m-85 -119.9 137.49 54.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -88.69 135.71 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -106.96 164.04 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.344 0.592 . . . . 0.0 112.275 -178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.794 ' HB2' HD11 ' A' ' 146' ' ' LEU . 23.0 tp60 -140.21 79.31 1.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.193 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.1 -67.69 0.22 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.607 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.48 -35.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -127.18 19.73 6.94 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.7 m -119.28 135.66 54.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.278 . . . . 0.0 111.139 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 26.8 mt -110.57 137.26 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 140' ' ' GLN . 5.2 mt -113.9 -16.32 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -153.94 138.05 16.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 31.2 p90 -139.79 132.32 28.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.689 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.561 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.77 145.98 51.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.302 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -132.73 119.31 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -124.13 160.09 28.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -97.26 148.32 23.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 132' ' ' LYS . 20.2 m -142.25 148.0 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -130.38 -47.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.6 m -78.51 125.39 29.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.096 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.882 0.373 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.07 80.02 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.449 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -103.75 81.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.58 92.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.084 0.469 . . . . 0.0 111.003 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 81' ' ' MET . 5.7 mpt_? -59.97 93.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.26 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 39' ' ' VAL . 1.5 tt -87.07 119.44 27.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.571 . . . . 0.0 110.836 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 38' ' ' LYS . 8.8 m-85 -122.74 -179.06 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.634 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.929 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.6 p -128.0 166.72 17.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.271 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.4 tt -156.37 109.06 2.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.186 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.76 HG21 HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.05 121.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.524 0.678 . . . . 0.0 112.29 -179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.745 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -127.22 112.84 15.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.417 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 88' ' ' THR . 10.6 t -78.34 87.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.186 0.517 . . . . 0.0 111.496 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.82 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -111.35 117.93 34.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.891 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.7 mt-30 -107.97 157.25 36.59 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' C ' HD13 ' A' ' 108' ' ' LEU . 22.0 Cg_exo -64.97 31.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.678 2.252 . . . . 0.0 112.883 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.566 ' N ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.42 -39.3 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.777 0.323 . . . . 0.0 110.73 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 2.5 mtm-85 -141.39 161.26 38.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.82 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.7 p -136.12 154.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.3 tp -121.53 127.64 51.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG22 ' A' ' 111' ' ' ILE . 4.8 mt -124.04 130.63 52.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.788 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.24 125.14 6.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.645 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 36.5 ttm -113.5 142.47 45.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.607 0.241 . . . . 0.0 110.445 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.7 mmmt -87.07 146.87 25.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -28.59 18.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.49 151.94 6.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.35 179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.96 -125.47 7.76 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -100.02 80.27 2.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.973 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 141.52 -13.95 2.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.947 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.844 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -44.02 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.77 21.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.986 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -116.43 157.7 24.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.677 0.238 . . . . 0.0 110.505 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.09 152.69 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.322 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.2 t30 -178.53 158.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.34 176.88 3.68 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.341 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.1 m-85 -100.82 97.86 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.301 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -73.22 167.13 54.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.205 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' THR . . . -170.79 122.7 0.99 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.242 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.32 145.4 39.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 111.294 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.941 HG21 HD22 ' A' ' 6' ' ' LEU . 2.7 t -78.08 111.08 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.618 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -47.7 173.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.292 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.23 66.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.191 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 45.58 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.981 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.67 173.01 9.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -99.29 143.21 29.81 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG12 HD21 ' A' ' 6' ' ' LEU . 2.3 mp -50.91 -33.3 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.4 tt0 -74.71 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 109.641 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.45 -38.43 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.581 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -37.66 72.51 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.492 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.929 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.64 -33.85 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -74.02 -53.91 9.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -62.45 -33.2 74.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.148 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.29 -20.15 32.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.804 HD21 HG13 ' A' ' 61' ' ' VAL . 17.5 tp -72.64 -49.65 30.42 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.5 tt0 -61.18 -27.46 68.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.65 -21.96 34.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -78.99 -43.94 23.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -136.28 25.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.858 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.41 13.71 11.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.601 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -101.51 109.36 21.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.083 0.468 . . . . 0.0 110.463 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.859 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.13 136.38 35.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.901 HG21 ' HG ' ' A' ' 64' ' ' LEU . 32.3 m -105.69 141.69 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.027 0.442 . . . . 0.0 111.807 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 t70 -79.85 -21.3 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.131 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.16 93.91 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.815 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.901 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.6 -176.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.85 101.12 4.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.824 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.4 ptpt -63.35 130.31 43.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 31.3 m -140.93 -48.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -110.79 104.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.703 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -91.72 113.94 26.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.746 HD11 ' CD1' ' A' ' 123' ' ' TRP . 13.4 mt -114.28 150.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.323 0.583 . . . . 0.0 112.057 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 21.3 t -128.96 149.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.457 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 139' ' ' PHE . 47.8 m-85 -125.61 117.92 24.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.394 . . . . 0.0 111.336 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -98.5 122.55 41.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.37 138.18 31.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 111.041 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.96 107.45 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.858 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.64 -16.08 56.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.38 136.92 19.54 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.574 0.226 . . . . 0.0 110.818 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.41 -30.55 19.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.428 2.085 . . . . 0.0 112.24 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 2.6 mt-10 -80.3 176.88 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.086 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -145.98 -163.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.359 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -146.11 111.37 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.0 t70 -105.93 102.82 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.692 0.282 . . . . 0.0 110.299 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.4 p -112.57 117.03 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 111.744 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -82.29 137.28 34.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.514 178.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.741 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 21.2 t -102.24 105.44 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.292 0.568 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-85 -98.91 138.54 35.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.891 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.7 p -121.39 117.34 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.077 HG22 HG22 ' A' ' 12' ' ' VAL . 2.0 t -100.25 -173.63 2.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.192 0.52 . . . . 0.0 112.012 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -160.41 -43.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.889 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.41 98.68 10.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.549 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.0 pt -102.92 178.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -134.12 -68.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.188 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.2 -163.9 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.678 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.58 162.33 36.95 Favored Pre-proline 0 CA--C 1.516 -0.348 0 CA-C-O 120.428 0.156 . . . . 0.0 111.186 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.4 Cg_exo -66.92 64.42 0.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.51 2.14 . . . . 0.0 109.578 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 94' ' ' THR . 6.0 t -76.49 61.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.413 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 mp0 -42.76 114.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.015 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 t -87.53 -178.65 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.785 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.92 -11.71 59.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.96 10.7 9.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.93 152.88 31.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 111.172 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' MET . 10.3 ttt180 -167.08 89.37 0.75 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.347 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' LEU . 69.1 Cg_endo -72.05 148.88 51.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.527 2.151 . . . . 0.0 112.857 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -130.04 127.67 40.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.212 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.778 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.7 m95 -88.94 126.47 35.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.981 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 23.0 m-85 -136.11 -165.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.315 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' VAL . 22.3 tt0 -92.16 159.91 15.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -78.23 -1.19 31.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.696 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -118.9 22.18 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -147.98 21.42 1.11 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.41 126.23 90.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.017 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.1 Cg_endo -91.67 97.6 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.534 2.156 . . . . 0.0 113.162 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.82 -18.2 58.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -27.83 67.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -102.31 24.31 10.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.571 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.9 mtp -122.19 -76.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.861 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.409 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -160.79 169.61 9.77 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.47 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 98.3 Cg_endo -84.36 14.66 2.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.778 2.319 . . . . 0.0 113.082 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -125.44 -19.33 5.06 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.733 0.301 . . . . 0.0 111.524 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.2 m-20 -48.85 -58.6 4.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 t -54.51 -16.97 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 74.4 m-85 -84.24 -32.57 24.41 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.746 ' CD1' HD11 ' A' ' 70' ' ' ILE . 68.6 p-90 -109.79 -12.2 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.33 -37.13 1.96 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 23.9 Cg_endo -62.92 -32.41 76.83 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.733 1.622 . . . . 0.0 112.899 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.3 pp -79.62 -30.47 41.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.41 -52.9 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.673 0.749 . . . . 0.0 109.167 178.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.14 -30.4 64.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.877 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -79.94 -6.06 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.316 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 66.54 44.17 2.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.958 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -132.13 159.2 39.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -106.69 125.01 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.698 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.666 ' HB2' HD22 ' A' ' 126' ' ' LEU . 14.0 m-85 -136.77 161.18 36.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.89 ' CD2' HG11 ' A' ' 153' ' ' VAL . 4.7 m-70 -125.78 125.12 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -117.95 136.55 12.47 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.495 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.7 m-85 -115.33 111.59 21.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 14.6 m-85 -111.85 137.89 49.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.804 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -88.32 143.3 27.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 1.2 m-30 -115.97 163.91 15.21 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.21 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.784 ' HB2' HD11 ' A' ' 146' ' ' LEU . 12.1 tp60 -139.23 70.78 1.37 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.983 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 115.01 -66.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.417 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -35.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -123.46 16.44 9.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 51.6 m -119.36 135.71 54.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 111.149 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 138' ' ' LYS . 26.2 mt -110.55 138.4 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.888 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 140' ' ' GLN . 8.3 mt -114.47 -17.11 11.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -153.72 143.67 22.0 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 120.797 0.332 . . . . 0.0 111.175 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -139.73 130.35 25.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.717 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -127.41 144.89 50.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.165 179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 122' ' ' TYR . 2.9 mp -133.93 124.94 27.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 26.5 mtt180 -125.97 160.02 31.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -101.96 149.46 24.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.89 HG11 ' CD2' ' A' ' 134' ' ' HIS . 20.2 m -145.67 147.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -133.02 -46.9 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 27.7 m -95.58 102.63 14.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.016 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 76.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -60.09 99.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.084 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -177.8 99.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.145 0.498 . . . . 0.0 111.126 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.6 OUTLIER -55.14 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.234 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD22 HG21 ' A' ' 39' ' ' VAL . 1.2 tt -86.27 117.39 25.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.54 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.42 -178.96 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.59 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.8 p -125.64 168.14 14.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.405 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.21 109.04 3.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.227 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.15 126.71 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.567 0.699 . . . . 0.0 112.126 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -126.38 112.67 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.861 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 88' ' ' THR . 12.2 t -86.91 105.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 0.0 111.866 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.884 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -114.89 158.42 21.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.752 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -132.22 157.0 79.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.229 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.49 22.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.525 2.15 . . . . 0.0 113.194 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -160.67 -40.39 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.625 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -134.07 157.42 46.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -122.67 157.53 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.516 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 103' ' ' PRO . 18.3 tp -118.44 112.97 20.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.658 HD11 ' SD ' ' A' ' 116' ' ' MET . 1.0 OUTLIER -109.98 146.39 35.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.07 123.77 7.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.243 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 40.1 ttm -113.51 142.38 46.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.477 0.179 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.77 146.81 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -89.79 -31.13 17.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.48 118.59 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.53 -121.46 1.03 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -100.07 23.81 9.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.684 0.278 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.57 30.64 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.992 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -55.1 147.73 15.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.652 0.263 . . . . 0.0 111.101 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.05 23.58 16.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.686 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.9 mtp180 -134.65 140.23 45.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.568 0.223 . . . . 0.0 110.512 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.2 153.33 21.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.1 t30 -179.05 145.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.69 169.92 2.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.217 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -100.56 99.57 10.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.86 0.362 . . . . 0.0 110.323 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -96.18 172.66 29.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.814 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.39 124.0 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.364 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -55.74 150.69 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.807 HG21 HD22 ' A' ' 6' ' ' LEU . 10.5 t -79.8 115.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -45.0 167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.376 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.13 74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.083 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.84 45.41 1.3 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.959 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.0 pt-20 -126.65 172.94 9.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -99.11 143.71 29.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.754 HG12 HD21 ' A' ' 6' ' ' LEU . 2.0 mp -50.87 -33.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.56 -27.02 61.11 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -82.63 -36.2 26.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.441 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.5 -37.24 58.48 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.364 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.41 -35.53 63.43 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -73.7 -55.44 6.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -60.34 -34.54 73.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.412 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.32 -21.23 31.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.621 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 10' ' ' VAL . 20.2 tp -68.76 -47.87 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.706 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.3 tt0 -61.15 -26.15 67.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.785 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.68 -21.91 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -80.23 -43.92 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -133.21 24.17 4.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.887 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.82 13.65 8.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.606 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.547 HD12 HD21 ' A' ' 19' ' ' LEU . 12.7 mt -103.93 112.21 25.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.116 0.484 . . . . 0.0 110.468 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.55 136.64 36.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.456 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.93 HG21 ' HG ' ' A' ' 64' ' ' LEU . 26.3 m -105.19 140.08 24.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.986 0.422 . . . . 0.0 111.859 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t0 -79.9 -19.89 47.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.054 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.53 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.93 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -61.32 -172.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.77 101.05 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.473 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 13.3 ptmt -60.34 132.24 53.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 127' ' ' LEU . 18.6 m -124.92 -49.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.182 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -146.66 173.82 26.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.764 -1.207 . . . . 0.0 113.449 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 4.8 mp0 -131.12 116.69 18.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG23 ' CE1' ' A' ' 137' ' ' PHE . 52.7 mt -100.77 146.95 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.2 t -129.07 149.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.006 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 81' ' ' MET . 18.1 m-85 -128.52 118.1 22.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.676 ' OE1' HD22 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -99.52 123.77 44.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.056 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -89.01 127.9 35.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.363 0.601 . . . . 0.0 110.968 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -76.38 114.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.751 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.44 -19.53 52.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.19 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 138.36 20.09 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.587 0.232 . . . . 0.0 110.777 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.0 -37.07 9.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.375 2.05 . . . . 0.0 112.162 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -67.06 169.99 7.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.676 HD22 ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -145.39 -165.75 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 8.6 ttm -147.39 111.99 5.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.562 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.9 t70 -104.33 102.65 12.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.425 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.8 p -108.3 116.76 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.902 0.382 . . . . 0.0 111.488 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.492 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 4.5 t60 -77.47 158.74 29.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.587 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.799 HG11 ' CE3' ' A' ' 123' ' ' TRP . 41.8 t -116.45 132.89 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.968 0.413 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE1' ' CD2' ' A' ' 84' ' ' HIS . 15.6 m-85 -135.11 142.3 46.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.279 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 13.6 p -128.32 117.65 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.012 HG22 HG22 ' A' ' 12' ' ' VAL . 10.9 t -99.28 -172.44 2.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -44.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.791 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 98.81 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 59' ' ' LEU . 50.7 pt -102.83 178.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -134.03 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.282 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.48 -163.32 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.47 160.39 50.86 Favored Pre-proline 0 CA--C 1.515 -0.397 0 CA-C-O 120.572 0.225 . . . . 0.0 111.103 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.7 Cg_exo -68.01 64.37 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.503 2.135 . . . . 0.0 109.37 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -76.66 61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.491 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.78 109.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.027 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -87.42 -176.34 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 -12.12 61.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.389 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.93 -36.46 6.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.727 0.298 . . . . 0.0 111.201 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.53 160.62 17.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -163.55 89.77 1.18 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.28 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HB2' HD11 ' A' ' 19' ' ' LEU . 66.9 Cg_endo -72.2 157.45 53.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.487 2.124 . . . . 0.0 112.812 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.24 125.08 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.529 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.789 ' CD1' HD13 ' A' ' 19' ' ' LEU . 7.6 m95 -94.4 121.94 36.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 21.6 m-85 -135.0 -162.81 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 148.0 29.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.884 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -75.55 -5.81 47.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -117.64 20.36 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.869 0.366 . . . . 0.0 110.031 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -142.37 20.55 2.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.631 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.84 128.08 88.67 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.024 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.69 98.88 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.492 2.128 . . . . 0.0 112.982 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.66 -18.2 56.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.755 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -28.45 68.93 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.05 27.84 4.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.238 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.3 mtp -126.63 -80.45 0.61 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.109 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -154.78 173.54 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.867 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 97.6 Cg_endo -86.45 15.9 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 113.034 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 13.5 m-20 -128.53 -24.54 3.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.357 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 10.4 m-20 -44.13 -54.55 5.47 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -60.26 -17.56 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.963 -179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.652 ' HD2' HD11 ' A' ' 150' ' ' LEU . 78.1 m-85 -85.47 -21.11 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.921 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -124.56 -14.99 6.72 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.865 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.05 -45.31 3.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 13.7 Cg_endo -58.26 -30.89 92.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.823 1.682 . . . . 0.0 112.793 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 133' ' ' PHE . 2.7 pp -80.18 -28.98 38.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.039 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -61.05 -52.81 63.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.94 -30.39 63.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.837 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.22 -9.97 59.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.355 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt 68.8 40.55 1.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -121.9 159.16 27.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.684 ' HB3' HG23 ' A' ' 153' ' ' VAL . 17.3 mttt -101.49 136.6 41.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.534 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 152' ' ' GLU . 21.7 m-85 -147.46 171.2 15.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.287 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -144.23 125.0 14.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.139 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -123.26 129.72 7.49 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 119.767 -1.206 . . . . 0.0 113.748 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.41 110.62 21.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 4.2 m-85 -114.58 136.43 53.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG2' HD12 ' A' ' 146' ' ' LEU . 16.8 ttmt -88.46 129.8 35.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -111.05 163.96 13.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.351 -177.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.938 ' HB2' HD11 ' A' ' 146' ' ' LEU . 8.8 tp60 -137.49 82.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 110.72 -71.78 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.77 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.29 17.04 11.47 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.9 m -119.41 132.48 55.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.386 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 139' ' ' PHE . 45.9 mt -110.46 144.02 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -123.66 -16.82 6.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.141 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -154.01 139.26 17.52 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.022 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 26.3 p90 -139.95 133.05 29.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.793 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.7 144.3 51.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.14 178.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 122' ' ' TYR . 3.5 mp -133.66 122.7 23.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.148 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.2 123.02 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 42.8 tt0 -74.35 142.02 45.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 132' ' ' LYS . 28.5 m -130.56 169.4 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.5 27.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.7 t -78.97 79.75 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.089 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.32 140.52 24.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.94 75.75 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.18 91.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -60.55 95.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.326 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.002 HD22 HG21 ' A' ' 39' ' ' VAL . 1.4 tt -86.66 117.87 25.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.452 0.644 . . . . 0.0 110.503 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 6.7 m-85 -122.33 -179.01 4.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.351 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.879 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 59.2 p -125.79 167.24 15.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.05 0.452 . . . . 0.0 111.479 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.25 108.98 2.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.991 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -109.35 125.14 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 112.259 -179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.93 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.95 112.59 15.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.335 178.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.001 HG22 HG22 ' A' ' 88' ' ' THR . 6.6 t -82.85 102.03 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.05 0.452 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -123.55 118.03 26.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.107 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.581 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.2 mt-30 -103.48 157.25 34.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.03 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' HD13 ' A' ' 108' ' ' LEU . 17.4 Cg_exo -64.59 27.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.467 2.111 . . . . 0.0 112.868 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 14' ' ' GLN . 22.8 mm100 -155.24 -41.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 20.0 mtt180 -142.05 161.3 38.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.39 154.64 40.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 103' ' ' PRO . 24.3 tp -121.54 110.48 16.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.7 mt -105.09 136.39 44.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.763 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.42 121.76 6.47 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.404 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.629 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 32.8 ttm -111.28 142.07 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.695 0.283 . . . . 0.0 110.704 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.1 mtpt -89.14 146.82 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.66 -31.69 17.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.943 0.402 . . . . 0.0 110.4 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.67 119.92 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.837 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.07 -120.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.423 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.18 24.0 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.615 0.245 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.25 28.39 0.06 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.357 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.98 149.28 27.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.903 0.351 . . . . 0.0 110.826 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.98 25.94 39.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.832 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 4.1 mtm180 -139.99 142.36 36.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.551 0.215 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.56 152.97 17.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.671 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 9.7 p30 178.65 152.89 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.56 172.18 2.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -96.52 99.68 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -87.28 155.15 26.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.009 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -135.55 -131.96 3.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.267 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -175.41 137.81 0.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.039 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.002 HG21 HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -88.53 100.48 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.751 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -54.69 177.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.116 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.71 48.03 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.01 172.62 9.81 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.3 p -110.43 139.7 45.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.923 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.818 HG12 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -52.02 -32.2 14.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 13.1 tt0 -75.69 -24.18 56.23 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.61 -40.03 17.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.844 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.48 89.83 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.359 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.879 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.44 -40.85 57.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -66.64 -56.09 12.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.999 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -36.31 75.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.3 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.25 -20.8 31.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.762 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.755 HD21 HG13 ' A' ' 61' ' ' VAL . 16.0 tp -70.56 -48.05 57.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.154 0.502 . . . . 0.0 110.767 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.6 tt0 -62.21 -27.96 69.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.51 -22.08 35.21 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.14 -44.12 26.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 m -135.53 25.06 3.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.913 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.47 14.68 9.55 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.632 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.7 mt -104.31 110.61 22.91 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.052 0.453 . . . . 0.0 110.537 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -95.38 136.58 35.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.416 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.1 m -106.03 140.15 25.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.067 0.46 . . . . 0.0 111.847 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 25.5 m-20 -79.95 -18.17 51.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.64 95.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -63.61 -177.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 100.96 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 9.1 pttp -64.34 122.67 17.25 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 127' ' ' LEU . 16.3 m -121.77 -46.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.114 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -128.28 123.61 4.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.305 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 28.1 mp0 -103.59 114.11 28.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.621 HG23 ' CE1' ' A' ' 137' ' ' PHE . 25.7 mt -109.38 149.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.324 0.583 . . . . 0.0 111.926 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.856 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 66.8 t -125.74 148.05 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.139 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 3.8 m-85 -123.79 117.93 26.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.924 0.392 . . . . 0.0 110.95 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 80' ' ' LEU . 7.5 mm-40 -104.32 123.3 47.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.229 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -82.56 134.19 35.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.259 0.552 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -80.53 107.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.759 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.59 -21.01 37.93 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.059 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -102.51 144.69 29.12 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.606 0.241 . . . . 0.0 110.749 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 -47.59 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.476 2.117 . . . . 0.0 112.523 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -62.07 167.25 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -144.03 -166.32 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.205 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 7.5 ttp -147.34 111.47 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.994 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 22.9 t0 -102.47 103.0 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.15 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -112.91 116.87 53.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 111.763 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' HB2' HG21 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -78.85 152.69 31.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.332 178.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.877 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 5.2 t -117.02 105.11 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.768 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.1 m-85 -99.13 134.86 41.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.459 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.4 p -116.41 117.11 29.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.001 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -100.95 -173.58 2.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.156 0.503 . . . . 0.0 111.786 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.38 -43.3 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.736 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.13 98.92 10.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.409 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.6 pt -102.8 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.778 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.97 -66.02 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 111.431 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.42 -163.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.822 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.947 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -120.64 160.69 43.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.582 0.229 . . . . 0.0 111.348 -179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.947 ' HD2' HG22 ' A' ' 94' ' ' THR . 13.9 Cg_exo -68.94 62.68 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 94' ' ' THR . 3.2 t -76.84 60.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.522 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.7 pt-20 -45.96 113.67 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.029 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.59 -176.6 5.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -71.72 -10.15 59.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.397 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.85 -37.13 6.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.301 . . . . 0.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.8 162.14 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' MET . 29.3 ttt180 -165.33 93.95 0.87 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.437 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.2 Cg_endo -72.87 155.35 53.46 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.596 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.8 t -138.93 119.63 14.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.543 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.4 m95 -84.01 117.26 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 2.0 m-85 -128.59 -167.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.418 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.4 mp0 -94.15 153.18 18.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 110.656 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.666 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -66.65 -11.88 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.725 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.1 21.22 13.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.79 14.82 3.12 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.007 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.657 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.77 126.99 90.37 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.131 178.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -93.06 96.1 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.743 2.296 . . . . 0.0 113.261 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.652 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -70.66 -18.43 62.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -71.45 -29.23 64.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.021 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.3 30.25 3.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.396 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtp -128.59 -78.17 0.56 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.059 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.417 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -161.87 172.74 5.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 94.4 Cg_endo -84.29 16.36 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.063 2.509 . . . . 0.0 113.446 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -126.87 -24.13 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.616 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 8.8 m-20 -43.65 -58.16 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -17.67 39.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.505 ' CE1' ' CD2' ' A' ' 148' ' ' TYR . 35.4 m-85 -85.71 -14.41 45.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.93 ' CH2' HD12 ' A' ' 11' ' ' LEU . 70.3 p-90 -127.41 -13.04 5.55 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.828 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -76.6 -52.15 2.24 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 118.007 0.367 . . . . 0.0 111.717 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.9 Cg_exo -48.75 -42.63 36.42 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.085 2.523 . . . . 0.0 114.395 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 133' ' ' PHE . 4.0 pp -81.11 -33.88 32.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 0.0 111.309 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.85 -29.4 63.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 13' ' ' LEU . 12.9 mt -71.88 -26.76 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.736 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 130' ' ' LYS . 30.5 mt-30 -83.05 2.7 33.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.393 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 79.5 31.11 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -113.33 153.55 28.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -116.64 135.1 54.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.601 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.717 ' CD1' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -149.32 171.31 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.185 0.517 . . . . 0.0 111.274 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 4.9 m-70 -135.28 125.05 25.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.363 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -120.93 148.79 17.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.49 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.856 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 10.0 m-85 -121.0 112.29 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.621 ' CE1' HG23 ' A' ' 70' ' ' ILE . 3.5 m-85 -111.17 128.84 56.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.887 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 147' ' ' ASP . 1.4 mtpt -88.55 124.13 33.73 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.0 m-85 -106.52 141.92 37.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.449 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.1 tp60 -79.78 -2.44 43.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.88 -79.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.064 -0.588 . . . . 0.0 111.858 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -156.77 17.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.435 0.16 . . . . 0.0 111.423 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -160.51 -39.01 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 111.439 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -79.4 135.19 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.695 0.283 . . . . 0.0 111.2 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.432 HG12 ' CE1' ' A' ' 139' ' ' PHE . 41.6 mt -109.94 133.6 54.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 140' ' ' GLN . 7.5 mt -114.35 -12.91 12.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.17 137.61 15.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.505 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 19.3 p90 -139.56 116.62 11.05 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.471 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.09 143.17 44.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.576 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.708 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -134.18 126.09 29.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -128.26 119.81 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.873 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.66 141.09 33.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.922 0.392 . . . . 0.0 111.013 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.86 161.81 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.75 -33.15 6.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.4 m -87.5 117.9 26.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.162 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.09 -174.09 32.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.51 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.98 -168.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 111.026 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.3 p 56.02 86.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.23 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.32 95.53 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.087 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 45' ' ' ILE . 1.2 tt -86.72 119.0 26.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 9.0 m-85 -122.77 -178.71 4.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.332 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 28.3 p -122.27 166.72 14.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.123 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.6 tt -156.22 109.26 2.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.799 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.83 HG21 HD22 ' A' ' 53' ' ' LEU . 1.6 p -116.48 130.04 71.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.599 0.714 . . . . 0.0 112.705 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.28 112.98 15.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.035 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HG22 ' A' ' 88' ' ' THR . 6.5 t -85.4 93.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.058 0.456 . . . . 0.0 111.694 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -101.24 158.47 16.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.939 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.27 157.1 79.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.026 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' C ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -66.19 23.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.391 2.061 . . . . 0.0 113.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLN . 33.2 mt-30 -160.63 -40.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' GLN . 10.1 ptt-85 -132.1 161.05 34.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.528 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.87 157.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.758 ' CD2' HD12 ' A' ' 59' ' ' LEU . 12.6 tp -117.14 114.18 23.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.513 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 111' ' ' ILE . 3.6 mt -109.71 143.03 40.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.61 108.74 3.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.814 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 7.8 ttm -98.02 142.35 29.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.554 0.216 . . . . 0.0 110.776 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -91.2 146.73 23.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -90.67 -34.8 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.072 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.923 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.41 151.74 8.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 111.244 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.56 -130.42 7.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.984 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -100.25 21.55 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.648 0.261 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.58 -1.93 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.314 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.93 153.24 0.31 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.739 0.77 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.91 20.61 14.16 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.721 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -126.91 158.43 36.8 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -110.92 152.99 26.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 2.1 p-10 -179.1 147.11 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 0.0 111.3 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -177.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.152 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -111.05 89.2 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.409 . . . . 0.0 110.243 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.92 154.76 19.97 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.006 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.18 -168.9 15.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.214 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.05 141.12 43.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.031 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.838 HG21 HD22 ' A' ' 6' ' ' LEU . 5.3 t -77.89 115.83 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.637 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -45.38 168.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.28 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.38 75.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.9 43.35 1.42 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.96 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 39' ' ' VAL . 2.7 pt-20 -126.66 173.23 9.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.1 p -101.44 143.26 31.68 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.806 0.336 . . . . 0.0 111.388 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 6' ' ' LEU . 3.1 mt -49.11 -31.92 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 54.5 tt0 -74.09 -32.21 63.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.82 -37.01 49.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.752 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' GLU . . . -77.64 -32.84 44.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.204 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.76 -34.35 62.48 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 64' ' ' LEU . 10.5 mtt180 -66.58 -54.67 21.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.716 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -27.51 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.34 -20.59 31.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.83 HD22 HG21 ' A' ' 10' ' ' VAL . 28.4 tp -75.18 -52.17 11.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.077 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 5.8 tt0 -58.67 -25.76 63.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -82.73 -21.84 34.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -81.86 -44.01 17.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -132.3 24.33 4.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.882 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 55.07 15.56 7.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.576 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.758 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.6 mt -108.18 108.3 19.29 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.958 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.96 172.14 10.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.279 179.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.715 ' CG1' HG21 ' A' ' 88' ' ' THR . 26.2 m -137.36 141.42 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.61 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -79.92 -19.93 46.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.16 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.54 91.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.695 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -54.11 -178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER -134.87 101.13 4.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.641 0.257 . . . . 0.0 110.997 178.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.89 133.57 55.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 127' ' ' LEU . 21.6 m -126.14 -49.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.373 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -145.11 173.08 25.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.485 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 7.2 tt0 -131.25 116.36 17.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.432 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.654 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.8 mt -102.85 146.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 24.9 t -129.01 149.31 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.0 m-85 -125.33 117.99 24.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.793 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -101.88 122.81 44.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -86.45 130.73 34.4 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.269 0.557 . . . . 0.0 111.015 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -78.53 108.68 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.722 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.98 41.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.21 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -102.61 140.01 20.71 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.601 0.239 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 -47.05 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.514 2.142 . . . . 0.0 112.274 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -61.34 173.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 111.189 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.66 -166.95 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.337 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.2 ttp -145.37 111.55 5.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.665 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.8 t0 -105.88 102.79 12.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.6 p -109.55 116.78 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.975 0.417 . . . . 0.0 111.276 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.897 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -76.69 161.11 28.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.86 HG11 ' CE3' ' A' ' 123' ' ' TRP . 43.3 t -116.83 136.35 54.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.013 0.435 . . . . 0.0 110.785 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.787 ' HB3' HD22 ' A' ' 64' ' ' LEU . 21.0 m-85 -137.13 139.93 41.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.298 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -126.07 118.19 24.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.99 HG22 HG22 ' A' ' 12' ' ' VAL . 7.2 t -100.17 179.45 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.087 0.47 . . . . 0.0 111.227 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -151.25 -47.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.665 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.95 98.78 11.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.782 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.726 HD13 HD13 ' A' ' 59' ' ' LEU . 17.4 pt -102.81 178.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.326 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -137.37 -69.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.285 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -50.54 178.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.828 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -106.98 163.01 17.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.564 0.221 . . . . 0.0 111.342 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.9 Cg_exo -67.87 62.51 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.652 2.234 . . . . 0.0 109.826 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 94' ' ' THR . 24.1 t -77.03 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.521 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.6 pt-20 -44.75 123.59 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.025 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.1 p -87.3 -172.92 4.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.764 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.76 -8.97 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.836 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -132.14 6.96 4.25 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.65 163.68 30.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' MET . 4.4 ttt180 -172.68 106.53 0.34 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HD11 ' A' ' 19' ' ' LEU . 71.9 Cg_endo -74.47 123.5 8.2 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.305 2.003 . . . . 0.0 112.004 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.5 m -112.12 119.58 38.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 13.4 m95 -83.66 104.16 13.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.283 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.53 -160.78 0.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -102.33 144.12 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.543 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -69.36 -11.05 60.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.559 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -118.36 21.89 12.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.849 0.357 . . . . 0.0 110.206 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.14 21.7 0.96 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.686 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.587 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.74 128.7 87.89 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.977 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -94.05 99.08 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.52 2.147 . . . . 0.0 113.009 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -80.69 -18.26 48.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.31 -30.18 71.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.34 26.01 7.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 2.8 mtp -122.25 -81.92 0.64 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.029 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.401 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 0.4 OUTLIER -152.25 170.07 8.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.5 Cg_endo -84.75 16.71 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.757 2.305 . . . . 0.0 112.965 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -130.51 -22.47 2.72 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.577 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 5.1 m-20 -49.47 -54.04 19.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.408 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 23.7 p -56.42 -17.58 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.533 ' CD1' HD11 ' A' ' 150' ' ' LEU . 9.0 m-85 -85.23 -37.18 20.38 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.86 ' CE3' HG11 ' A' ' 85' ' ' VAL . 67.3 p-90 -104.95 -14.95 15.27 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.699 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.1 OUTLIER -76.35 -34.85 1.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 30.5 Cg_endo -63.94 -34.57 59.3 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.604 1.536 . . . . 0.0 112.711 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -77.14 -30.3 55.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.81 -51.7 68.89 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -63.4 -23.92 67.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.62 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -84.1 2.61 38.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.406 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.73 25.91 12.41 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.891 0.377 . . . . 0.0 111.287 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -117.76 159.14 23.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.778 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 153' ' ' VAL . 13.1 mttt -106.66 131.81 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.099 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.742 ' HB2' HD22 ' A' ' 126' ' ' LEU . 21.5 m-85 -143.3 157.89 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' HG21 ' A' ' 153' ' ' VAL . 20.8 m170 -120.48 125.14 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -117.87 133.11 10.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.332 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 3.8 m-85 -113.66 110.71 20.64 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.442 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-85 -109.89 126.42 53.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.72 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -88.59 122.52 32.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 75' ' ' VAL . 16.0 m-85 -105.37 145.95 30.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.979 0.419 . . . . 0.0 112.015 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.778 ' HB2' HD11 ' A' ' 146' ' ' LEU . 13.4 tp60 -79.7 -5.11 54.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.409 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.83 -77.8 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.962 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -159.38 19.69 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.474 0.178 . . . . 0.0 111.398 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -160.43 -41.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 111.205 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 9.6 m -78.9 135.24 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.939 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 118' ' ' PRO . 52.0 mt -110.01 132.04 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 140' ' ' GLN . 4.0 mt -113.3 -10.7 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.719 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -153.89 138.29 16.72 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.944 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -139.2 128.79 24.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.293 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.08 145.62 49.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.589 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.9 mp -133.91 123.35 24.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -125.77 159.92 31.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 2.9 pt-20 -99.29 148.49 24.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.798 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 134' ' ' HIS . 6.5 m -145.81 159.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -155.96 31.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.864 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 23.5 m -151.1 -57.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.149 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.37 163.77 29.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 79' ' ' GLU . . . -138.95 -178.61 5.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.59 101.59 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.195 0.521 . . . . 0.0 111.082 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -57.16 95.37 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.169 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.993 HD22 HG21 ' A' ' 39' ' ' VAL . 2.1 tt -86.52 117.98 25.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.443 0.64 . . . . 0.0 110.615 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 2.0 m-30 -121.88 -179.04 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.62 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 29.0 p -127.62 166.62 17.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.248 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.8 tt -156.06 108.95 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.616 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -109.62 128.92 65.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.563 0.697 . . . . 0.0 112.446 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.965 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -126.77 112.9 15.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.903 178.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 88' ' ' THR . 11.9 t -88.24 93.04 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.128 0.489 . . . . 0.0 111.841 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -100.3 158.44 15.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.779 179.487 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.62 157.13 77.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.085 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.2 Cg_endo -66.72 24.24 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.464 2.109 . . . . 0.0 113.131 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -160.51 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.371 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -132.12 161.14 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.433 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.803 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -129.18 157.8 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.802 ' CD2' HD12 ' A' ' 59' ' ' LEU . 30.8 tp -109.17 120.98 44.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.707 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 116' ' ' MET . 2.6 mt -122.51 125.26 45.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -76.24 123.9 7.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.398 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.525 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 42.0 ttm -113.51 142.25 46.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -92.88 144.94 24.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -92.17 -31.88 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.505 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.841 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -171.01 121.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.925 178.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.07 -122.17 1.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.376 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -100.18 23.08 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.628 0.251 . . . . 0.0 111.201 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -175.45 22.85 0.06 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.43 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -52.39 119.13 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.015 0.408 . . . . 0.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.53 18.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.294 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.3 mtt180 -79.98 156.34 27.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.19 153.19 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.553 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 27.3 t-20 -177.95 157.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.388 . . . . 0.0 111.054 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.91 -166.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB2' HG13 ' A' ' 10' ' ' VAL . 24.0 m-85 -120.17 89.74 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -88.08 153.39 24.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.072 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 7' ' ' TYR . . . -133.29 -136.15 3.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.232 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' CB ' ' CE1' ' A' ' 7' ' ' TYR . 10.7 pttt -164.85 141.58 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 HD22 ' A' ' 6' ' ' LEU . 2.1 t -83.86 103.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -50.57 179.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.98 63.56 0.22 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.3 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.95 43.95 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.29 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.55 173.04 9.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' ASP . 60.0 p -101.59 141.21 34.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.875 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.734 HG12 HD21 ' A' ' 6' ' ' LEU . 2.4 mp -50.66 -32.25 10.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.0 -26.38 56.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 44' ' ' THR . 37.5 m-20 -81.44 -37.45 28.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.535 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.95 -36.54 73.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.527 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.894 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.03 -35.37 61.94 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.606 ' CG ' HD12 ' A' ' 64' ' ' LEU . 14.9 mtt180 -72.92 -55.57 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.809 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -59.14 -34.61 72.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.182 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.843 HD22 HG21 ' A' ' 10' ' ' VAL . 16.2 tp -69.31 -52.08 30.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.627 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB2' HG23 ' A' ' 60' ' ' THR . 11.7 tt0 -59.18 -27.93 66.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.5 -22.3 35.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.521 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -73.97 -44.02 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 3.6 t -144.15 30.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.755 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 94' ' ' THR . . . 54.9 13.87 4.94 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.625 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.802 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.0 mt -99.3 109.18 21.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.007 0.432 . . . . 0.0 110.158 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -92.0 177.26 6.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.681 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.77 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.3 m -142.36 138.05 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.767 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -79.86 -16.57 55.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.125 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.86 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 86' ' ' PHE . 1.1 mt -57.74 174.21 0.25 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.17 101.33 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.217 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.78 133.97 54.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 127' ' ' LEU . 35.8 m -129.84 -47.86 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.415 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -139.98 129.28 4.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.703 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HG2' ' CG ' ' A' ' 84' ' ' HIS . 63.8 mt-30 -102.89 116.53 32.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 28.3 mt -107.84 150.14 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 136' ' ' TYR . 21.3 t -121.15 149.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.528 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.6 m-85 -128.27 118.06 22.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 29.4 tt0 -102.56 116.17 32.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -82.51 130.73 35.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.804 0.812 . . . . 0.0 111.167 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG22 ' HE2' ' A' ' 138' ' ' LYS . 3.7 t -90.44 0.2 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.115 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.74 0.62 11.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.876 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -137.63 151.18 70.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.715 0.293 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.07 -33.14 6.26 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.569 2.18 . . . . 0.0 112.188 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.763 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -75.77 -168.01 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.168 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -149.48 -167.88 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.248 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.4 ttp -147.15 111.15 5.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 110.767 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 46.3 t0 -101.98 102.76 13.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -111.98 116.9 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.008 0.433 . . . . 0.0 111.845 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CG ' HG21 ' A' ' 45' ' ' ILE . 22.0 m170 -77.53 153.82 33.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.387 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.87 HG11 ' CE3' ' A' ' 123' ' ' TRP . 12.4 t -116.87 102.8 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.197 0.522 . . . . 0.0 110.825 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.874 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.2 m-85 -99.18 150.34 22.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.05 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.4 m -136.93 117.33 13.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.024 HG22 HG22 ' A' ' 12' ' ' VAL . 15.3 t -95.64 179.67 5.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -143.3 -46.63 0.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.187 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.41 95.13 8.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.305 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG12 ' A' ' 61' ' ' VAL . 10.4 pt -103.86 177.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.224 0.535 . . . . 0.0 111.714 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 93' ' ' GLY . 8.9 mm-40 -105.27 73.51 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.785 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -20.25 89.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.387 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 96' ' ' VAL . 95.2 m -160.42 55.43 0.69 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 110.627 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' N ' HD21 ' A' ' 59' ' ' LEU . 60.9 Cg_endo -74.35 73.9 3.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.963 1.775 . . . . 0.0 109.864 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 94' ' ' THR . 3.0 t -77.11 64.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.426 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 1.8 mp0 -38.77 107.25 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.142 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 -172.85 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.12 -5.37 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.576 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.35 -41.54 3.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.44 156.47 19.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.909 0.385 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' MET . 67.2 ttt180 -154.34 99.58 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 97' ' ' GLU . 54.4 Cg_endo -67.26 138.18 46.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.329 2.019 . . . . 0.0 111.939 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 12.2 m -127.84 119.59 25.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 7.6 m95 -88.5 107.98 19.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.667 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -115.31 -162.12 0.81 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.139 -178.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 19.6 mt-30 -98.91 145.96 26.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -70.86 -10.75 60.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.48 21.12 13.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 0.0 110.279 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -147.69 21.52 1.15 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.615 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.13 126.48 90.3 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.772 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 52.5 Cg_endo -92.86 98.52 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.458 2.106 . . . . 0.0 113.38 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' CE1' ' CD2' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -79.32 -18.38 52.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -29.82 70.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.92 27.08 6.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.402 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 20' ' ' LEU . 3.2 mtp -123.84 -81.92 0.64 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.215 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -151.89 170.71 7.53 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.928 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 69.7 Cg_endo -85.19 16.8 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.997 2.465 . . . . 0.0 113.162 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 p-10 -128.42 -27.85 2.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.737 0.303 . . . . 0.0 111.437 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.606 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.6 m-20 -45.28 -52.97 9.0 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.428 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -59.4 -16.93 26.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' HD2' HD11 ' A' ' 150' ' ' LEU . 35.4 m-85 -83.54 -28.4 28.65 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.965 ' CH2' HD12 ' A' ' 11' ' ' LEU . 50.3 p-90 -113.44 -17.0 12.34 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.327 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.616 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 m-85 -61.97 -51.77 72.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.56 0.219 . . . . 0.0 111.036 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 34.6 Cg_exo -57.68 -30.85 90.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.625 2.217 . . . . 0.0 112.579 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.76 HD13 ' CG ' ' A' ' 133' ' ' PHE . 4.6 mt -79.21 -31.56 43.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.433 . . . . 0.0 110.402 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.618 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.4 OUTLIER -63.15 -52.7 61.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.6 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.58 -25.87 60.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.567 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.1 mp0 -83.39 2.88 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.266 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 53.76 35.47 21.48 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.958 0.409 . . . . 0.0 111.232 -179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.21 158.14 26.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -112.69 139.72 48.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.76 ' CG ' HD13 ' A' ' 126' ' ' LEU . 1.1 p90 -149.45 171.12 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 111.463 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 69' ' ' GLN . 2.2 t60 -131.77 124.98 30.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -124.46 147.17 16.48 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.278 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -120.98 111.74 17.88 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 70' ' ' ILE . 3.5 m-30 -110.63 123.86 50.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.419 . . . . 0.0 111.817 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.874 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.1 tttt -88.6 124.1 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.0 m-85 -103.15 150.33 23.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.889 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.625 ' HA ' HD11 ' A' ' 146' ' ' LEU . 19.9 tp60 -79.93 -22.85 42.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.24 -42.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.408 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 174.55 -32.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.618 0.247 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -113.93 -26.58 8.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.587 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 8.4 m -89.59 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 56.2 mt -109.9 132.71 57.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.07 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 140' ' ' GLN . 2.2 mt -114.21 -12.02 12.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.82 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -153.9 136.46 15.12 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.91 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -139.37 131.87 28.67 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.537 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -128.16 141.57 51.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.605 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.729 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.6 mp -134.02 124.47 26.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -130.65 119.72 22.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.773 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.85 140.95 35.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.14 157.68 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.52 31.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -113.84 147.78 37.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.134 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.767 0.317 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.31 -32.72 2.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.49 92.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.81 99.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.166 0.508 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -58.59 94.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.934 HD22 HG21 ' A' ' 39' ' ' VAL . 2.4 tt -86.57 118.1 25.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.436 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 38' ' ' LYS . 8.1 m-85 -122.54 -179.03 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.975 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.93 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 24.4 p -124.56 167.96 13.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.927 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -156.35 108.95 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.734 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.67 126.04 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.531 0.681 . . . . 0.0 111.786 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.928 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -126.94 112.9 15.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.539 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.116 HG22 HG22 ' A' ' 88' ' ' THR . 15.7 t -87.27 116.4 29.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -129.65 158.49 39.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.032 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -133.4 156.97 79.2 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.062 179.513 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 25.27 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.434 2.089 . . . . 0.0 113.144 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' GLN . 7.2 mm-40 -160.53 -41.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.361 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.14 160.51 37.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.798 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.1 p -127.09 155.88 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 14.7 tp -118.3 116.39 26.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.27 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.8 mt -116.76 146.89 42.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.105 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.89 125.97 8.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.522 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 37.4 ttm -113.67 142.22 46.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 110.584 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 mmmt -89.3 146.76 24.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 25' ' ' ARG . 3.8 mttt -89.47 -30.81 18.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.48 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.49 121.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.877 179.158 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.35 -122.29 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.377 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.09 23.43 9.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.71 28.55 0.06 OUTLIER Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.126 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -56.4 149.09 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.848 0.324 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.14 24.12 19.93 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.791 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mtp85 -136.27 141.75 43.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.555 0.217 . . . . 0.0 110.55 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -92.97 152.8 19.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.415 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 20' ' ' LEU . 7.1 t-20 -179.94 155.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.386 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.95 169.95 11.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.214 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.4 m-85 -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.388 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -99.08 156.96 20.06 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.151 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.16 151.69 23.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.153 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 8.3 pttt -82.18 142.92 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.934 HG21 HD22 ' A' ' 6' ' ' LEU . 8.1 t -75.34 112.04 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.561 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -45.64 170.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.419 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.84 65.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.131 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.57 43.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.085 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.58 172.76 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p -99.23 141.39 32.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.14 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HD21 ' A' ' 6' ' ' LEU . 2.7 mp -50.33 -32.85 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -80.18 -37.02 34.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.574 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.11 -35.35 64.34 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.446 179.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.4 -33.34 60.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HG2' HD11 ' A' ' 64' ' ' LEU . 22.9 mtt180 -75.61 -54.11 7.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -34.37 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.289 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.26 -20.61 31.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.651 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HG21 ' A' ' 10' ' ' VAL . 20.6 tp -71.82 -48.03 49.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' HG23 ' A' ' 60' ' ' THR . 15.8 tt0 -61.36 -26.17 67.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.821 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.64 -21.96 34.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.4 mt-10 -80.15 -43.99 20.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 m -133.73 24.05 3.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.888 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.05 13.67 9.29 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.471 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 19' ' ' LEU . 11.4 mt -102.95 111.34 23.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.51 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.856 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -96.09 136.56 36.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.273 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.962 HG21 ' HG ' ' A' ' 64' ' ' LEU . 21.9 m -106.89 140.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.108 0.48 . . . . 0.0 111.833 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 3.1 t0 -79.97 -19.0 48.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.26 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.74 98.06 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.947 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.962 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.58 -173.01 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.98 101.23 4.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.935 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -60.24 123.02 15.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.125 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 127' ' ' LEU . 8.2 m -121.04 -50.23 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -134.66 165.55 24.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 119.962 -1.114 . . . . 0.0 113.354 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 28.4 mt-30 -131.37 114.05 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.758 0.313 . . . . 0.0 110.322 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 123' ' ' TRP . 4.3 mt -105.08 147.82 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 111.154 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 136' ' ' TYR . 31.3 t -128.18 149.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.499 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 88.7 m-85 -130.18 120.51 24.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.898 0.38 . . . . 0.0 111.401 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 46.9 tt0 -97.56 127.87 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.61 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 22.3 m-85 -82.43 129.02 34.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -62.8 129.08 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.78 55.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.662 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' PHE . 14.0 mt-10 -132.21 140.34 37.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.21 -43.37 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.224 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.2 tt0 -60.33 166.34 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -144.13 -168.44 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.462 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -146.08 111.69 5.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.682 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -105.56 102.92 12.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.5 p -110.11 116.89 53.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.006 0.432 . . . . 0.0 111.713 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 69' ' ' GLN . 2.1 t60 -79.57 155.03 28.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.701 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.616 HG11 ' CE3' ' A' ' 123' ' ' TRP . 72.4 t -111.38 134.6 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 110.6 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.4 m-85 -135.16 125.97 27.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.988 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 43.6 t -112.49 117.28 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.116 HG22 HG22 ' A' ' 12' ' ' VAL . 8.1 t -97.62 -174.1 2.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.216 0.531 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.11 -43.02 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.84 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.45 98.55 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.295 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HD22 ' A' ' 59' ' ' LEU . 48.5 pt -102.97 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.005 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -133.08 -67.18 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -58.45 -163.35 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.949 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -123.26 161.01 47.58 Favored Pre-proline 0 CA--C 1.514 -0.408 0 CA-C-O 120.485 0.184 . . . . 0.0 111.206 -179.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.949 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.6 Cg_exo -67.55 64.54 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.46 2.107 . . . . 0.0 109.519 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 94' ' ' THR . 2.8 t -76.46 61.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.531 -178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 12.2 pt-20 -44.33 111.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.191 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -87.56 -177.41 5.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -68.32 -12.79 61.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.341 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.65 -37.54 6.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.719 0.295 . . . . 0.0 111.13 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.442 ' HE2' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -107.9 162.17 14.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.247 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.5 ttt180 -166.44 91.0 0.8 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.6 Cg_endo -74.38 155.74 45.92 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.385 2.056 . . . . 0.0 112.782 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.25 123.76 12.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.385 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.967 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 6.9 m95 -92.74 123.49 36.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.2 m-85 -134.51 -160.57 1.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.7 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.426 ' O ' HG12 ' A' ' 18' ' ' VAL . 59.0 mt-30 -84.19 150.06 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.833 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.3 pt? -75.97 -4.86 43.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.512 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.64 17.94 15.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.173 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -140.89 22.79 2.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.641 HD11 HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -72.89 128.66 87.73 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.159 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -93.78 99.53 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.548 2.165 . . . . 0.0 112.591 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.0 OUTLIER -80.65 -18.06 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.333 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -66.06 -26.18 67.37 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.02 28.71 4.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.397 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 20.8 mtm -131.15 -48.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.593 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.516 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER 174.04 173.75 0.23 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.741 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 82.2 Cg_endo -88.44 16.59 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.184 2.59 . . . . 0.0 113.29 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.1 p30 -129.5 -22.9 2.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.687 0.28 . . . . 0.0 111.612 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 14.8 m-20 -46.45 -53.57 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -59.19 -17.65 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.607 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD1' HD11 ' A' ' 150' ' ' LEU . 20.5 m-85 -85.58 -27.25 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.928 ' CH2' HD12 ' A' ' 11' ' ' LEU . 67.0 p-90 -114.67 -11.7 12.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.862 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.53 -44.97 3.34 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 87.8 Cg_exo -47.28 -39.59 27.36 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.482 2.121 . . . . 0.0 113.444 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -75.15 -30.99 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.423 . . . . 0.0 110.165 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -61.67 -48.59 80.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.354 0.597 . . . . 0.0 109.617 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 111' ' ' ILE . 6.2 mt -67.52 -29.81 69.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -85.94 2.27 46.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.637 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt 61.59 53.75 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -138.91 159.33 42.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' CB ' HG23 ' A' ' 153' ' ' VAL . 7.3 mttt -111.95 127.55 55.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HB2' HD22 ' A' ' 126' ' ' LEU . 17.7 m-85 -137.02 170.93 15.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 71' ' ' VAL . 20.7 t-80 -138.51 125.18 20.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.646 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.05 134.04 9.64 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.42 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.541 ' CE2' HG11 ' A' ' 71' ' ' VAL . 13.8 t80 -113.79 110.51 20.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.675 ' CE1' HG23 ' A' ' 70' ' ' ILE . 2.2 m-85 -116.9 135.28 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -88.9 135.02 33.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.215 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.43 164.34 11.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 -178.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.673 ' HB2' HD21 ' A' ' 146' ' ' LEU . 2.6 tp60 -120.64 -0.86 10.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.674 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.41 ' C ' ' CE2' ' A' ' 139' ' ' PHE . . . 171.93 -41.37 0.17 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.178 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 173.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.875 0.337 . . . . 0.0 111.544 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -120.25 12.03 11.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 42.9 m -119.3 134.9 54.96 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.891 0.377 . . . . 0.0 111.38 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.426 HD11 ' HG2' ' A' ' 118' ' ' PRO . 56.7 mt -110.15 143.94 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.644 178.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.3 mt -120.15 -14.96 8.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.277 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -153.9 136.42 15.09 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.536 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 43.8 p90 -139.45 131.24 27.51 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.78 145.92 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.0 mp -133.61 122.4 23.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.997 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -128.86 128.85 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -74.54 142.1 44.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG23 ' CB ' ' A' ' 132' ' ' LYS . 11.9 m -131.74 142.12 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.96 -55.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -121.06 83.61 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.127 -179.967 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.23 -65.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.574 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.67 -166.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.755 0.312 . . . . 0.0 111.053 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p 55.96 85.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.622 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -62.19 96.06 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.156 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 39' ' ' VAL . 2.2 tt -86.66 119.84 27.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.843 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.8 m-85 -122.7 -179.01 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.869 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.893 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 19.3 p -128.59 168.58 15.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.133 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.8 tt -156.19 108.99 2.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.833 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -105.58 122.49 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 111.844 -179.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.882 HD12 ' HH2' ' A' ' 123' ' ' TRP . 1.6 mt -126.95 112.71 15.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.286 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.042 HG22 HG22 ' A' ' 88' ' ' THR . 6.8 t -82.58 96.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.043 0.449 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -115.12 117.97 32.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.135 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 16' ' ' GLN . 11.8 mt-30 -108.13 157.42 36.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.929 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.688 ' C ' HD13 ' A' ' 108' ' ' LEU . 35.4 Cg_endo -64.82 30.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.468 2.112 . . . . 0.0 113.028 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' N ' HD13 ' A' ' 108' ' ' LEU . 13.4 mm-40 -160.45 -40.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 161.15 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.072 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.776 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.4 p -133.86 158.6 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.546 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 59' ' ' LEU . 13.5 tp -120.53 129.05 53.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 111.073 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 111' ' ' ILE . 14.3 mt -129.14 125.18 36.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 33' ' ' ASN . . . -67.91 117.01 8.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.725 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.568 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 31.2 ttm -99.1 142.45 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -88.6 146.76 24.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.677 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -32.76 16.01 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.078 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -161.34 -179.22 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 0.0 111.365 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 -138.27 14.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.08 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -99.99 23.82 9.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.756 0.312 . . . . 0.0 110.833 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' C ' ' HB2' ' A' ' 23' ' ' LYS . . . -140.08 -20.88 0.36 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.589 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -35.85 126.04 0.71 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.1 0.45 . . . . 0.0 112.025 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.72 -26.17 15.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.705 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' MET . 19.7 mtm180 -79.96 149.05 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.677 0.275 . . . . 0.0 110.522 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.568 ' CE3' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.12 152.54 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 11.6 p30 173.76 149.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.17 178.52 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.792 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.706 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -106.67 115.89 30.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 0.0 110.259 179.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -108.05 170.95 15.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.151 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.57 146.85 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.214 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 9.4 pttt -80.23 144.99 32.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.781 0.324 . . . . 0.0 111.234 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 6' ' ' LEU . 9.4 t -75.43 114.1 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.613 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.11 171.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.382 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.46 65.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.56 43.31 0.5 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.062 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.68 172.99 9.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -98.79 142.48 30.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.878 0.371 . . . . 0.0 111.187 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.776 HG12 HD21 ' A' ' 6' ' ' LEU . 2.6 mp -50.47 -33.66 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.032 -179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 86' ' ' PHE . 47.0 tt0 -74.44 -28.9 61.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.27 -34.15 49.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.506 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.43 43.87 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.746 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -31.65 61.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.664 0.268 . . . . 0.0 110.434 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' LEU . 3.1 ppt_? -84.06 -47.62 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' CG ' ' NE ' ' A' ' 50' ' ' ARG . 7.6 mtm180 -62.61 -35.05 78.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.4 -19.51 33.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.25 179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 10' ' ' VAL . 15.8 tp -68.13 -48.21 66.02 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.908 ' HB2' HG23 ' A' ' 60' ' ' THR . 9.1 tt0 -64.44 -25.54 68.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.44 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.37 -21.79 35.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.46 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.91 -43.81 19.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -134.92 2.8 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.83 -22.78 16.07 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.302 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.3 mt -65.03 112.16 3.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 109.983 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.908 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -101.13 136.32 41.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -179.644 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.926 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.6 m -108.94 138.41 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 t70 -80.09 -16.13 55.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.894 178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 176.09 97.21 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.931 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -63.48 -175.28 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.05 101.17 4.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.81 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 7.0 pttp -62.48 129.29 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 127' ' ' LEU . 17.0 m -127.21 -46.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.51 148.94 19.83 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.029 -179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.1 tm0? -117.67 114.45 23.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 110.133 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 123' ' ' TRP . 25.9 mt -103.38 149.29 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.022 0.439 . . . . 0.0 111.304 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 10.2 t -125.42 149.39 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CE2' ' CG ' ' A' ' 139' ' ' PHE . 6.3 t80 -126.48 117.83 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 2.3 pm0 -110.36 129.74 55.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -96.68 137.96 34.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.272 0.558 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -82.49 117.57 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.799 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.47 -21.07 47.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.209 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.02 140.33 21.55 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.649 0.261 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 -45.62 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.504 2.136 . . . . 0.0 112.264 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.612 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.1 tt0 -58.57 168.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.267 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.29 -165.9 2.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.136 -179.934 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.622 ' HE2' ' HB2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -145.34 111.23 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 179.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 35.8 t0 -101.6 102.8 13.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.7 p -112.21 116.82 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.0 111.764 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.48 ' CG ' HG21 ' A' ' 45' ' ' ILE . 25.4 m80 -77.7 155.64 31.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.535 178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.77 HG11 ' CZ3' ' A' ' 123' ' ' TRP . 52.0 t -116.91 102.5 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.294 0.569 . . . . 0.0 110.348 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 m-85 -99.11 141.6 31.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.968 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.2 p -126.8 117.35 22.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.042 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.92 177.26 5.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.228 0.537 . . . . 0.0 111.893 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -145.99 -45.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.31 90.29 7.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' A' ' 59' ' ' LEU . 2.9 pt -103.73 161.89 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.296 0.57 . . . . 0.0 111.732 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 93' ' ' GLY . 5.5 mm-40 -102.57 78.25 1.69 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.56 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 92' ' ' GLN . . . -19.38 87.28 0.01 OUTLIER Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.291 -178.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 96' ' ' VAL . 12.0 m -159.32 63.02 2.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.304 . . . . 0.0 110.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 94' ' ' THR . 12.7 Cg_exo -70.56 68.54 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.462 179.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.936 HG23 HG22 ' A' ' 94' ' ' THR . 34.3 t -77.77 61.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.749 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.9 pt-20 -43.7 123.27 3.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m -87.35 -173.37 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 -13.31 62.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.554 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.17 3.95 5.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.93 161.9 33.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 103' ' ' PRO . 60.5 ttt180 -170.52 101.85 0.43 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 36.9 Cg_endo -64.21 124.14 12.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.295 1.996 . . . . 0.0 111.895 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.6 m -112.59 119.69 39.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.255 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 7.9 m95 -86.51 114.84 23.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.724 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -165.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.972 0.415 . . . . 0.0 111.463 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.426 ' C ' HG12 ' A' ' 18' ' ' VAL . 8.0 mt-30 -102.44 151.07 22.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.128 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.4 pt? -72.95 -9.14 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.612 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.25 22.61 12.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.868 0.366 . . . . 0.0 110.294 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.24 21.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.538 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.89 126.03 90.79 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.215 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 51.2 Cg_endo -92.63 99.2 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.649 2.233 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.53 -18.05 52.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.706 179.58 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -64.5 -31.53 72.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.5 29.92 3.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.897 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -125.48 -77.39 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.739 -179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -161.22 166.18 15.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.257 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 97.8 Cg_endo -82.33 15.59 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.726 2.284 . . . . 0.0 113.033 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -126.83 -20.1 4.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 -179.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 16.7 m-20 -52.82 -52.59 56.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 125' ' ' PRO . 1.7 t -58.1 -17.14 16.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 148' ' ' TYR . 4.4 m-85 -84.96 -31.11 23.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.882 ' HH2' HD12 ' A' ' 11' ' ' LEU . 69.8 p-90 -109.46 -34.4 6.53 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.725 ' CZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.12 -50.6 68.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.2 Cg_endo -52.98 -24.03 23.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.998 1.799 . . . . 0.0 112.057 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.775 HD13 ' CB ' ' A' ' 133' ' ' PHE . 11.2 mt -81.67 -34.32 30.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.252 0.549 . . . . 0.0 109.826 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -60.29 -57.25 13.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.763 178.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -26.03 16.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 44.6 tp60 -84.7 2.52 41.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.71 29.7 14.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -118.4 138.63 52.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 153' ' ' VAL . 28.3 mttt -82.98 132.28 35.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.775 ' CB ' HD13 ' A' ' 126' ' ' LEU . 17.0 m-85 -143.79 151.83 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 16.4 m170 -121.76 125.14 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.69 135.24 10.03 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.64 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.83 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 5.9 m-85 -107.94 119.23 38.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 43.0 m-85 -115.41 121.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 6.8 tttt -88.92 136.56 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CG ' ' CE2' ' A' ' 72' ' ' PHE . 13.9 m-85 -120.92 163.98 17.39 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.87 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.8 tp60 -130.88 87.53 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.417 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.05 -63.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.277 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.34 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.17 -16.57 9.07 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 17.0 m -83.43 135.7 34.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.561 0.219 . . . . 0.0 111.18 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 40.9 mt -110.43 133.33 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 140' ' ' GLN . 0.3 OUTLIER -114.1 -13.09 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.808 179.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.74 134.34 13.63 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.233 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 47.3 p90 -138.94 117.69 12.29 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.08 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -113.03 146.44 39.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.508 179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.65 124.99 27.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.001 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 1.8 mmp_? -130.76 160.68 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 38.5 tt0 -108.97 150.46 27.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.741 0.305 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 132' ' ' LYS . 27.9 m -142.93 174.86 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.64 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 m -84.93 109.37 18.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.1 -179.946 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.45 103.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.616 ' HB3' ' CG ' ' A' ' 79' ' ' GLU . . . -101.26 176.45 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t 177.77 103.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.026 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.39 93.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.019 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 39' ' ' VAL . 2.3 tt -86.96 119.97 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 110.947 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 45.0 m-85 -122.14 -179.0 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.571 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 27.5 p -124.01 166.42 15.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.258 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.1 tt -153.03 109.13 3.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -111.97 126.69 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.537 0.684 . . . . 0.0 112.26 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.902 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.4 mt -127.17 112.98 15.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.396 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.023 HG22 HG22 ' A' ' 88' ' ' THR . 17.6 t -87.07 83.1 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.0 111.896 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -98.27 158.45 15.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.74 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -134.07 156.85 78.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.163 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' C ' HD13 ' A' ' 108' ' ' LEU . 43.0 Cg_endo -67.4 25.88 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 112.995 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLN . 3.3 pt20 -160.54 -41.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.274 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -135.02 160.87 36.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.435 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.791 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 1.4 p -127.97 157.2 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 110.724 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 103' ' ' PRO . 20.1 tp -120.16 112.7 19.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.226 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' A' ' 111' ' ' ILE . 3.5 mt -114.25 142.58 46.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.939 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.65 126.86 8.98 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.385 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.614 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 35.0 ttm -113.53 142.22 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -87.47 146.91 25.62 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.296 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -31.52 18.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.893 0.378 . . . . 0.0 110.349 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.85 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.47 138.82 3.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.955 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.99 -127.19 3.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.273 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -100.24 23.43 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.179 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.4 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.85 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -60.33 148.81 35.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.996 0.398 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.65 27.39 42.4 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.892 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' MET . 76.0 mtt-85 -141.5 141.14 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.212 . . . . 0.0 110.652 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.97 152.67 18.49 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.501 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 20' ' ' LEU . 13.5 p30 -178.4 157.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 174.58 2.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.221 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -106.33 95.76 5.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.434 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -93.49 162.37 25.61 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.945 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.56 -129.86 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.339 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.43 140.27 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 6' ' ' LEU . 2.6 t -81.23 106.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.817 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.47 177.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.212 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.75 64.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.27 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.46 43.33 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.11 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.68 173.31 9.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' ASP . 72.5 p -101.6 142.5 32.86 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.99 0.424 . . . . 0.0 110.779 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.856 HD13 HD21 ' A' ' 6' ' ' LEU . 2.7 mt -51.1 -33.03 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.099 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.14 -24.92 58.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 44' ' ' THR . 2.3 m-20 -81.66 -40.86 22.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.56 85.08 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.307 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.938 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.32 -36.01 61.13 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 64' ' ' LEU . 45.7 mtm180 -70.59 -54.86 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -33.6 74.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.345 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 3.8 mm-40 -84.19 -19.34 34.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 21.5 tp -74.52 -47.52 32.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.84 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.9 tt0 -59.21 -26.0 64.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -82.72 -24.91 33.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -73.16 -43.96 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -136.78 24.82 3.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.86 14.01 9.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.397 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 91' ' ' ILE . 11.1 mt -101.08 111.63 23.89 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.984 0.421 . . . . 0.0 110.442 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -97.84 136.45 38.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.411 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.914 HG21 ' HG ' ' A' ' 64' ' ' LEU . 15.0 m -106.28 138.68 30.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.075 0.464 . . . . 0.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -80.0 -16.6 54.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.413 179.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.41 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.914 ' HG ' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -62.45 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.742 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -134.9 101.31 4.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.77 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 1.9 pttm -59.07 124.27 19.38 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 127' ' ' LEU . 26.3 m -114.16 -50.64 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.144 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.86 159.6 27.63 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.885 -1.15 . . . . 0.0 113.372 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -116.77 114.38 23.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.256 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 123' ' ' TRP . 41.9 mt -102.75 146.7 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.08 149.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.542 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -132.72 127.55 34.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.332 . . . . 0.0 111.227 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -107.63 111.13 23.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -82.61 128.75 34.62 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.81 0.814 . . . . 0.0 111.244 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.1 t -89.48 0.62 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.02 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.03 0.71 10.78 Favored Glycine 0 C--N 1.309 -0.934 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.833 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -137.59 127.3 15.3 Favored Pre-proline 0 CA--C 1.528 0.109 0 CA-C-N 115.644 -0.278 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.01 -23.52 35.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.346 2.031 . . . . 0.0 112.235 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.616 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 3.9 mt-10 -85.55 -169.93 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.157 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -141.63 -164.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.405 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.1 ttp -146.53 111.6 5.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.793 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -107.83 102.68 11.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 0.0 110.408 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.3 p -112.63 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.547 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -82.7 152.3 25.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.66 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.715 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.3 t -106.41 138.0 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 110.623 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.884 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.0 m-85 -137.91 125.83 22.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 29.3 t -114.2 117.72 31.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.023 HG22 HG22 ' A' ' 12' ' ' VAL . 12.5 t -98.77 -173.07 2.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 111.609 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -159.98 -42.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 99.09 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.118 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.51 HD12 HD22 ' A' ' 59' ' ' LEU . 50.4 pt -102.84 178.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -129.49 -69.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.345 -178.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -59.44 -164.33 0.12 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.679 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.903 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.88 163.05 33.68 Favored Pre-proline 0 CA--C 1.515 -0.399 0 CA-C-O 120.377 0.132 . . . . 0.0 111.068 -179.443 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.903 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.3 Cg_exo -65.71 65.4 0.4 Allowed 'Trans proline' 0 CA--C 1.506 -0.877 0 C-N-CA 122.538 2.159 . . . . 0.0 109.593 179.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' THR . 9.0 t -76.61 60.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.49 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.8 pt-20 -45.05 117.53 1.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.988 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 m -87.52 -178.74 6.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -11.98 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.462 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.98 -32.35 6.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.625 0.25 . . . . 0.0 111.342 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.93 163.25 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 22' ' ' MET . 4.2 ttt180 -170.1 98.84 0.46 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.492 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.848 ' HB2' HD11 ' A' ' 19' ' ' LEU . 92.2 Cg_endo -80.68 157.82 21.61 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.78 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -145.24 123.57 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.59 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.818 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.1 m95 -89.71 117.71 28.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.689 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 23.0 m-85 -129.25 -160.92 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.678 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 18' ' ' VAL . 47.1 mt-30 -86.4 151.22 23.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.5 pt? -75.82 -3.0 32.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.84 17.72 15.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 110.132 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -140.48 22.62 2.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.639 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.95 126.59 90.42 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.865 179.335 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.453 ' HG2' ' CD1' ' A' ' 32' ' ' TRP . 62.1 Cg_endo -91.21 98.34 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.465 2.11 . . . . 0.0 113.413 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -76.05 -18.49 59.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.293 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -24.97 59.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.12 26.8 4.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 1.9 mtm -135.18 -71.56 0.48 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -157.42 168.28 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.878 0.37 . . . . 0.0 111.243 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 145' ' ' ILE . 83.0 Cg_endo -84.85 16.04 2.06 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.175 2.584 . . . . 0.0 113.133 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.475 ' HB3' ' CE2' ' A' ' 137' ' ' PHE . 24.4 m-20 -128.24 -17.15 4.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.601 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 6.7 m-20 -53.21 -44.96 68.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 5.2 t -60.85 -17.19 48.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 150' ' ' LEU . 13.9 m-85 -84.78 -41.34 16.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.0 p-90 -98.9 -3.24 35.7 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.637 ' CZ ' HD11 ' A' ' 11' ' ' LEU . 1.9 m-85 -76.3 -49.46 3.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -52.94 -33.28 61.26 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.549 2.166 . . . . 0.0 113.39 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -78.33 -32.82 49.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 110.125 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.555 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.75 -53.66 54.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 109.66 178.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mt -63.57 -27.23 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.984 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 43.2 tp60 -83.62 2.38 37.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.559 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.97 19.58 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.726 0.298 . . . . 0.0 111.385 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -110.82 159.25 17.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.715 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 mttp -106.69 132.99 52.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 126' ' ' LEU . 23.7 m-85 -141.58 160.44 40.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 14.0 m170 -120.85 125.29 47.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.668 179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -120.59 131.53 8.81 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.443 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.78 118.93 36.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 15.9 m-85 -118.11 126.37 52.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.099 0.476 . . . . 0.0 112.122 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.671 ' HE2' HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -88.92 123.43 33.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.272 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.1 m-85 -103.19 154.95 18.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.761 -178.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 146' ' ' LEU . 3.0 tp60 -90.18 -21.76 22.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.55 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.8 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.03 -34.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.15 -20.31 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.561 -179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.1 m -93.34 135.45 34.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 118' ' ' PRO . 62.7 mt -110.05 137.53 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.945 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.4 mt -118.45 -13.32 9.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -154.33 138.62 16.64 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 111.279 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -139.3 133.84 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.794 0.33 . . . . 0.0 111.437 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 145.45 51.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.543 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.4 mp -133.84 122.87 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.029 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -126.68 159.43 33.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.7 OUTLIER -99.9 148.77 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 132' ' ' LYS . 23.7 m -144.0 144.98 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.95 -46.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.967 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.8 m -63.84 143.41 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.174 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.833 0.349 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.32 65.29 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.37 -179.64 6.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.04 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.06 89.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.178 0.514 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.85 94.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.32 179.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 39' ' ' VAL . 5.1 tt -86.95 119.57 27.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.599 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 15.2 m-85 -122.18 -179.46 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.855 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.2 p -123.59 169.59 11.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.154 0.502 . . . . 0.0 111.889 -179.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.23 109.15 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.106 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.3 p -113.58 128.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.854 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.31 112.44 15.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.276 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.017 HG22 HG22 ' A' ' 88' ' ' THR . 15.3 t -80.21 94.47 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.135 0.493 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD23 ' CE1' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -117.09 117.86 30.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.777 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' HD12 ' A' ' 13' ' ' LEU . 10.8 pt20 -105.91 157.55 34.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.37 32.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.725 2.283 . . . . 0.0 114.671 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 14' ' ' GLN . 10.6 pt20 -160.92 -41.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.715 0.293 . . . . 0.0 111.444 178.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.18 161.57 37.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.619 ' HB ' HD22 ' A' ' 13' ' ' LEU . 4.2 p -130.53 158.42 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.08 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 103' ' ' PRO . 19.2 tp -111.44 116.37 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.805 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.661 ' CD1' HG22 ' A' ' 111' ' ' ILE . 2.0 mt -112.04 131.45 55.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.63 119.43 5.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.647 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.9 ttm -108.44 142.3 39.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -86.7 146.53 26.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -33.03 14.66 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.009 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -166.74 154.16 9.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 111.294 179.55 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -128.31 8.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.053 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -100.12 76.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.727 0.299 . . . . 0.0 110.909 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.42 -7.22 2.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.551 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -42.3 141.09 1.01 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.261 0.53 . . . . 0.0 111.711 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.56 65.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.907 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mmt180 -136.42 130.69 33.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.647 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -82.26 153.52 25.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.421 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -178.44 146.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.58 179.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.165 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.744 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -108.46 96.69 6.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 0.0 110.526 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.6 157.2 15.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.725 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.34 -121.6 1.76 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.326 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.23 134.76 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.019 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.697 HG21 HD22 ' A' ' 6' ' ' LEU . 20.9 t -75.55 104.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.78 171.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.223 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.64 63.62 0.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.52 35.6 0.28 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.44 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.655 ' HG3' HG13 ' A' ' 39' ' ' VAL . 2.5 pt-20 -126.59 172.87 9.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' ASP . 65.3 p -101.45 141.69 33.94 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.06 0.457 . . . . 0.0 110.964 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 8' ' ' THR . 7.5 mt -50.19 -33.32 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.858 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -75.13 -25.8 58.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.908 179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' THR . 1.7 m-20 -81.1 -37.86 28.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.528 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.18 -36.38 79.6 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.718 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.855 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -76.62 -34.34 58.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 64' ' ' LEU . 28.1 mtp180 -71.16 -53.77 13.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.724 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -64.54 -31.08 72.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 29.9 tp10 -84.3 -19.5 33.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.356 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 19.9 tp -74.58 -48.89 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.328 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.844 ' HB2' HG23 ' A' ' 60' ' ' THR . 20.9 tt0 -60.15 -27.37 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.436 -179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 52' ' ' GLU . 7.6 pt-20 -82.93 -21.97 33.98 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -79.43 -43.92 22.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -130.96 21.01 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.855 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.69 14.04 9.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.504 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 19' ' ' LEU . 8.1 mt -106.82 107.23 18.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.844 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -87.12 151.55 23.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.689 179.485 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.95 HG21 ' HG ' ' A' ' 64' ' ' LEU . 24.0 m -121.13 143.6 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.6 t0 -82.05 -20.64 37.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.28 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.89 100.01 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.759 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.95 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.2 mp -65.39 -174.02 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -134.88 101.26 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.96 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 5.9 ttpp -61.55 123.79 18.87 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 127' ' ' LEU . 16.9 m -137.64 -50.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -102.81 146.95 16.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.103 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' HIS . 3.6 tt0 -132.01 114.34 14.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.666 HD11 ' CG ' ' A' ' 123' ' ' TRP . 3.1 mt -119.61 150.07 22.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 112.0 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 136' ' ' TYR . 9.7 t -127.48 149.28 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.273 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 139' ' ' PHE . 9.2 m-85 -133.0 118.08 18.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.911 0.386 . . . . 0.0 111.529 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -97.55 132.99 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -101.9 130.8 48.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.104 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.757 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -76.84 121.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.851 -179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.68 52.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.309 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.79 109.55 61.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.532 0.206 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.23 -27.59 6.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.414 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 175.0 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.97 -160.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 12.5 mtp -147.13 111.88 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.979 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.3 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.204 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.91 120.0 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.802 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.6 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.5 m-70 -93.8 145.3 24.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.713 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 123' ' ' TRP . 27.2 t -107.49 134.62 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 120.923 0.392 . . . . 0.0 110.276 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 2.3 m-85 -135.79 125.75 25.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.3 m -110.64 117.31 33.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.017 HG22 HG22 ' A' ' 12' ' ' VAL . 12.0 t -96.13 -172.75 2.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.158 0.504 . . . . 0.0 111.534 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -160.25 -46.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.861 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.33 99.24 11.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.014 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 60' ' ' THR . 42.9 pt -102.95 178.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -140.01 -64.45 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.031 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.27 -173.62 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.582 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.95 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -116.85 160.65 35.95 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 120.495 0.188 . . . . 0.0 111.24 -179.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 94' ' ' THR . 16.4 Cg_exo -67.76 62.9 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.537 2.158 . . . . 0.0 109.644 178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 94' ' ' THR . 6.4 t -76.7 60.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.614 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 4.5 pt-20 -45.15 116.84 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.034 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -87.43 -178.83 6.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.64 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -11.08 59.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.574 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.04 -28.43 7.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.434 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.39 159.11 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.451 . . . . 0.0 111.471 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -164.15 97.12 0.95 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.82 ' HB2' HD11 ' A' ' 19' ' ' LEU . 73.7 Cg_endo -72.96 158.99 48.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.655 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.15 119.69 9.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.484 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.7 m95 -85.59 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.513 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -120.06 -168.98 1.71 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -85.89 150.99 24.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.408 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.552 ' CB ' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -71.32 -10.4 59.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.741 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -118.2 22.46 12.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -141.25 17.39 2.24 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.059 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.4 124.56 90.96 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.092 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -92.24 98.06 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.818 2.346 . . . . 0.0 113.056 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -77.24 -18.1 57.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.85 -29.89 71.08 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -100.14 28.8 4.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.944 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD11 ' A' ' 20' ' ' LEU . 5.4 mtp -133.98 -172.61 3.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.461 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.19 169.18 0.38 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.891 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.481 ' HB2' HD12 ' A' ' 145' ' ' ILE . 64.9 Cg_endo -86.37 15.77 2.12 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.91 2.407 . . . . 0.0 113.002 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 122' ' ' TYR . 0.7 OUTLIER -122.87 -22.0 5.4 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.335 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 116' ' ' MET . 7.0 m-20 -43.59 -59.12 2.32 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 66.6 p -59.57 -17.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 119' ' ' ASP . 73.4 m-85 -85.05 -19.13 32.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.854 ' CH2' HD12 ' A' ' 11' ' ' LEU . 69.1 p-90 -126.75 -9.13 6.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -76.61 -48.49 2.95 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.24 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 86.9 Cg_exo -47.16 -37.64 23.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.748 2.298 . . . . 0.0 113.214 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -76.19 -31.38 58.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.079 179.778 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -62.95 -51.63 66.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.671 178.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' LEU . 4.7 mt -62.35 -24.84 67.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.44 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -84.75 2.64 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.37 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 62.88 22.88 13.68 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -119.3 159.13 24.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -111.83 125.03 53.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.708 ' HB2' HD22 ' A' ' 126' ' ' LEU . 9.5 m-85 -127.88 169.87 13.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' GLN . 1.7 t-80 -126.08 126.64 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.247 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -122.45 126.04 6.25 Favored Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.86 -1.162 . . . . 0.0 113.25 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' HG11 ' A' ' 71' ' ' VAL . 5.4 t80 -111.32 111.74 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 0.4 OUTLIER -116.91 137.3 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 112.082 -178.311 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.757 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -88.74 137.72 32.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.366 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -103.4 164.21 11.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 111.334 -178.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' HD21 ' A' ' 146' ' ' LEU . 34.8 tp60 -111.24 -1.38 16.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.348 179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.72 -44.14 0.12 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.26 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 -34.03 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.96 -22.72 7.17 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 140' ' ' GLN . 18.4 m -89.22 137.44 32.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 111.323 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 118' ' ' PRO . 72.5 mt -109.48 143.09 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 140' ' ' GLN . 6.9 mt -122.72 -11.44 8.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.3 OUTLIER -153.98 137.41 15.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.689 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -139.82 135.18 32.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.023 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.592 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.65 145.12 51.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.035 178.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.63 121.86 22.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.904 0.383 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 12.9 mmt180 -126.83 160.27 31.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.703 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.0 OUTLIER -97.77 147.66 24.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.854 0.359 . . . . 0.0 110.901 -179.88 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.8 m -144.91 138.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.43 -48.32 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.5 m -99.42 -58.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.109 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.69 -92.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.523 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.86 96.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.77 99.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 81' ' ' MET . 10.4 mmp_? -60.15 94.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.134 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 39' ' ' VAL . 2.0 tt -86.92 118.73 26.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.921 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HE1' ' A' ' 81' ' ' MET . 7.4 m-85 -122.61 -179.04 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.308 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 64.3 p -125.77 170.09 11.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 123' ' ' TRP . 1.7 tt -152.87 109.03 3.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.095 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 53' ' ' LEU . 1.4 p -112.89 125.78 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.582 0.706 . . . . 0.0 111.802 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 2.1 mt -126.78 112.67 15.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.207 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 88' ' ' THR . 4.1 t -90.95 96.96 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.6 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.89 HD21 ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -104.34 158.41 16.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.97 179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -132.35 157.05 79.29 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.041 179.533 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' C ' HD13 ' A' ' 108' ' ' LEU . 40.1 Cg_endo -66.79 23.98 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.458 2.105 . . . . 0.0 113.175 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' GLN . 45.9 mt-30 -160.61 -40.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.499 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' GLN . 8.4 ptt-85 -133.45 161.06 35.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.439 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.782 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -127.43 155.87 38.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.61 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 103' ' ' PRO . 25.1 tp -113.37 115.66 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.72 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 HG22 ' A' ' 111' ' ' ILE . 9.4 mt -118.89 134.68 55.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.94 122.2 5.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.179 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.61 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 27.7 ttm -113.75 142.12 46.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 7.9 mtpt -89.06 146.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -89.73 -31.52 17.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 0.0 110.51 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.92 160.75 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.935 179.217 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 -128.54 9.59 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.221 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -100.12 80.82 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 110.91 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.9 -7.48 2.69 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.311 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.854 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -45.57 141.51 2.74 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.143 0.471 . . . . 0.0 111.516 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.31 20.62 67.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.039 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' MET . 62.9 mtp180 -133.5 150.25 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.61 0.243 . . . . 0.0 110.556 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.61 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -110.94 152.8 26.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.433 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' CA ' HD22 ' A' ' 20' ' ' LEU . 9.2 p30 -178.06 176.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.74 172.31 52.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.498 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.732 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -104.3 97.4 7.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 0.0 110.29 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -94.91 157.69 22.27 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.209 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.99 147.74 16.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.255 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 1.9 ptmt -83.82 144.81 29.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.774 HG21 HD22 ' A' ' 6' ' ' LEU . 5.4 t -75.54 110.1 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.549 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -45.81 170.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.303 -179.647 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -66.42 70.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 113.14 44.55 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.943 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.8 pt-20 -126.68 172.95 9.87 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -99.74 143.4 30.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.812 HG22 HG22 ' A' ' 8' ' ' THR . 5.6 mt -50.78 -33.58 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.065 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -74.53 -26.7 60.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 109.769 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -38.14 28.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.609 179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.47 -35.49 75.6 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.499 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.854 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.57 -33.88 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HG2' HD11 ' A' ' 64' ' ' LEU . 21.9 mtt180 -75.1 -54.36 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.014 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -34.35 75.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.445 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.16 -20.09 33.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.533 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 10' ' ' VAL . 18.5 tp -70.93 -48.13 55.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 60' ' ' THR . 16.3 tt0 -60.94 -26.89 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.798 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.66 -21.93 34.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.8 -43.89 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.725 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -133.78 24.0 3.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.905 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 56.03 14.64 8.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.531 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' CD2' ' A' ' 19' ' ' LEU . 7.5 mt -105.34 107.11 17.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.855 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -88.9 155.42 19.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.653 179.422 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.927 HG21 ' HG ' ' A' ' 64' ' ' LEU . 13.6 m -129.4 138.83 53.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 111.626 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 26.4 t0 -79.92 -17.7 52.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 177.43 101.53 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.878 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.927 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -68.9 -168.71 0.14 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -134.93 101.11 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.609 178.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 pttp -59.54 132.75 54.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 127' ' ' LEU . 19.1 m -121.2 -49.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -154.93 175.8 32.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.39 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' CG ' ' CD2' ' A' ' 84' ' ' HIS . 26.6 mt-30 -131.65 119.54 21.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.763 HG23 ' CE1' ' A' ' 137' ' ' PHE . 49.6 mt -103.01 150.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.772 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.17 149.47 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.988 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 137' ' ' PHE . 38.9 m-85 -132.12 117.99 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.813 ' CD ' HD22 ' A' ' 80' ' ' LEU . 36.7 mm-40 -99.95 125.25 45.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.398 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 129.72 36.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 111.071 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.625 HG22 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -77.1 111.64 14.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.812 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.97 -20.83 46.08 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.242 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.31 111.55 64.18 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.456 0.169 . . . . 0.0 110.727 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -47.46 -33.48 17.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.527 2.151 . . . . 0.0 112.445 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.548 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.0 tt0 -67.92 171.25 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.813 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -143.52 -167.83 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.414 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.527 ' HE1' ' HB ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -146.17 111.41 5.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.698 179.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -106.21 102.91 12.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.395 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 83' ' ' VAL . 11.9 p -105.21 117.12 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 111.814 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 45' ' ' ILE . 58.9 t-80 -76.97 155.37 32.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.587 HG11 ' CE3' ' A' ' 123' ' ' TRP . 66.5 t -114.11 133.12 61.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 10.8 m-85 -139.29 145.57 39.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.162 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 7.8 p -135.33 117.46 15.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.058 HG22 HG22 ' A' ' 12' ' ' VAL . 11.9 t -98.03 -170.7 2.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 0.0 111.908 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -160.22 -42.67 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.795 179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 98.73 11.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.259 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' THR . 44.9 pt -103.07 178.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.329 . . . . 0.0 111.007 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -137.79 -66.27 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -54.84 -173.05 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.605 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -116.39 161.69 30.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.513 0.197 . . . . 0.0 111.179 -179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 94' ' ' THR . 15.1 Cg_exo -68.27 63.51 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.452 2.102 . . . . 0.0 109.359 178.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 94' ' ' THR . 6.6 t -76.68 61.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.71 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -44.12 116.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.938 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.2 p -87.36 -177.4 5.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.818 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -11.58 60.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -115.47 -32.5 5.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.552 0.215 . . . . 0.0 111.408 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 161.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.5 ttt180 -168.39 101.06 0.54 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.748 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.4 Cg_endo -70.91 148.66 58.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.244 1.963 . . . . 0.0 112.29 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.4 m -134.37 119.35 18.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.532 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.622 ' CD1' HD13 ' A' ' 19' ' ' LEU . 8.3 m95 -83.33 108.18 16.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.91 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -160.17 0.71 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.142 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.45 ' C ' HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -100.79 145.53 28.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.86 0.362 . . . . 0.0 110.815 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.89 ' HB2' HD21 ' A' ' 13' ' ' LEU . 1.4 pt? -69.85 -11.35 60.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.47 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -117.25 20.8 13.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -148.15 22.47 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.456 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.743 HG22 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -72.85 127.84 89.02 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.138 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.63 98.84 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.48 2.12 . . . . 0.0 112.8 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HA ' ' HG3' ' A' ' 116' ' ' MET . 0.1 OUTLIER -76.78 -18.21 58.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.242 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -71.6 -24.7 61.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.92 25.55 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.771 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.589 ' HG3' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mtm -132.59 -69.68 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 82.6 m95 -159.83 162.96 23.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.049 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 117' ' ' TRP . 91.4 Cg_endo -81.78 15.57 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.869 2.38 . . . . 0.0 113.093 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.6 p30 -127.66 -18.71 4.28 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.59 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 4.0 m-20 -50.92 -50.58 57.31 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.42 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 26.2 p -58.65 -18.73 33.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.754 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD11 ' A' ' 150' ' ' LEU . 25.2 m-85 -85.55 -26.59 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 68.4 p-90 -117.0 -10.7 10.88 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.4 -47.88 3.24 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.823 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 65.8 Cg_exo -51.39 -36.08 56.89 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.437 2.091 . . . . 0.0 113.114 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.6 OUTLIER -77.97 -32.5 51.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 110.136 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -56.48 -52.52 64.4 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.23 -26.52 62.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.681 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 6.8 mt-30 -86.23 2.72 46.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 57.86 25.64 12.3 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -106.81 159.18 16.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -107.65 142.12 38.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.914 179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -149.53 171.19 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.239 0.543 . . . . 0.0 111.543 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 69' ' ' GLN . 4.1 t60 -141.36 124.92 16.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.083 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -126.65 149.56 17.6 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.641 -178.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CE1' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -121.2 118.18 28.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.763 ' CE1' HG23 ' A' ' 70' ' ' ILE . 7.7 m-85 -121.27 132.77 55.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.72 135.42 33.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.051 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 144' ' ' THR . 0.3 OUTLIER -109.5 163.51 13.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.191 0.52 . . . . 0.0 112.122 -178.343 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.774 ' HB2' HD11 ' A' ' 146' ' ' LEU . 6.5 tp-100 -138.32 77.48 1.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.96 -67.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.549 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.401 ' O ' ' CE1' ' A' ' 139' ' ' PHE . 1.8 mt-30 -179.32 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.11 16.5 10.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 58.0 m -119.32 134.45 55.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.697 0.285 . . . . 0.0 111.412 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 34.5 mt -110.58 139.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.844 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 140' ' ' GLN . 1.9 mt -116.82 -17.61 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.5 OUTLIER -154.2 138.9 17.0 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.161 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.495 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 47.5 p90 -139.71 132.02 28.34 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.675 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.71 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.622 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.82 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.9 mp -134.21 125.18 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -128.63 119.61 25.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.771 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -81.61 140.77 34.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.0 164.88 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.65 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.6 m -78.08 97.46 5.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.366 -0.826 . . . . 0.0 111.151 179.93 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.815 0.341 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.71 1.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.74 -167.94 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.054 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 p 56.61 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.219 0.533 . . . . 0.0 111.212 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -64.27 96.73 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.095 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.976 HD22 HG21 ' A' ' 39' ' ' VAL . 1.7 tt -86.75 120.33 27.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.875 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.7 m-85 -122.63 -178.89 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.69 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 40.0 p -127.35 166.29 18.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.393 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -156.27 108.86 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.104 179.253 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.772 HG21 HD22 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -110.29 124.97 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.537 0.684 . . . . 0.0 112.109 -179.556 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.875 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.8 15.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.418 178.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 88' ' ' THR . 5.1 t -83.19 89.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.112 0.482 . . . . 0.0 111.216 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -94.63 158.31 15.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.79 179.871 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.636 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -140.62 156.97 68.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.993 179.65 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 16' ' ' GLN . 19.1 Cg_exo -65.33 20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.377 2.051 . . . . 0.0 113.011 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 72.3 mt-30 -160.27 -40.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -129.34 161.18 30.88 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -179.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -134.19 148.05 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.054 179.843 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 103' ' ' PRO . 31.9 tp -113.44 116.88 30.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -115.87 145.38 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.65 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.879 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.598 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 35.7 ttm -112.42 142.31 45.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 3.2 mmmt -85.13 146.79 26.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -91.95 -31.49 15.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 110.107 179.912 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -163.78 140.63 6.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.918 179.066 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.91 -138.08 13.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.333 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.6 75.27 9.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.335 . . . . 0.0 110.762 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.35 -15.36 1.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.78 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -43.5 94.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.158 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.58 -8.87 8.24 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.942 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' MET . 48.9 mtt-85 -118.54 164.39 15.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.601 0.239 . . . . 0.0 110.451 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.598 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -111.03 146.73 36.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.25 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.5 p30 -168.8 153.65 6.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 9' ' ' LEU . . . -58.38 172.82 3.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.241 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.722 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -99.36 101.05 12.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.429 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -90.62 171.36 36.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.069 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 52' ' ' GLU . . . -174.47 114.41 0.5 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.379 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.1 pttt -58.28 143.37 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 6' ' ' LEU . 3.4 t -75.46 112.57 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.62 172.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.4 65.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.83 43.66 0.48 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.99 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 3.2 pt-20 -126.66 172.89 9.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.0 p -100.51 144.34 29.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.035 0.445 . . . . 0.0 111.324 -179.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 8' ' ' THR . 2.9 mt -50.91 -33.54 12.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.151 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 26.4 tt0 -76.93 -22.93 52.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.972 0.415 . . . . 0.0 110.123 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.73 -39.94 17.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.686 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.62 -37.31 84.77 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.386 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.01 -39.6 61.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -68.12 -55.67 11.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.056 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mmt-85 -60.44 -36.07 77.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.398 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 78.7 mm-40 -84.12 -19.49 34.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.772 HD22 HG21 ' A' ' 10' ' ' VAL . 14.7 tp -69.02 -46.47 67.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.587 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.85 ' HB2' HG23 ' A' ' 60' ' ' THR . 4.2 tt0 -63.35 -26.86 68.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.46 -21.96 35.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -80.74 -43.81 19.65 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.714 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.6 m -132.32 23.42 4.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.941 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.43 14.35 8.91 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.661 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 91' ' ' ILE . 11.2 mt -106.27 110.33 22.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 110.633 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.85 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -93.01 143.51 26.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.12 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.873 HG21 ' HG ' ' A' ' 64' ' ' LEU . 28.2 m -112.06 140.05 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.014 0.435 . . . . 0.0 111.893 -179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.5 m-20 -79.94 -17.87 51.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.215 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 175.63 94.65 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.773 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.873 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.3 mp -60.32 -177.23 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -135.02 101.16 4.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -61.04 131.94 52.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.301 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 127' ' ' LEU . 18.2 m -132.76 -48.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -130.43 134.53 7.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.499 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' CG ' ' CE1' ' A' ' 84' ' ' HIS . 10.1 mt-30 -111.8 114.23 27.07 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.747 HG23 ' CE1' ' A' ' 137' ' ' PHE . 38.4 mt -107.36 150.07 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.051 0.453 . . . . 0.0 111.357 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.57 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.7 t -125.48 149.23 30.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.879 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 139' ' ' PHE . 1.4 m-85 -123.66 122.32 37.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.5 tt0 -104.32 120.42 41.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.03 135.47 33.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.038 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.654 HG13 ' HE2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -81.73 108.73 15.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.85 -179.705 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.17 -19.16 49.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.378 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -107.22 113.15 62.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.543 0.211 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.3 -36.48 29.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.489 2.126 . . . . 0.0 112.391 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' O ' HD23 ' A' ' 80' ' ' LEU . 2.5 tt0 -64.41 173.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -148.56 -170.03 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -136.88 111.31 8.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.629 179.329 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.18 102.43 12.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 83' ' ' VAL . 14.7 p -114.38 119.27 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.555 ' HB2' HG21 ' A' ' 45' ' ' ILE . 1.6 t60 -80.87 147.69 30.26 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.688 HG11 ' CE3' ' A' ' 123' ' ' TRP . 4.2 t -114.35 102.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.258 0.551 . . . . 0.0 110.393 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 m-85 -98.93 140.43 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.22 -179.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 28.1 p -123.48 117.39 25.01 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.028 HG22 HG22 ' A' ' 12' ' ' VAL . 1.7 t -99.61 -173.34 2.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.3 -44.1 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.774 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.95 98.66 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.26 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.2 pt -103.03 178.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -66.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 -179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.15 -167.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.911 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -121.67 162.54 35.98 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-O 120.441 0.162 . . . . 0.0 111.129 -179.517 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.911 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -66.91 63.87 0.59 Allowed 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 122.487 2.125 . . . . 0.0 109.53 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 94' ' ' THR . 4.9 t -76.8 59.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.694 -178.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.4 pt-20 -46.3 117.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.797 179.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.946 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 1.8 m-20 -71.89 -5.72 36.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.672 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.62 -25.37 4.36 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 159.26 19.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.955 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 ttt85 -169.84 98.78 0.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' LEU . 89.5 Cg_endo -79.61 159.22 25.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.382 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -145.08 128.2 16.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.593 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.82 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.8 m95 -92.87 114.37 26.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 24.6 m-85 -123.63 -168.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -93.38 162.72 13.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.999 HD13 HD21 ' A' ' 128' ' ' LEU . 28.0 mt -64.31 -17.95 64.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.36 19.32 20.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.565 179.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -131.39 12.63 5.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.817 -179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -82.71 125.05 76.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.729 178.549 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 58.8 Cg_endo -91.2 96.5 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.46 2.107 . . . . 0.0 114.124 -178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.688 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -70.79 -28.24 64.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.813 179.227 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -76.29 -28.73 57.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.568 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.88 29.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.246 179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 20' ' ' LEU . 29.0 ttp -140.32 -81.7 0.26 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.863 -179.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 118' ' ' PRO . 0.8 OUTLIER -142.8 157.95 60.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 117' ' ' TRP . 86.3 Cg_endo -83.09 12.32 2.99 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.727 2.285 . . . . 0.0 113.098 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 4.2 m-20 -122.48 -11.42 8.3 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.694 0.283 . . . . 0.0 111.253 179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . 21.4 m-20 -51.53 -61.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 111.977 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -17.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.841 ' CD1' HD11 ' A' ' 150' ' ' LEU . 28.0 m-85 -84.67 -29.36 25.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.875 ' CH2' HD12 ' A' ' 11' ' ' LEU . 64.3 p-90 -113.98 -4.26 13.25 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.589 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 4.7 m-85 -75.46 -49.75 3.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.651 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 124' ' ' PHE . 31.2 Cg_exo -59.03 -27.0 83.8 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.618 2.212 . . . . 0.0 112.411 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 133' ' ' PHE . 20.1 mt -79.25 -35.0 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 109.824 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.94 -57.35 13.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.758 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.999 HD21 HD13 ' A' ' 108' ' ' LEU . 2.3 mt -59.02 -29.53 67.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.737 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.56 -9.15 58.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.322 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 68.06 45.1 1.36 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 159.17 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 153' ' ' VAL . 6.4 mttt -110.2 125.03 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.866 ' HB2' HD13 ' A' ' 126' ' ' LEU . 14.6 m-85 -134.68 163.18 30.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' HG23 ' A' ' 71' ' ' VAL . 13.7 t-80 -130.86 125.31 33.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.891 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' ILE . . . -122.46 144.7 16.16 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 119.991 -1.1 . . . . 0.0 113.434 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -117.81 113.27 21.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.747 ' CE1' HG23 ' A' ' 70' ' ' ILE . 4.4 m-85 -116.72 135.79 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.474 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HE2' HG13 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -88.62 143.31 27.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -115.55 164.07 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.208 0.528 . . . . 0.0 112.014 -178.582 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.799 ' HB2' HD11 ' A' ' 146' ' ' LEU . 28.4 tp60 -138.51 75.47 1.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.114 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.32 -102.99 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.443 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -4.36 0.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.07 22.01 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 52.9 m -119.49 137.31 53.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.709 0.29 . . . . 0.0 111.153 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 118' ' ' PRO . 41.5 mt -110.97 140.71 28.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.151 178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 140' ' ' GLN . 2.2 mt -119.18 -16.23 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.05 137.57 15.94 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.164 -179.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . 51.2 p90 -139.82 130.94 26.42 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.66 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -128.66 145.7 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.344 179.198 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.841 HD11 ' CD1' ' A' ' 122' ' ' TYR . 2.9 mp -133.31 123.77 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.083 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.405 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -125.05 159.96 30.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.6 pm0 -99.01 149.03 23.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 132' ' ' LYS . 16.8 m -144.33 138.55 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.104 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.92 -47.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 t -60.3 119.99 8.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.11 179.98 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.848 0.356 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.13 -135.51 2.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.536 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -151.03 -168.02 2.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.76 96.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -61.23 95.19 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.253 179.471 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.014 HD22 HG21 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -86.63 118.75 26.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.422 0.63 . . . . 0.0 110.611 -179.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.4 m-85 -122.32 -178.86 4.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.687 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.991 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 23.9 p -127.12 166.26 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.314 -179.26 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.569 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.7 tt -156.31 109.2 2.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.761 HG21 HD22 ' A' ' 53' ' ' LEU . 1.2 p -108.56 125.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.477 0.656 . . . . 0.0 112.338 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.926 HD12 ' CH2' ' A' ' 123' ' ' TRP . 0.9 OUTLIER -126.66 112.74 15.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.17 178.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 88' ' ' THR . 21.8 t -80.34 75.44 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.231 0.538 . . . . 0.0 111.569 -178.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -99.48 117.82 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.697 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.538 ' N ' HD12 ' A' ' 13' ' ' LEU . 32.3 mt-30 -104.7 157.42 34.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.226 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.652 ' C ' HD13 ' A' ' 108' ' ' LEU . 36.2 Cg_endo -64.9 31.58 0.09 OUTLIER 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.575 2.183 . . . . 0.0 112.945 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLN . 12.5 pt20 -160.41 -40.53 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.716 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 161.37 38.18 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' A' ' 13' ' ' LEU . 2.8 p -131.82 156.95 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 105' ' ' TRP . 25.1 tp -121.4 117.53 27.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.428 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 33' ' ' ASN . 2.6 mt -115.8 159.11 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.518 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 108.48 3.09 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.558 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.572 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 5.6 ttm -98.71 143.03 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' C ' ' HA ' ' A' ' 29' ' ' ALA . 4.4 mmmt -82.98 142.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -33.66 13.62 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.242 -179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -167.84 -178.21 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 111.437 179.679 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.08 -137.41 14.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.042 -179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.13 59.43 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.815 0.341 . . . . 0.0 110.701 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 29' ' ' ALA . . . 179.71 -31.62 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.388 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -22.07 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.19 42.92 49.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 31' ' ' ARG . 16.2 mtm105 -146.18 110.55 5.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' MET . 2.1 m95 -73.02 153.97 40.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' N ' HD22 ' A' ' 20' ' ' LEU . 11.2 p30 178.3 149.39 0.21 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.942 0.401 . . . . 0.0 111.498 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.75 -164.55 2.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -117.24 89.31 3.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -86.9 157.12 29.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.103 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.31 -147.62 5.3 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -153.44 142.19 21.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 0.0 111.038 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HD22 ' A' ' 6' ' ' LEU . 1.3 t -89.35 99.09 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.747 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -53.93 169.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -55.12 91.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.28 48.47 2.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.583 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -126.06 172.71 9.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -110.81 139.56 46.01 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 6' ' ' LEU . 1.3 mp -52.43 -32.19 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.32 -178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 23.0 tt0 -74.72 -24.76 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.71 -39.36 20.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.82 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.15 -36.55 85.6 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.339 179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.47 -40.51 61.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CG ' HD12 ' A' ' 64' ' ' LEU . 22.7 mtt180 -67.65 -55.22 14.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.053 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -58.26 -36.51 73.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.153 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -84.34 -22.35 30.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.593 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 10' ' ' VAL . 18.6 tp -69.09 -50.11 51.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.677 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.832 ' HB2' HG23 ' A' ' 60' ' ' THR . 18.3 tt0 -61.29 -29.09 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.424 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -82.51 -22.72 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.482 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 1.6 mm-40 -77.84 -43.9 28.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -137.19 29.87 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.191 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.65 16.65 3.96 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.866 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 91' ' ' ILE . 29.1 mt -104.46 118.16 35.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.998 0.427 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -104.13 136.3 44.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.903 HG21 ' HG ' ' A' ' 64' ' ' LEU . 17.2 m -106.35 137.69 35.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.16 0.505 . . . . 0.0 111.905 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -79.73 -14.02 59.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.105 178.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 179.45 90.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.989 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.68 179.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.562 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 4.7 t60 -135.31 101.14 4.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.689 0.28 . . . . 0.0 111.102 179.052 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -64.27 134.23 54.31 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.083 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 127' ' ' LEU . 26.9 m -132.49 -47.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.642 -179.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -133.93 135.33 7.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.504 -179.222 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.6 114.45 28.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' A' ' 123' ' ' TRP . 15.1 mt -106.79 149.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.211 0.529 . . . . 0.0 111.629 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 136' ' ' TYR . 20.7 t -126.69 147.68 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.378 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 4.7 m-85 -127.66 118.18 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.457 -179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 5.6 tt0 -99.67 127.77 45.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -82.52 133.75 35.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG23 ' HE2' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -68.18 126.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.973 -179.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.58 21.34 64.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.721 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -131.86 142.15 44.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -44.14 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.538 2.158 . . . . 0.0 112.249 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.811 ' HG3' ' HB3' ' A' ' 3' ' ' ALA . 1.1 tt0 -59.51 169.38 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.247 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -149.11 -167.68 2.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.282 179.994 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 2.3 ttp -147.2 111.33 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.761 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 33.4 t0 -102.88 102.9 13.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.5 p -112.67 116.79 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 111.771 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.553 ' CB ' HG21 ' A' ' 45' ' ' ILE . 1.8 t60 -77.77 148.2 34.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 13.9 t -112.74 103.85 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 -179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.937 ' HB3' HD22 ' A' ' 64' ' ' LEU . 2.4 m-85 -98.98 151.13 21.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.851 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.6 m -137.03 117.44 13.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.103 HG22 HG22 ' A' ' 12' ' ' VAL . 6.4 t -98.13 -170.98 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.225 0.536 . . . . 0.0 111.829 -178.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -160.3 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.494 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.6 100.19 12.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.909 178.919 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 59' ' ' LEU . 43.5 pt -102.4 174.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.784 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -125.28 -70.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 0.0 111.836 -178.603 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.86 -159.41 2.4 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.923 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -95.69 176.64 2.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 94' ' ' THR . 31.8 Cg_endo -88.35 53.9 2.17 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.416 2.078 . . . . 0.0 108.903 178.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 96' ' ' VAL . 95.1 t -77.47 83.93 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.284 -178.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 3.2 mm-40 -60.88 -138.33 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.405 178.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 18.1 t -133.0 -177.43 4.5 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.851 0.358 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.21 -21.39 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.43 20.15 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.031 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.418 ' HE1' ' HG2' ' A' ' 23' ' ' LYS . 1.3 tpt -139.91 148.7 42.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.708 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 22' ' ' MET . 8.9 tpt180 -147.22 128.58 7.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.093 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' LEU . 67.3 Cg_endo -86.74 145.4 7.82 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.292 1.995 . . . . 0.0 112.465 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -135.73 119.5 17.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 179.609 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.771 ' CD1' HD13 ' A' ' 19' ' ' LEU . 12.7 m95 -91.68 105.06 17.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.917 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 104' ' ' CYS . 22.3 m-85 -118.42 -164.86 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -88.75 151.18 22.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 15' ' ' PRO . 1.5 pt? -70.01 -6.94 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.41 19.1 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 0.0 110.271 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -140.4 19.77 2.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.534 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.646 HG23 HG11 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -73.38 127.22 89.29 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.751 179.17 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -94.35 97.71 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.569 2.179 . . . . 0.0 113.168 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -82.22 -18.3 43.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.419 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 -32.73 74.48 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.85 30.68 4.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.885 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.674 ' HE1' ' CE1' ' A' ' 124' ' ' PHE . 1.2 ttm -126.67 -70.8 0.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -162.57 168.15 11.07 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 117' ' ' TRP . 84.2 Cg_endo -85.8 13.8 2.64 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.873 2.382 . . . . 0.0 113.342 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 1.2 p-10 -125.29 -23.1 4.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.849 0.357 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 53.1 m-20 -50.35 -53.69 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 8.7 t -57.02 -17.21 9.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 126' ' ' LEU . 9.5 m-85 -84.47 -32.63 23.9 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.926 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -108.91 -3.87 17.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.674 ' CE1' ' HE1' ' A' ' 116' ' ' MET . 2.1 m-85 -76.54 -51.09 2.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 111.017 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 73.9 Cg_exo -49.86 -35.11 38.96 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.97 2.446 . . . . 0.0 113.218 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -77.52 -33.34 54.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.548 HD11 ' CZ3' ' A' ' 123' ' ' TRP . 0.2 OUTLIER -59.31 -53.15 61.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.47 0.652 . . . . 0.0 109.647 178.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.1 -28.69 66.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.703 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 4.1 tp-100 -84.85 2.58 41.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.448 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 60.01 22.88 12.02 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.309 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -109.45 159.15 17.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.886 179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -110.64 125.88 53.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 126' ' ' LEU . 15.8 m-85 -134.08 164.04 28.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.084 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' NE2' HG23 ' A' ' 71' ' ' VAL . 7.2 t60 -125.4 125.16 42.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.964 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.81 133.81 9.6 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.403 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -111.91 110.77 21.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-85 -111.58 125.81 54.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 111.827 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.584 ' HE2' HG23 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -88.58 129.37 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.623 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 72' ' ' PHE . 24.3 m-85 -112.87 163.21 14.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.0 111.76 -178.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.734 ' CG ' HD21 ' A' ' 146' ' ' LEU . 10.3 mm-40 -84.42 -37.62 21.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.06 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.729 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -178.5 28.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -160.21 -47.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 111.265 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 15.6 m -81.63 137.97 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 118' ' ' PRO . 67.4 mt -110.03 138.27 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.257 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.734 HD21 ' CG ' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -118.41 -9.49 10.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.912 179.529 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -153.81 134.74 13.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.88 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.42 ' CD2' ' CZ ' ' A' ' 122' ' ' TYR . 22.2 p90 -139.08 130.08 26.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.581 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.486 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.13 145.51 50.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.349 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 122' ' ' TYR . 1.5 mp -133.23 121.8 23.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -124.37 160.0 29.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 1.4 pt-20 -100.19 148.06 25.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.58 138.99 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.24 36.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.7 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.136 -179.992 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.21 178.78 11.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.55 76.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.866 0.365 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -175.98 95.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 81' ' ' MET . 3.6 mmt85 -61.85 96.62 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.414 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 HG21 ' A' ' 39' ' ' VAL . 2.9 tt -86.41 118.27 25.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.484 -179.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.2 m-85 -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.096 -179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.95 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 20.4 p -126.31 167.53 15.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.704 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.3 tt -155.54 108.78 2.76 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 53' ' ' LEU . 1.5 p -109.99 124.27 66.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.452 0.644 . . . . 0.0 111.959 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.975 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.5 mt -127.14 112.89 15.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.37 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 88' ' ' THR . 10.2 t -82.58 96.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.992 0.425 . . . . 0.0 111.387 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.719 HD23 ' CZ ' ' A' ' 124' ' ' PHE . 0.1 OUTLIER -121.34 117.91 28.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.005 179.975 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 13' ' ' LEU . 8.0 mt-30 -101.58 157.15 34.23 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.215 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.34 30.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.478 2.119 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -160.59 -39.05 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 110.827 179.567 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -142.27 161.2 38.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.684 ' CG2' HD22 ' A' ' 13' ' ' LEU . 3.0 p -131.78 154.0 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' PRO . 26.2 tp -117.37 112.53 20.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -109.76 141.26 42.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.039 -179.694 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.23 127.63 9.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.706 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.531 ' HE3' ' CE3' ' A' ' 32' ' ' TRP . 29.0 ttm -112.92 142.63 45.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.252 . . . . 0.0 110.6 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -86.15 146.99 26.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.356 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -88.85 -34.2 17.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.957 0.408 . . . . 0.0 110.533 -179.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.865 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -168.16 138.66 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.862 179.634 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.59 -125.7 3.54 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.132 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -100.32 23.45 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.911 -0.17 . . . . 0.0 111.423 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -166.94 17.07 0.08 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.713 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.34 123.52 16.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.263 0.532 . . . . 0.0 110.91 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -14.1 60.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.775 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' MET . 22.2 mtt180 -97.4 154.53 17.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.669 0.235 . . . . 0.0 110.395 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.543 ' CB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -110.43 153.38 25.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.368 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 20' ' ' LEU . 5.8 t-20 -176.62 161.64 2.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.885 0.374 . . . . 0.0 111.231 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.94 -176.85 8.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.42 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.755 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.2 m-85 -111.67 91.52 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.313 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -92.78 170.24 31.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.901 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.54 145.31 8.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.317 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 6.2 pttm -77.22 143.31 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 0.0 111.182 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.943 HG21 HD22 ' A' ' 6' ' ' LEU . 16.2 t -75.49 112.65 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -45.65 169.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.51 65.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.181 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.74 42.38 0.45 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.113 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 39' ' ' VAL . 3.8 pt-20 -126.59 172.89 9.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -98.66 142.3 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.08 0.467 . . . . 0.0 111.127 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.746 HD13 HD21 ' A' ' 6' ' ' LEU . 3.4 mt -50.49 -33.57 11.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.002 -179.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -77.43 -24.61 50.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.057 179.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.44 -37.11 28.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.445 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.46 62.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.691 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.95 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.87 -41.81 51.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -74.68 -46.46 37.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -61.38 -37.16 82.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -84.14 -19.41 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.025 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 10' ' ' VAL . 17.1 tp -68.87 -48.31 63.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.439 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.853 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -60.78 -26.14 67.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.584 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -82.4 -21.93 35.6 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -77.52 -44.14 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.58 29.27 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.787 -179.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 54.25 16.43 6.58 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.555 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 19' ' ' LEU . 5.4 mt -104.24 104.41 14.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.353 0.597 . . . . 0.0 110.872 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -87.56 157.34 19.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 179.456 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -128.93 142.26 44.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.653 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.95 -21.73 43.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.238 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 179.01 99.26 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.805 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.885 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.5 mp -62.4 -174.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -135.11 101.22 4.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.671 179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 12.9 pttm -63.18 134.97 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 127' ' ' LEU . 36.0 m -126.14 -47.82 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.149 -179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -143.22 170.88 25.26 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.927 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 26.3 mt-30 -131.59 114.4 14.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.868 0.366 . . . . 0.0 110.543 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 123' ' ' TRP . 16.4 mt -100.64 145.7 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.793 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 49.3 t -129.12 147.16 33.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 81' ' ' MET . 19.3 m-85 -121.26 126.1 48.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.561 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 5.5 tt0 -121.47 121.74 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.246 179.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 76.3 t80 -82.19 138.84 34.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.492 . . . . 0.0 110.506 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.938 HG21 HD12 ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.91 114.92 23.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.701 -179.854 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -20.42 33.43 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.982 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.46 ' CG ' ' CD2' ' A' ' 74' ' ' PHE . 10.2 mm-40 -117.47 152.41 49.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 111.111 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.53 -43.84 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.05 156.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.061 0.457 . . . . 0.0 111.457 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -146.01 -167.29 2.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.349 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -144.0 111.57 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.746 179.133 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 36.2 t0 -100.95 102.04 12.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 83' ' ' VAL . 13.7 p -116.17 116.74 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.965 0.412 . . . . 0.0 112.037 -178.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.597 ' HB2' HG21 ' A' ' 45' ' ' ILE . 5.6 t-80 -75.13 154.55 37.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.878 HG11 ' CE3' ' A' ' 123' ' ' TRP . 55.4 t -116.95 106.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 0.0 110.798 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -104.93 150.63 24.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.145 -179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.2 m -136.85 117.11 13.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.059 HG22 HG22 ' A' ' 12' ' ' VAL . 3.3 t -98.45 -173.67 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.272 0.558 . . . . 0.0 111.867 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -160.18 -44.89 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.595 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.07 98.95 10.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.874 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' THR . 46.0 pt -103.0 178.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.279 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -143.17 -59.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -55.15 -168.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -120.07 149.75 49.72 Favored Pre-proline 0 CA--C 1.518 -0.277 0 CA-C-O 120.71 0.29 . . . . 0.0 111.58 -179.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 94' ' ' THR . 42.3 Cg_endo -73.51 65.31 4.63 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.757 1.638 . . . . 0.0 109.011 178.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 94' ' ' THR . 2.7 t -76.16 64.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.643 -178.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.2 pt-20 -43.86 111.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.858 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.37 -172.92 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.73 -7.37 50.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 -179.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' NH1' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.64 -24.48 7.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.61 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.36 163.98 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.428 . . . . 0.0 111.245 -179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 67.9 ttt180 -170.59 97.15 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.594 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.775 ' HB2' HD11 ' A' ' 19' ' ' LEU . 72.7 Cg_endo -74.59 160.15 41.7 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.457 2.105 . . . . 0.0 112.48 -179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -145.12 126.23 14.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.73 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.774 ' CD1' HD13 ' A' ' 19' ' ' LEU . 6.9 m95 -93.4 118.68 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 104' ' ' CYS . 21.4 m-85 -133.53 -166.98 1.86 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' VAL . 9.8 mt-30 -84.32 165.04 18.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 13' ' ' LEU . 2.0 pt? -89.24 9.63 25.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.474 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.37 24.56 7.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.873 0.368 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -152.25 22.12 0.65 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.807 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -73.37 128.11 87.89 Favored Pre-proline 0 N--CA 1.465 0.279 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.056 179.16 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.7 98.83 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.553 2.169 . . . . 0.0 112.747 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -81.84 -18.12 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.074 179.69 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -64.09 -27.08 68.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.36 28.21 5.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.406 179.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 20' ' ' LEU . 33.9 mtm -124.79 -76.28 0.59 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.101 -179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -160.53 171.45 7.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.981 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 145' ' ' ILE . 78.2 Cg_endo -83.34 18.4 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.033 2.489 . . . . 0.0 113.156 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 145' ' ' ILE . 12.2 m-20 -129.82 -28.1 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.751 0.31 . . . . 0.0 111.417 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.631 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 36.5 m-20 -43.79 -56.13 4.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 125' ' ' PRO . 7.5 t -58.68 -17.48 22.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -85.34 -26.14 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.975 ' CH2' HD12 ' A' ' 11' ' ' LEU . 66.4 p-90 -114.92 -18.79 11.19 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.818 ' CE1' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.17 -48.83 47.41 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.431 -179.808 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 124' ' ' PHE . 50.1 Cg_exo -53.44 -34.36 71.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.269 1.979 . . . . 0.0 112.377 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.81 HD13 ' CG ' ' A' ' 133' ' ' PHE . 3.8 mt -76.42 -31.24 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -62.6 -50.44 71.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.698 179.025 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.39 -26.14 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 1.2 mp0 -83.04 3.08 31.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.247 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 55.33 35.79 25.69 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.973 0.416 . . . . 0.0 111.223 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.21 153.57 32.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.567 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -107.55 131.22 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CG ' HD13 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -149.31 171.02 17.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 111.148 -179.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.624 ' NE2' HG11 ' A' ' 153' ' ' VAL . 3.8 m-70 -132.22 125.12 30.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.616 179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -114.06 135.74 12.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.059 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.793 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 7.2 m-85 -115.59 114.07 24.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.591 ' CE1' HG23 ' A' ' 70' ' ' ILE . 28.3 m-85 -112.92 129.25 56.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.653 -179.203 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.728 ' CE ' HG13 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -88.48 121.69 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 74' ' ' PHE . 8.6 p90 -103.12 157.23 17.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.36 0.6 . . . . 0.0 112.41 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.921 ' HB2' HD11 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -107.21 7.46 29.45 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.767 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.39 -52.59 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.75 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.37 -19.79 11.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.391 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.701 HG21 ' CD ' ' A' ' 140' ' ' GLN . 18.5 m -94.52 131.22 40.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.035 0.445 . . . . 0.0 111.405 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 118' ' ' PRO . 50.1 mt -110.17 133.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.822 178.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 75' ' ' VAL . 9.9 mt -114.23 -10.75 12.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.495 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.07 138.97 17.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.689 179.742 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.429 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 42.1 p90 -139.13 132.42 29.96 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.483 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.494 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -128.63 144.94 51.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.202 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.684 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.9 mp -133.95 123.29 24.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.807 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -127.52 119.84 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.6 141.13 32.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.624 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.4 m -124.24 174.9 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.19 37.16 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 155' ' ' THR . 7.8 t -77.66 92.68 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.127 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.861 0.362 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.89 158.76 8.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.44 -172.08 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p 55.28 87.25 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.105 0.478 . . . . 0.0 111.251 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.75 96.16 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.987 HD22 HG21 ' A' ' 39' ' ' VAL . 1.8 tt -86.72 116.5 24.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 8.5 m-85 -122.61 -178.83 4.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.825 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 70.5 p -128.69 168.42 15.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 9' ' ' LEU . 3.5 tt -156.02 108.74 2.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.871 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.764 HG21 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 112.247 -179.406 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.807 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.1 mt -127.03 112.54 15.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.262 178.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 88' ' ' THR . 12.6 t -75.94 96.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.945 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -120.27 118.05 29.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.717 -179.213 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 16' ' ' GLN . 4.4 mp0 -105.17 157.18 34.88 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' C ' HD13 ' A' ' 108' ' ' LEU . 31.7 Cg_endo -63.99 28.03 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.397 2.065 . . . . 0.0 113.446 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' N ' HD13 ' A' ' 108' ' ' LEU . 1.1 pt20 -160.74 -34.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.657 0.265 . . . . 0.0 111.284 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 106' ' ' PHE . 12.1 mtt85 -140.11 161.51 37.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.778 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 1.5 p -140.02 155.89 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.756 0.313 . . . . 0.0 110.801 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD1' ' CD1' ' A' ' 105' ' ' TRP . 13.5 tp -113.92 123.55 50.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.721 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.722 HD11 HG22 ' A' ' 111' ' ' ILE . 3.1 mt -117.52 135.68 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.4 115.96 4.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.594 ' HE1' ' CE2' ' A' ' 32' ' ' TRP . 7.8 ttm -102.24 142.26 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.638 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -88.26 147.21 24.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.243 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -40.56 8.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.339 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.515 ' HD2' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -141.97 -173.97 3.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 111.082 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 -144.69 17.38 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.929 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.43 25.26 7.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.524 0.202 . . . . 0.0 111.253 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -173.93 35.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.544 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' ARG . . . -41.09 -91.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.006 0.403 . . . . 0.0 110.994 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.67 76.84 0.01 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.515 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 2.7 ttm180 -157.75 124.47 4.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.727 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -86.1 153.09 22.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.657 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -179.83 151.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.82 -176.09 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.203 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -109.8 92.99 4.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.891 0.377 . . . . 0.0 110.38 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . -95.36 157.36 21.92 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.011 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.63 150.37 21.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.274 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -82.68 146.86 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.987 HG21 HD22 ' A' ' 6' ' ' LEU . 4.9 t -75.42 109.84 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' GLY . 21.8 mm-40 -45.14 168.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.423 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -63.57 76.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . 104.45 45.78 1.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.03 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 2.6 pt-20 -126.63 172.99 9.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -99.19 143.3 29.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.791 HG12 HD21 ' A' ' 6' ' ' LEU . 2.5 mp -50.67 -33.49 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.88 -27.12 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.26 -37.84 27.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.09 -36.76 72.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.411 179.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.825 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -75.43 -33.14 60.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HG2' HD11 ' A' ' 64' ' ' LEU . 47.5 mtt180 -74.87 -54.11 7.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.959 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -34.33 74.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.254 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -84.3 -20.17 32.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.642 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD22 HG21 ' A' ' 10' ' ' VAL . 17.8 tp -71.35 -47.59 55.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HB2' HG23 ' A' ' 60' ' ' THR . 17.7 tt0 -62.61 -26.34 68.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -82.61 -21.83 35.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -80.36 -43.93 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -132.02 22.31 4.53 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.836 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.81 13.51 8.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.525 -179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 91' ' ' ILE . 11.5 mt -106.15 109.33 21.24 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.21 0.529 . . . . 0.0 110.75 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.857 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -89.13 156.33 18.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.642 179.463 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.891 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.0 m -124.97 141.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 111.851 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.9 t70 -79.93 -21.4 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.137 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.73 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.692 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.891 ' HG ' HG21 ' A' ' 61' ' ' VAL . 1.4 mp -59.86 -173.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -134.88 101.16 4.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.805 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 8.3 pttt -65.53 134.79 54.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 127' ' ' LEU . 34.7 m -133.21 -46.96 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.614 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -131.23 157.77 22.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.282 -179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 41.7 mt-30 -125.31 114.28 18.71 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 123' ' ' TRP . 63.1 mt -103.92 147.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.635 -179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 t -128.56 146.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.408 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' CE2' ' CE1' ' A' ' 139' ' ' PHE . 4.1 m-85 -124.06 118.04 26.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.8 119.18 38.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.255 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -83.72 133.47 34.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.196 0.522 . . . . 0.0 110.955 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -80.78 107.22 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.713 -179.732 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.17 -19.44 46.1 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.202 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -106.27 117.65 56.76 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.55 0.215 . . . . 0.0 110.751 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 -45.54 33.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.437 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.645 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.2 tt0 -58.78 172.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -148.66 -165.11 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.232 -179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.7 ttp -147.14 111.4 5.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.741 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 11.3 t0 -103.63 102.88 12.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.198 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.9 p -113.04 116.89 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.918 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 45' ' ' ILE . 4.3 t-80 -73.93 154.61 39.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG11 ' CE3' ' A' ' 123' ' ' TRP . 60.2 t -117.01 103.72 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 0.0 110.475 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 66' ' ' LYS . 14.7 m-85 -104.2 151.17 23.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 19.1 p -136.71 117.58 14.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.056 HG22 HG22 ' A' ' 12' ' ' VAL . 1.8 t -98.13 -173.87 2.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.283 0.564 . . . . 0.0 111.894 -178.212 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.19 -45.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.676 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 98.98 10.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.02 179.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 60' ' ' THR . 45.2 pt -103.18 178.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -134.9 -66.18 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.066 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.94 -172.2 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.664 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -115.17 162.45 24.26 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.36 0.124 . . . . 0.0 111.111 -179.54 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 94' ' ' THR . 21.4 Cg_exo -65.86 64.37 0.43 Allowed 'Trans proline' 0 CA--C 1.508 -0.795 0 C-N-CA 122.558 2.172 . . . . 0.0 109.732 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 94' ' ' THR . 11.9 t -76.81 59.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.496 -178.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 3.9 pt-20 -45.1 119.0 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.6 p -87.32 -179.23 6.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.63 -10.6 58.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.541 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -115.36 -29.56 6.52 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 111.439 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.25 155.51 21.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' MET . 20.6 ttt-85 -155.7 95.58 2.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.351 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 64.8 Cg_endo -71.2 139.9 36.27 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.509 2.14 . . . . 0.0 112.356 -179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.03 120.46 24.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.438 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 8.7 m95 -88.85 127.49 35.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.105 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.962 ' CE2' HG23 ' A' ' 111' ' ' ILE . 2.0 p90 -150.6 -173.98 4.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.634 -179.019 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 1.8 tt0 -81.99 167.37 18.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 111.419 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -94.25 18.45 10.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.604 -179.672 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -126.99 27.27 5.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -159.94 25.5 0.18 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.835 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.962 HG23 ' CE2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -73.02 125.3 91.14 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.295 179.344 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 45.7 Cg_endo -94.25 98.16 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.581 2.188 . . . . 0.0 112.365 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -81.36 -18.1 46.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -64.67 -25.21 67.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.47 28.85 7.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.313 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 7.2 mtp -127.84 -80.91 0.59 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' HB2' ' OD2' ' A' ' 120' ' ' ASP . 76.3 m95 -151.2 161.8 28.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 145' ' ' ILE . 89.7 Cg_endo -80.42 12.89 2.4 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.636 2.224 . . . . 0.0 113.037 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . 1.8 p30 -123.87 -21.5 5.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.733 0.302 . . . . 0.0 111.421 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.573 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 35.6 m-20 -46.5 -59.37 3.02 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -17.54 5.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 150' ' ' LEU . 7.8 m-85 -84.95 -23.23 28.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.902 ' CE3' HG11 ' A' ' 85' ' ' VAL . 69.5 p-90 -120.29 -12.21 9.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.66 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 0.0 OUTLIER -76.34 -41.7 3.1 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 19.6 Cg_endo -59.6 -32.73 96.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.912 1.741 . . . . 0.0 113.004 -179.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' A' ' 133' ' ' PHE . 1.5 pp -79.35 -30.95 42.89 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -57.53 -53.28 59.95 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.244 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -25.66 23.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.671 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.0 tp-100 -88.13 2.56 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER 59.02 27.5 16.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 111.412 179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -112.16 153.53 26.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 153' ' ' VAL . 1.7 mtpt -101.46 125.08 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' HD22 ' A' ' 126' ' ' LEU . 12.8 m-85 -136.05 158.05 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.877 ' NE2' HG11 ' A' ' 153' ' ' VAL . 4.5 m-70 -119.03 125.05 48.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.923 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -116.56 130.17 8.83 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.184 -179.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 71' ' ' VAL . 3.0 m-85 -113.67 110.74 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.149 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 119' ' ' ASP . 12.7 m-85 -110.08 127.85 55.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 111.943 -178.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.529 ' HE2' HG13 ' A' ' 75' ' ' VAL . 3.4 tttt -88.59 121.28 30.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.638 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.7 m-85 -103.79 145.93 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.168 0.509 . . . . 0.0 112.09 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.731 ' HB2' HD11 ' A' ' 146' ' ' LEU . 2.0 tp-100 -79.9 -7.13 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.616 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.72 -44.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 175.74 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.512 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -114.59 -31.22 6.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.534 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 140' ' ' GLN . 16.2 m -84.03 134.53 34.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.741 0.305 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 118' ' ' PRO . 53.3 mt -110.09 132.23 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.073 178.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 140' ' ' GLN . 3.9 mt -113.54 -11.63 13.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.48 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -153.89 139.2 17.56 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.962 -179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.455 ' CD2' ' CE1' ' A' ' 122' ' ' TYR . 50.3 p90 -139.2 130.88 27.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.321 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.488 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -125.9 146.48 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.558 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 122' ' ' TYR . 3.1 mp -133.69 122.87 24.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 133' ' ' PHE . 2.1 mmp_? -124.87 160.02 29.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 9.0 pt-20 -107.2 149.71 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.877 HG11 ' NE2' ' A' ' 134' ' ' HIS . 17.2 m -145.47 141.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.074 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.19 -53.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.998 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.23 143.44 48.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.97 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.798 0.333 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.19 46.33 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -152.78 95.86 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -177.36 100.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.038 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -57.36 93.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.24 179.587 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 45' ' ' ILE . 1.4 tt -86.93 113.71 22.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.356 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 18.3 m-30 -122.27 -178.7 3.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.837 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 49' ' ' ALA . 17.3 p -122.49 166.26 15.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.52 . . . . 0.0 111.566 -179.134 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 9' ' ' LEU . 2.2 tt -151.31 109.12 3.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.005 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 HD22 ' A' ' 53' ' ' LEU . 1.8 p -113.48 127.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.526 0.679 . . . . 0.0 112.563 -179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.906 HD12 ' CH2' ' A' ' 123' ' ' TRP . 1.3 mt -127.31 112.59 15.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.885 178.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HG22 ' A' ' 88' ' ' THR . 8.8 t -85.11 93.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.173 0.511 . . . . 0.0 111.384 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -102.63 120.09 39.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.328 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' O ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.32 157.92 55.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 178.949 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.16 18.61 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.471 2.114 . . . . 0.0 113.848 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' GLN . 13.6 mt-30 -161.05 -40.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.879 0.371 . . . . 0.0 110.61 179.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -120.72 161.0 22.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.29 179.61 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.817 ' HB ' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -124.85 152.79 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 103' ' ' PRO . 16.4 tp -112.32 116.93 31.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.948 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 5.7 mt -120.66 133.55 55.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.15 119.65 4.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.155 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 40.5 ttm -113.62 142.04 46.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.674 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 2.0 mtpt -87.81 146.78 25.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -89.69 -30.9 17.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.48 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.8 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -170.21 127.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 179.114 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.69 -123.46 1.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.411 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.12 23.66 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.651 0.262 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -174.93 26.26 0.07 OUTLIER Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.306 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB2' ' HA ' ' A' ' 25' ' ' ARG . . . -58.23 144.02 42.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.858 0.329 . . . . 0.0 110.89 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.1 19.71 46.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.872 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.1 mtt85 -127.72 134.93 49.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.536 0.208 . . . . 0.0 110.518 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' MET . 0.0 OUTLIER -93.46 153.43 18.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.324 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 116' ' ' MET . 5.3 p30 -175.83 150.44 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 173.87 2.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 m-85 -105.28 93.99 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.44 9.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.507 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.32 -102.75 1.92 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.345 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.45 150.66 7.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.822 HG21 HD22 ' A' ' 6' ' ' LEU . 3.5 t -85.69 114.63 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -45.91 171.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.393 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.02 65.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.059 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 39' ' ' VAL . 3.6 pt-20 -126.57 173.12 9.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.1 p -101.03 142.44 32.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.503 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.925 HD11 HD21 ' A' ' 6' ' ' LEU . 3.7 mt -48.34 -32.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 86' ' ' PHE . 28.8 tt0 -74.69 -33.89 62.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 109.758 179.291 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -33.54 60.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.958 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.11 -31.57 28.24 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.423 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.886 ' HB2' ' HB ' ' A' ' 8' ' ' THR . . . -74.37 -34.45 63.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.311 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -78.81 -49.45 12.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -61.62 -34.83 76.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -84.07 -20.99 31.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.144 179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 10' ' ' VAL . 16.1 tp -69.2 -49.28 58.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.527 179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.872 ' HB2' HG23 ' A' ' 60' ' ' THR . 14.9 tt0 -57.86 -26.09 61.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.723 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.48 -22.79 35.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -78.04 -44.11 27.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -134.5 24.93 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.887 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 93' ' ' GLY . . . 57.09 13.53 9.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD12 ' CD2' ' A' ' 19' ' ' LEU . 11.8 mt -104.63 111.65 24.42 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.829 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.872 HG23 ' HB2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -94.47 150.67 20.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.983 179.541 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.849 HG21 ' HG ' ' A' ' 64' ' ' LEU . 27.6 m -117.33 139.92 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.069 0.462 . . . . 0.0 111.869 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 5.0 t0 -79.83 -17.9 52.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.187 178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' ASP . . . 178.35 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.869 HD22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -60.04 -177.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.117 178.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.02 101.21 4.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 15.1 ptmt -59.82 131.43 50.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 127' ' ' LEU . 21.7 m -120.41 -49.47 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.976 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -147.53 173.97 27.45 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.222 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HB3' ' ND1' ' A' ' 134' ' ' HIS . 4.5 tt0 -131.55 116.74 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' CG ' ' A' ' 123' ' ' TRP . 13.8 mt -103.23 149.66 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.095 0.474 . . . . 0.0 111.166 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 136' ' ' TYR . 19.9 t -129.18 149.22 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.647 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' ' CE1' ' A' ' 139' ' ' PHE . 5.3 m-85 -128.1 120.15 26.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 111.216 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.2 tt0 -103.15 110.69 22.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.52 126.91 32.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.753 0.787 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 139' ' ' PHE . 4.2 t -90.08 3.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.073 -179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -121.28 -0.11 11.42 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.871 178.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -137.5 151.58 71.37 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.1 -27.99 11.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.509 2.139 . . . . 0.0 112.293 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 1.2 mt-10 -83.4 -169.42 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.281 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -147.02 -166.38 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.162 -179.978 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.9 ttp -147.09 111.42 5.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.74 0.305 . . . . 0.0 110.809 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 8.7 t70 -104.67 102.6 12.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.835 0.35 . . . . 0.0 110.385 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 83' ' ' VAL . 14.0 p -110.71 116.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 111.452 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.84 ' CB ' HG21 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -78.08 162.68 26.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.557 179.037 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.823 HG11 ' CE3' ' A' ' 123' ' ' TRP . 38.6 t -116.81 135.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.586 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.869 ' HB3' HD22 ' A' ' 64' ' ' LEU . 1.3 m-85 -135.15 134.49 40.24 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.939 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 41.9 t -122.28 117.64 26.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.97 HG22 HG22 ' A' ' 12' ' ' VAL . 10.7 t -100.1 -172.46 2.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.127 0.489 . . . . 0.0 111.576 -178.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -160.31 -44.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.667 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.26 99.73 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.868 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 60' ' ' THR . 49.4 pt -102.77 178.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 -65.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.281 -179.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -57.97 -163.05 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.648 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -125.58 158.26 65.39 Favored Pre-proline 0 CA--C 1.513 -0.444 0 CA-C-O 120.508 0.194 . . . . 0.0 111.479 -179.434 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 94' ' ' THR . 17.3 Cg_exo -67.11 65.75 0.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.49 2.126 . . . . 0.0 109.309 178.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 94' ' ' THR . 2.5 t -76.33 61.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.653 -178.156 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 2.8 pt-20 -48.19 113.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 t -87.43 -176.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -11.63 61.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -110.14 -38.45 5.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.706 0.289 . . . . 0.0 111.216 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -109.22 161.92 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.212 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 22' ' ' MET . 12.8 ttt180 -168.78 100.35 0.52 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.539 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.793 ' HB2' HD11 ' A' ' 19' ' ' LEU . 61.1 Cg_endo -71.11 156.26 59.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.298 1.999 . . . . 0.0 112.05 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 21.4 m -138.14 119.48 14.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.625 ' CD1' HD13 ' A' ' 19' ' ' LEU . 9.2 m95 -83.6 98.96 9.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -160.7 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.253 -179.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 18' ' ' VAL . 37.5 mt-30 -106.21 167.84 9.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.893 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 13' ' ' LEU . 3.6 mt -82.24 -18.99 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.403 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.12 20.64 16.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.217 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -145.74 18.11 1.46 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.97 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.615 ' HB ' ' HE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -73.65 126.12 89.97 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.805 178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -93.77 98.04 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.574 2.183 . . . . 0.0 113.639 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.615 ' HE1' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -76.84 -18.09 58.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.949 179.314 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -66.38 -29.34 69.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.16 29.34 4.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.166 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' TRP . 6.9 mtp -131.26 -80.25 0.52 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.146 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 15.5 m95 -155.63 161.78 28.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.935 -179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 145' ' ' ILE . 76.5 Cg_endo -78.33 11.56 2.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.714 2.276 . . . . 0.0 112.956 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.424 ' HA ' ' CD2' ' A' ' 122' ' ' TYR . 1.3 p30 -123.01 -22.25 5.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.628 0.251 . . . . 0.0 111.574 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.62 ' HA ' ' NE1' ' A' ' 123' ' ' TRP . 12.4 m-20 -50.68 -46.58 58.77 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 113' ' ' PHE . 1.2 m -60.56 -17.25 44.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.572 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 119' ' ' ASP . 20.8 m-85 -84.84 -39.93 17.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.906 ' CH2' HD12 ' A' ' 11' ' ' LEU . 56.9 p-90 -101.69 -2.53 30.06 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.623 ' N ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 m-85 -76.24 -49.7 3.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 124' ' ' PHE . 9.9 Cg_endo -54.35 -31.46 67.73 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.4 2.067 . . . . 0.0 113.327 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 ' HA ' ' A' ' 123' ' ' TRP . 0.3 OUTLIER -79.69 -33.76 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.0 110.089 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.601 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -60.24 -55.46 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.489 0.661 . . . . 0.0 109.575 178.827 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 108' ' ' LEU . 2.6 mt -61.06 -28.02 68.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.856 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 7.4 tp60 -84.04 2.51 38.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 0.1 OUTLIER 58.9 21.21 8.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.265 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 159.21 17.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 70.6 mttt -107.54 133.98 51.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.715 ' HB2' HD22 ' A' ' 126' ' ' LEU . 27.5 m-85 -143.92 159.42 42.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.047 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.701 ' CD2' HG11 ' A' ' 153' ' ' VAL . 11.7 m170 -121.4 125.25 46.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.802 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 149' ' ' THR . . . -121.69 133.3 9.38 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 119.943 -1.123 . . . . 0.0 113.396 -179.157 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CE1' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.71 110.74 20.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.33 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 70' ' ' ILE . 5.1 m-85 -111.17 124.2 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 0.0 111.758 -178.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HE3' HG21 ' A' ' 75' ' ' VAL . 15.7 ttpt -88.68 120.91 30.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 75' ' ' VAL . 20.6 m-85 -103.35 153.28 20.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.762 0.315 . . . . 0.0 111.32 -179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.664 ' OE1' HG21 ' A' ' 144' ' ' THR . 4.5 pt20 -79.85 -26.95 40.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.05 0.452 . . . . 0.0 110.412 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.3 -65.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.957 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -170.68 24.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.457 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.34 -43.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.781 0.324 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.664 HG21 ' OE1' ' A' ' 140' ' ' GLN . 14.9 m -81.48 137.98 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 118' ' ' PRO . 65.8 mt -110.07 134.79 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.281 179.024 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.98 -8.37 11.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.706 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -154.11 134.46 13.38 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.887 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -139.11 131.12 27.88 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -128.39 144.69 51.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.35 121.85 22.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -123.71 158.84 30.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 133' ' ' PHE . 0.3 OUTLIER -101.61 149.4 24.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 134' ' ' HIS . 27.7 m -144.34 141.96 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -176.54 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 36.4 m -66.48 90.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.105 179.96 . . . . . . . . 0 0 . 1 stop_ save_